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EXAMINATION OF NUCLEUS ACCUMBENS MECHANISMS UNDERLYING THE 
MOTIVATION FOR PHYSICAL ACTIVITY 
by 
Gregory N. Ruegsegger 
Dr. Frank Booth, Dissertation Supervisor 
ABSTRACT 
Physical inactivity, a primary contributor to numerous diseases including obesity, 
type 2 diabetes, depression, and dementia, has reached pandemic levels worldwide. 
Alarmingly, the percentage of individuals engaging in physical activity is low and 
decreasing. Accelerometry data shows that > 90% of adults fail to meet the U.S. Physical 
Activity Guidelines despite the excess of knowledge suggesting exercise improves health. 
Therefore, beginning to understand the molecular mechanisms which influence physical 
activity levels is imperative for the development of therapies to reduce sedentary 
behavior. The work presented in this dissertation made use of three independent 
experimental paradigms in rats to test the hypothesis that differences in the mesolimbic 
dopamine system associate with/cause changes in voluntary physical activity. In the first 
study, rats selectively bred for high (HVR) or low (LVR) voluntary wheel running 
distance were used to assess inherent differences in opioidergic signaling between HVR 
and LVR, as well as the influence of dopamine on opioid-induced changes in voluntary 
wheel running. Mu-opioid receptor expression and function was increased in the nucleus 
accumbens (NAc) of HVR compared to LVR. Likewise, naltrexone injection decreased 
dopamine-related mRNA expression in mesolimbic brain regions and reduced wheel 
running in HVR, but not LVR. Finally, lesion of dopaminergic neurons in the NAc 
xv 
 
prevented the decrease in running following naltrexone administration in HVR, 
suggesting opioidergic signaling requires downstream dopaminergic activity to influence 
voluntary running. In the second study, the transgenerational effect of maternal Western 
diet (WD) on offspring voluntary wheel running was assessed. Wheel running was 
increased in female WD offspring from 4-7 weeks of age, but decreased running from 16-
19 weeks of age, compared to offspring from chow fed dams. These age-specific changes 
in wheel running are associated with the up- and down-regulation of dopamine receptor 1 
in the NAc at 6 and 18 weeks of age, respectively, in WD female offspring, which in turn 
was negatively associated with leptin receptor mRNA in the ventral tegmental area. In the 
third study, age-related influences on wheel running were assessed in 8 and 14 week-old 
rats. In addition to a ~60% reduction in running, RNA-sequencing revealed down-
regulations in networks related to cAMP-mediated signaling and synaptic plasticity in the 
NAc from 8 to 14 weeks-old. The down-regulations of these networks was mirrored by 
reductions in dendritic spine density in the NAc from 8 to 14 weeks-old. Additionally, 
intra-NAc injection of the Cdk5 inhibitor roscovitine, a known modulator of dendritic 
density and dopamine signaling, dose-dependently decreased wheel running. Despite the 
varying experimental models used in this dissertation, these findings collectively suggest 
that alterations in dopaminergic signaling in the NAc associate with, and influence, 
voluntary physical activity.  
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CHAPTER 1: Introduction 
 
Physical inactivity is a major cause of chronic diseases 
In the 5th century BC, the ancient physician Hippocrates stated: “All parts of the 
body, if used in moderation and exercised in labors to which each is accustomed, become 
thereby healthy and well developed and age slowly; but if they are unused and left idle, 
they become liable to disease, defective in growth and age quickly.” However, by the 21st 
century, the value of physical activity for health has drastically declined. 
Physical inactivity has reached pandemic levels in the United States and now 
presents a major public health problem. In 1993, McGinnis & Foege (McGinnis and 
Foege, 1993) first classified physical inactivity as a cause of chronic diseases and death. 
Strong evidence shows that physical inactivity is associated with at least 35 chronic 
diseases, including major non-communicable diseases such as type 2 diabetes (T2D) and 
coronary heart disease (CHD), and premature mortality (Booth et al., 2012). Predictions 
by Lee et al. (Lee et al., 2012) suggest that physical inactivity is responsible for between 
6-10% of T2D, CHD, and breast and colon cancer prevalence, and this percentage is 
further elevated for specific diseases  (i.e. 30% for ischemic heart disease) (WHO, 2010). 
Collectively, these striking findings recently led the World Health Organization to 
declare physical inactivity as the fourth leading risk factor for death worldwide, 
responsible for ~6% of the deaths worldwide in 2008 (Lee et al., 2012; WHO, 2010). 
These are dumbfounding numbers and, in my opinion, are mostly unnoticed since chronic 
diseases associated with physical inactivity are non-communicable. For example, I 
speculated that the ~6 million deaths caused by physical inactivity each year are much 
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less publicized than the 11,315 tragic deaths from Ebola virus disease up to January, 
2016.  
Remarkably, the elimination of physical inactivity may be expected to increase 
life expectancy of the world’s population by 0.68 years, making inactivity a risk factor 
comparable to well established risk factors such as smoking and obesity (Lee et al., 
2012). For comparison, smoking reduces life expectancy by ~10 years, while extreme 
class II obesity (BMI > 35) with no physical activity is associated with 7.2 fewer years of 
life compared to the normal weight group with > 7.5 MET-hr/wk (Moore et al., 2012). In 
the same study of ~650,000 individuals, brisk walking for 75 min/wk or 450 min/wk was 
associated with gains in life expectancy of 1.8 and 4.5 years, respectively, relative to 0-
MET hr/wk (Moore et al., 2012). Additionally, the associated morbidity caused by 
physical inactivity, including health-related quality of life as well as direct and indirect 
economic costs, equates to $154 to $419 per person in the United States (Chenoweth and 
Leutzinger, 2006). In view of its prevalence and global reach, strategies to reduce the 
pandemic levels of physical inactivity must be undertaken to lessen its far-reaching 
economic, social, and environmental consequences. 
 
The majority of individuals are not physically active despite believing exercise is good 
for health 
Published in 1953, Jeremy Morris conducted the first rigorous, epidemiological 
studies investigating physical inactivity and chronic disease risk (Morris et al., 1953). 
Since this pioneering report, many studies have documented health benefits of physical 
activity. Despite this knowledge, a Report from the U.S. Department of Health & Human 
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Services states that most adults and many children lead relatively sedentary lifestyles and 
are not active enough to achieve the health benefits of exercise despite the well-known 
benefits of physical activity (US Dept. of Health and Human Services, 2008). 
Alarmingly, the percentage of Americans engaging in physical activity is low and 
decreasing. Troiano et al. (Troiano et al., 2008) reported that 42% of children ages 6-11 
years obtain the recommended U.S. government guidelines of 60 min/day of physical 
activity, whereas only 8% of adolescents (12- 17 years old) achieve this goal, as shown in 
Figure 1.1. In addition, adherence among adults is <5% in meeting the U.S. guidelines of 
obtaining 30 min/day of physical activity. From these data, it can be concluded that 88% 
of the total United States population (or roughly 282 out the 319-million-person 
population of the United States in 2014) do not meet governmental standards for physical 
activity. In addition, limited available questionnaire data suggests that 31% of the world’s 
population in 2009 did not obtain the minimum recommended levels of physical activity 
(Hallal et al., 2012). 
In light of these statistics, many investigators feel that the identification of genetic 
and/or orally active agents that mimic the effects of endurance exercise is a longstanding 
medical goal (Narkar et al., 2008). However, the expert opinion of Hawley et al. (Hawley 
et al., 2014) suggests that “finding ways to motivate people to adapt and maintain a 
physically active lifestyle will have a greater impact than searching for potential 
pharmacological treatments.” Together, the above opinions suggest more significant 
efforts should be made to understand the neuromolecular mechanisms which control the 
motivation to be physically active. 
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Physical activity levels decline during juvenile and adolescent life 
 The level of physical activity achieved at any point in the lifespan is the 
combination of a complex interaction among genetic, biological, psychological, and 
environmental factors. Several studies support the notion that physical activity levels 
begin to fall during adolescence. As stated above, Troiano et al. (Troiano et al., 2008) 
reported a ~34% decline in physical activity between 6-11 and 12-17 years of age. A 
2002 accelerometer study by Trost et al. (Trost et al., 2002) observed a 40% decline in 
time spent performing moderate-vigorous physical activity going from the groupings 1st-
3rd grades to 4th-to 6th grade, with ~9 years of age serving as the chronological age 
transition between groups. Additionally, the age at which the average amount of physical 
activity was below U.S. Physical Activity Guidelines occurred at ~15-16 years for both 
 
Figure 1.1. Physical activity adherence in the United States. Accelerometry data 
collected from 6,329 individuals showing the percentage of the U.S. population, by 
age, who fail to meet U.S. federal activity guidelines [adapted from Troiano et al. 
(Troiano et al., 2008)]. 
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sexes (Trost et al., 2002). In 2014, Wolff-Hughes et al. (Wolff-Hughes et al., 2014) 
analyzed data from 3,700 U.S. youth in the US 2003-2006 National Health and Nutrition 
Examination Survey. From the age of 6- to 11-years old, the minutes of physical activity 
in U.S. girls and boys dropped ~67% and ~60%, respectively (Wolff-Hughes et al., 
2014). Further, at 8.7 and 10 years of age, 50% of girls and of boys, respectively, 
engaged in <60 min of daily intermittent moderate-vigorous physical activity. Similar 
findings by Rääsk et al. (Raask et al., 2015) show that pubertal boys (11.5 to 13.9 years 
of age) started to be less active according to accelerometer data in their pubertal period. 
Findings from rodent studies provide similar results. 
In 1969, Jakubczak (Jakubczak, 1969) demonstrated that declines in free wheel 
running activity begin early in the life of rats (66 d, or ~ 9 weeks of age), and this decline 
in continuous through early adulthood (186 d). Additionally, studies by our lab suggest 
that voluntary wheel running initially declines at 8 weeks of age, a timeframe comparable 
to the age at which activity decreases in humans and associated with the onset of puberty 
(Sengupta, 2013). Importantly, there are developmental similarities between humans and 
rodents that allow translation of the age-specific changes of human life to both juvenile 
and adult rat models, as shown in Figure 1.2. 
Taken together, these reports show that by ~9-11 years of age, 50% of U.S. youth 
are not undertaking sufficient daily physical activities for health according to U.S. 
Physical Activity Guidelines, and this phenomenon appears to be conserved across 
species. However, it is unknown whether there is a biological basis for the drop in 
average physical activity per day occurring between 6-11 years of age. 
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Is there a biological basis for physical inactivity? 
 Despite the pandemic levels of physical inactivity, little is known about the 
underlying genetic and biological factors that may contribute to the regulation of physical 
inactivity behavior. While social and cultural pressures certainly influence physical 
activity in humans, they do not regulate these behaviors entirely. Observations as early as 
1954 demonstrate that physical activity volition has a biological basis (Mayer et al., 
1954). In their study, Mayer et al. (Mayer et al., 1954) noted that obese hyperglycemic 
mice were far less active than non-obese littermates, and that inactivity, rather than 
overnutrition, was the major factor. However, when obese mice are bred against mice 
with a so-called “waltzing gene,” the increased physical activity is sufficient to prevent 
the development of obesity. Studies in animals and humans estimate the genetic 
component for physical inactivity to be between 20-80% (Festing, 1977; Kaprio et al., 
1981; Lauderdale et al., 1997; Lerman et al., 2002; Lightfoot et al., 2004; Lightfoot et al., 
2008). Additionally, in a recent study following 1654 twins from 420 monozygotic and 
352 dizygotic same-sex twin pairs, den Hoed et al. (den Hoed et al., 2013) provided 
heritability estimates of physical activity levels. Results indicated that sedentary behavior 
 
Figure 1.2. Comparison of rat and human age. The age of rats in weeks for 
juvenile, adolescent, and adult life compared to years from childhood to adulthood in 
humans (Andreollo et al., 2012; Sengupta, 2013). 
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is moderately heritable in adults. Additive genetic factors (i.e., heritability) explained 
31% (95% CI: 9%, 51%) of the variance in the time spent performing sedentary behavior, 
with the remaining variance predominantly explained by unique environmental factors.  
Evolutionary perspectives also argue that while selection did not operate to cope 
with the detrimental effects of long-term physical inactivity, humans adapted to avoid 
unnecessary exertion due to limited energy supply. Lieberman (Lieberman, 2015) states 
that while humans evolved for regular, moderate amounts of endurance physical activity 
in conjunction with hunter-gather behaviors, humans are equally well evolved to be 
physically inactive. For example, hunter-gathers in camp spent a majority of their time 
sitting on the ground, doing chores, or engaging in activities that require little energy 
expenditure (Lieberman, 2015). The evolutionary pressures selecting to avoid excess 
physical activity may be best exemplified by energy balance assessments, as described by 
Lieberman in the following: 
 
“it is important to note that hunter-gatherers tend to have much smaller body 
masses than people in developed nations, so estimates of their active energy 
expenditure (TEE-RMR) relative to body mass indicate that they expend on 
average 30 kcal/kg/d, almost twice that of Americans, which is 17 kcal/kg/d 
(Lieberman, 2015). In other words, hunter-gatherers who are very physically active 
for only 4 to 6 h/d are still nearly twice as active as people in postindustrial 
economies, which explains why they are under such strong selection to be inactive 
as much as possible. I know of no behavioral studies on inactivity among hunter-
gatherers but predict that they are just as keen to avoid physical activity.” 
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Data on energy budgets in hunter-gathers suggests that since energy intake often matched 
energy expenditure (sometimes greater, sometimes less), inessential physical activity, 
which we often consider as exercise today, may have been maladaptive. Furthermore, 
humans, especially females, have an evolutionary ability to store large amounts fat to 
have sufficient energy stores to afford for numerous unusually energy-costly demands of 
human biology in pregnancy compared to other primates such as, delayed development, 
larger bodies and brains, and rapid reproduction rates (Lieberman, 2015). In total, strong 
selection pressures not only appear to shape human desires to engage in physical activity, 
but also physical inactivity. 
Further support for a genetic component of voluntary physical activity can be 
found in mice bred for high voluntary wheel running (Rhodes et al., 2005), and rats bred 
for high or low voluntary wheel running (Roberts et al., 2013). In high voluntary running 
mice, single-gene quantitative trait loci (QTL) analysis has been used to identify regions 
of the genome that may mediate the motivation of physical activity (Lightfoot et al., 
2008). In doing so, Lightfoot et al. identified specific sections of chromosome 13 
associated with running distance and duration, respectively. Similarly, transcriptomic 
analysis of the nucleus accumbens (NAc) has identified at least 13 transcripts inherently 
differently expressed between high and low voluntary running rats (Roberts et al., 2014). 
Additional details about specific genetic contributes to voluntary physical 
activity/inactivity are discussed in the following sections. 
 While, it is necessary to investigate environmental and non-genetic factors, as 
well as their interactions with genetic factors, to understand fully the complex 
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mechanisms that contribute to the regulation of physical activity, the above examples 
provide strong evidence to suggest that genetic factors influence the desire to be 
physically active. 
 
Nucleus accumbens, dopamine, and physical activity motivation 
 Although detailed mechanisms describing the neurobiology of wheel running 
motivation are incomplete, substantial evidence suggests the mesolimbic dopaminergic 
pathway, specifically the nucleus accumbens (NAc), plays an important role in 
determining voluntary running behavior (Knab et al., 2009; Knab et al., 2012; Knab and 
Lightfoot, 2010). In the mesolimbic dopamine system, dopaminergic neurons originating 
in the ventral tegmental area (VTA) project to various limbic nuclei including the NAc, 
amygdala, hippocampus, ventral pallidum, and medial prefrontal cortex (mPFC), and 
changes in dopamine (DA) transmission play central roles in modulating the flow of 
information through the limbic system (Carr et al., 1999; Kalivas and Nakamura, 1999; 
Napier and Maslowski-Cobuzzi, 1994; Sesack et al., 2003). These nuclei, through 
interconnections via dopaminergic neurons, have implications in central functions such as 
reward, motivation, learning, and motor movement (Smith et al., 2009). An overview of 
the mesolimbic DA system, as well as additional neuro-modulators of DA release and 
reward, is shown in Figure 1.3. 
Located in ventral striatum, the NAc is a key component of the basal ganglia – a 
collection of subcortical nuclei that control a wide variety of psychomotor behaviors. 
Nearly all of the functions attributed to the NAc are intimately tied to its rich 
dopaminergic innervation (Nicola et al., 2000). The vast majority (90-95%) of neurons in 
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the NAc are GABAergic medium spiny neurons (MSNs) that predominantly receive 
dopaminergic input from the VTA of the midbrain (Meredith, 1999). NAc MSNs express 
D1-like (D1) (includes dopamine receptor (Drd) 1 and Drd5) and D2-like (D2) (includes 
Drd2, Drd3, and Drd4) DA receptors, with the former activating adenylate cyclase to 
increase cAMP and the latter inhibiting adenylate cyclase (Missale et al., 1998; Stoof and 
Kebabian, 1981). The collective contributions of DA receptor and downstream signaling 
leads to changes in gene expression, most notably the induction of immediate early genes 
of the Fos family (e.g. c-fos and ΔFosB) (Hiroi et al., 2002; Nestler et al., 2001; Rhodes 
et al., 2003) and brain derived neurotrophic factor (Bdnf) (Ernst et al., 2006).  
The NAc is commonly referred to as a ‘hub’ for processing signals related to 
motivational stimuli (Salamone and Correa, 2012), making it an ideal target to identify 
changes in reward-related signaling that may influence behavior. Furthermore, the NAc is 
involved in mediating motivational behavioral processes, specifically those that include 
the exertion of effort and sustained task engagement (Salamone and Correa, 2012), and 
the NAc may act as a ‘filter’ or ‘gate’ for information traveling to and from various 
limbic and motor areas of the brain (Roesch et al., 2009). Since the early characterization 
as the neural interface between the limbic ‘motivation’ and motor systems (Mogenson et 
al., 1980), the NAc and its associated circuitry has been shown to mediate many 
motivating and rewarding behaviors. For example, drug self-administration (Yao et al., 
2006), ethanol consumption (Barkley-Levenson et al., 2016), and food intake (Baldo et 
al., 2013), are influenced by the NAc. 
Previous findings have established that the NAc plays an important role in 
determining running behavior in rodents (Knab et al., 2009; Knab et al., 2012; Knab and 
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Lightfoot, 2010; Waters et al., 2008). A report by Knab et al. (Knab et al., 2009) suggests 
that differences in D1 receptors as well as tyrosine hydroxylase (Th) mRNA, an enzyme 
required for catecholamine synthesis of DA, in the NAc are associated with differences in 
running distance between mouse strains. Similar findings by Greenwood et al. 
(Greenwood et al., 2011) show that voluntary wheel running is rewarding, and over time, 
able to alter behavior and affect the neuroplasticity of the mesolimbic reward pathway. In 
the same study, 6 weeks of voluntary wheel running increased Th mRNA in mesolimbic 
brain regions, decreased Drd2 mRNA in the NAc, and increased ΔFosB/FosB 
immunoreactivity, a transcription factor associated with rewarding behavior and chronic 
drug reward, in the NAc. Additionally, the same report by Greenwood et al. (Greenwood 
et al., 2011) used a conditioned place preference paradigm to show that rats spent more 
time in a context paired with wheel-running compared to a non-paired context, a finding 
that is consistent with the place preference developed in the context of either cocaine or 
morphine. 
DA receptor expression levels in the striatum have been posited to influence 
physical activity, and is elevated following five continuous days of exercise (Foley et al., 
2006). Mice bred by Garland for high voluntary running distance display dysfunctional 
dopaminergic profiles in the NAc compared to control mice (Rhodes and Garland, 2003; 
Rhodes et al., 2001). Further, agonism (Knab et al., 2012) and antagonism (Rhodes and 
Garland, 2003) of Drd1 in the NAc paradoxically both decrease wheel running in high 
running mice to a greater extent than in control mice. This suggests the following: 1) DA 
signaling in high running is optimally primed to achieve reward associated with running, 
2) DA is required for wheel running motivation, and 3) animals run to achieve the 
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rewarding effects of DA and do not want to run when DA signaling is artificially 
activated. In addition, the depletion of NAc DA by 6-hydroxydopamine (6-OHDA) 
decreases wheel running (Robbins and Koob, 1980). Recent findings by Beeler et al. 
using Drd2 knockdown mice also suggest a direct link between reduced dopamine 
function and reduced physical activity (Beeler et al., 2016). Importantly, in this study 
Beeler et al. also suggest that the primary contribution of decreased Drd2 signaling to 
obesity is via reductions in energy expenditure rather than the initiation of compulsive 
overeating. Additionally, several reports have demonstrated other mesolimbic structures, 
such as the VTA and PFC, also contribute to the reward derived from physical activity, 
potentially through their interactions with the NAc (Greenwood et al., 2011; Isobe and 
Nishino, 2001; Rhodes et al., 2005). 
 Together, these data suggest the NAc is an intriguing and potentially rich loci to 
study biological factors that influence the motivation to be physically active. Given the 
infancy of this area of research and the vast ramifications of a physical inactive lifestyle, 
significant efforts should be made to determine potential mechanisms by which 
molecular changes in the NAc drive the motivation for exercise. 
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Figure 1.3. Neurocircuits implicated in reward and motivation. Sagittal section of a 
representative rodent brain illustrating the pathways and receptors implicated in rewarding 
behavior. Note the high convergence of dopaminergic inputs on the nucleus accumbens. In 
response to a rewarding stimulus, DA is released from the ventral tegmental area to the 
nucleus accumbens through direct actions on DA terminals. In addition, opioids activate 
opioid receptors in the ventral tegmental area, nucleus accumbens, and amygdala through 
direct or indirect actions via interneurons. Opioids facilitate the release of DA in the 
nucleus accumbens by an action either in the ventral tegmental area or the nucleus 
accumbens, and are also hypothesized to act independent of the DA system. Activation of 
γ-aminobutyric acid-A (GABAA) receptors or GABA release in the ventral tegmental area 
or nucleus accumbens also influence both opioid peptide and DA release in the nucleus 
accumbens. Additionally, nicotine and cannabinoids facilitate the release of DA in the 
nucleus accumbens through mechanisms either in the ventral tegmental area or the nucleus 
accumbens. Abbreviations: AC, anterior commissure; AMG, amygdala; ARC, arcuate 
nucleus; BNST, bed nucleus of the stria terminalis; Cer, cerebellum; C-P, caudate-
putamen; DMT, dorsomedial thalamus; FC, frontal cortex; Hippo, hippocampus; IF, 
inferior colliculus; LC, locus coeruleus; LH, lateral hypothalamus; N Acc., nucleus 
accumbens; OT, olfactory tract; PAG, periaqueductal gray; RPn, reticular pontine nucleus; 
SC, superior colliculus; SNr, substantia nigra pars reticulata; VP, ventral pallidum; VTA, 
ventral tegmental area (Koob and Volkow, 2010). 
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Opioids influence nucleus accumbens dopamine signaling 
 In addition to D1- and D2-like DA receptors, NAc MSNs are dense in mu- (μ), 
delta (δ), and kappa- (κ) opioid receptors, and opioidergic neurons in the striatum that 
receive DA projections for the VTA are involved in the interface between the limbic and 
motor systems (Depue and Collins, 1999). Like D1- and D2-like receptors, the effects of 
the μ-, δ-, and κ- receptor activation on downstream DA content/signaling vary. Findings 
by Spanagel et al. (Spanagel et al., 1990) in anesthetized rats suggest that selective 
agonism of the μ- and δ- opioid receptor in the NAc increase DA release while, in 
contrast, κ- receptor opioid agonism in the NAc decreases DA release. The opposing 
actions from the bi-functional opioid receptors are further influenced by two separate 
pathways in striatal GABAergic MSNs, as follows: 1) the striatonigral “direct” pathway 
express dynoprphin and D1-like dopamine receptors (Gerfen and Young, 1988); and 2) 
on the other hand, neurons in the striatopallidal “indirect” pathway express enkephalin 
and D2-like dopamine receptors (Schiffmann et al., 1991). These two pathways are 
thought to serve opposing roles for processing reward with direct pathway activation 
promoting reward and indirect pathway activation reducing reward (Kravitz et al., 2012).  
 Opioids are known to influence many rewarding behaviors, with several notable 
examples being drugs of abuse, ethanol consumption, and feeding behavior. Daily 
injection of the μ-opioid receptor agonist morphine increases food consumption in rats 
(Baldo et al., 2010). In contrast, Levine et al. (Levine et al., 1985) demonstrated that the 
opioid receptor antagonist naloxone (which has the greatest affinity for the μ-receptor) 
decreases food intake in rats. Similar findings have been reported with the rewarding 
behavior of ethanol consumption (Valenta et al., 2013). Interestingly, modulation of the 
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μ-opioid receptor appears to influence ethanol intake in a DA-dependent mechanism in 
the NAc, as determined by a measurement of extracellular DA in vivo using microdialysis 
probes inserted into the NAc (Valenta et al., 2013), but influence feeding behavior 
independent of DA (Will et al., 2006). Likewise, these distinctions in opioidergic 
signaling activity in the NAc have been posited to modulate the degree of reward 
associated with physical activity (Gerfen and Young, 1988), as described next. 
 
Opioids influence physical activity motivation 
 Minimal attention has focused on the relationship between opioids and voluntary 
wheel running. However, the limited literature suggests opioidergic signaling in the 
ventral striatum and NAc influences voluntary wheel running. Specifically, mice selected 
for high wheel running have decreased κ-opioid receptor (Oprk1) mRNA expression in 
the dorsal striatum compared to non-selected mice (Mathes et al., 2010). In the study 
described in a previous section by Greenwood et al. (Greenwood et al., 2011), 6 weeks of 
wheel running up-regulated δ-opioid receptor (Oprd1) mRNA expression in the NAc. 
Furthermore, intraperitoneal injection of the opioid receptor antagonist naloxone has been 
shown to suppress wheel running in rats (Sisti and Lewis, 2001). Other published wheel 
running studies in rodents and hamsters similarly demonstrate that both opioid 
antagonists and agonists initially suppress running behavior (Schnur, 1985; Schnur and 
Barela, 1984; Schnur et al., 1983; Sisti and Lewis, 2001). Intriguingly, in one of these 
reports, repeated administration or recovery from the opioid agonist morphine later 
increased running to hyperactive levels (Schnur, 1985; Schnur et al., 1983; Sisti and 
Lewis, 2001). However, the authors of this study noted one limitation in that the same 
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cohort of rats was used for three separate experiments and the authors could not rule out 
the possibility that either drug sensitization or tolerance could account for their 
paradoxical data. Nonetheless, this evidence suggests that endogenous and exogenous 
opioid action in the NAc and striatum influence wheel running behavior. 
Several reports have demonstrated that the opioid receptor ligands enkephalin 
(Enk) and dynorphin (Dyn) also influence wheel running behavior. In rats selectively 
bred for high (HCR) and low running capacity (LCR), which also display high and low 
wheel running behavior, respectively, HCR rats expressed less Enk mRNA than LCR rats 
in the NAc (Monroe et al., 2014). Additionally, these expression patterns were not altered 
after three weeks of wheel running, leading the authors of this study to speculate that 
differences in NAc Enk may influence inherent differences in wheel running (Monroe et 
al., 2014). Similarly, Enk projections from the ventral striatum have been shown to 
inhibit motivation-based locomotion (Haber, 2011), and low Enk mRNA is indicative of 
increased dopaminergic tone (Nikoshkov et al., 2008). Both Dyn and Enk have crucial 
roles in regulating the transcription factor ΔFosB. Werme et al. (Werme et al., 2002) 
found that running wheel access for 30 days reduces ΔFosB in NAc Enk-containing 
neurons, and selective overexpression of ΔFosB in striatal Enk-containing neurons 
decreased running compared to non-transgenic mice. For the opposing Dyn-pathway, in 
the study above by Werme et al., it was observed that 30 days of wheel access increased 
ΔFosB in NAc Dyn-containing neurons. Further, ΔFosB overexpression in striatal Dyn-
containing neurons increased running, suggesting that dynorphin may regulate the 
incentive motivation or reward associated with wheel running (Werme et al., 2002). 
Additionally, multiple findings indicate lesioning of dopaminergic neurons decreases 
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Dyn expression in striatal neurons and this effect is mediated by D1-like receptors 
(Engber et al., 1992; Gerfen et al., 1990; Gerfen et al., 1991).  
The neurochemical mechanisms by which opioids influence wheel running may 
be shared with the mechanisms by which opioids affect drug addiction. Access to 
voluntary running wheels for either 11 or 30 days resulted in the self-administration of 
significantly fewer doses of the Oprm1 agonist morphine in an operant lever-pressing 
task compared to sedentary control rats (Hosseini et al., 2009). Further, the development 
of conditioned place preference to the effects of morphine were precluded after as few as 
8 days of wheel running (Lett et al., 2002) Given that the naturally rewarding properties 
of morphine are attenuated by voluntary physical activity, it is likely that the 
reward/value derived from physical activity either outcompetes, or substitutes for, the 
reward of drugs. These findings make studies designed to test the beneficial influences of 
opioids on wheel running behavior in reference to drug addiction very intriguing given 
the plethora of data concerning opioids and drug addiction. 
  
Nucleus accumbens dopaminergic signaling diminishes during adolescence and 
adulthood 
As described above, physical activity levels first decline near the onset of puberty 
in both humans and rodents. While complex factors such as cellular energy production, 
reductions in circulation and removal of waste products, alterations in cellular membrane 
trafficking, and alterations in muscle structure and innervation would impact the ability to 
locomote, this dissertation will more thoroughly consider possible neurobiological 
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mechanisms that impact not only the ability to be physically active, but additionally the 
motivation to be physically active. 
Findings by Andersen (Andersen, 2002) in the NAc and striatum of rats 
demonstrate that at puberty (7 wks of age), cAMP production in the NAc is ~35% higher 
relative to adulthood (14 wks of age) and forskolin-stimulated cAMP is ~300% higher at 
7 wks compared to 14 wks of age. Moreover, changes in forskolin-stimulated cAMP 
accumulation in the NAc were parallel to the decline in locomotor activity between 7 and 
14 wks of age. The significance of cAMP is that it demonstrates bidirectional properties 
in NAc MSNs, with D1-like and D2-like receptors increasing and decreasing cAMP, 
respectively. The same report also reported an age-dependent decrease in Drd1 mRNA in 
the NAc in striatum from 7 to 14 wks of age. This finding led the authors to conclude that 
age-dependent pruning of D1-like receptors in the NAc and striatum may mediate 
changes in susceptibility to various behavior beginning at the time of puberty. 
Similar findings have been reported for the Drd2. Age-related decreases in Drd2 
concentration in the striatum represent one of the greatest neurochemical changes in aged 
brains, according to Roth (Roth, 1995), and the loss of this receptor with increasing age 
has been noted in rodents, monkeys, and humans (Roth and Joseph, 1994). However, 
these findings were in middle-aged to older adult animals. Additionally, the number of 
dopaminergic neurons in the NAc and striatum decreases with increasing age, with the 
human decline estimated at a rate of 5-10% per decade (Naoi and Maruyama, 1999). 
Conversely, similar declines in total DA content were not observed across a similar 
timeframe (Joseph and Roth, 1992). 
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Nonetheless, the loss of DA receptors and DA neurons with advancing age have 
been associated with decreased motivation for various behaviors, and have been 
hypothesized to underlie age-related declines in the motivation to be physically active 
(Ingram, 2000). Therefore, any search for the biological basis of the age-related decline 
in physical activity motivation should place significant emphasis on examining circuity 
related to the DA reward system. 
 
Maternal nutritional status influences offspring nucleus accumbens dopamine signaling 
as well as spontaneous activity  
In 1956, Waddington provided the first conclusive evidence demonstrating that 
the inheritance of a characteristic can be altered in response to an environmental stimulus, 
a finding often associated with the origin of epigenetics (Waddington, 1956). Since 
Waddington’s initial observation, multiple environmental stimuli have been shown to 
give rise to progeny with altered genetic and phenotypic profiles. 
Calorie dense, high-fat diet (HFD) or Western diet (WD) is well-recognized for 
increasing the risk for obesity, as well as the well-described negative health consequences 
of obesity such as increased risk for T2D, CVD, hypertension, and dyslipidemia, among 
others. In addition, maternal HFD consumption during pregnancy and nursing appears to 
promote genetic changes in the offspring. For example, exposure to HFD during prenatal 
development increases the susceptibly of the offspring to developing obesity and 
metabolic disease, in turn leading to further transgenerational disease transmission 
(Boerschmann et al., 2010; Mingrone et al., 2008). Alarmingly, in the United States the 
incidence of obesity among pregnant women ranges from 20-38% (Yogev and Catalano, 
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2009). Diabetes during pregnancy also increases the risk for obesity in both children 
(Mehta et al., 2012) and in adults (Lawlor et al., 2011). 
 In addition to disease risk, maternal HFD is postulated to influence offspring 
physical activity levels. Rowland (Rowland, 1998) proposed that through components 
related to energy balance control, an “activity-stat” may regulate the propensity for 
physical activity. This “activity-stat” is speculated to be influenced by environmental 
factors during critical pre- and post-natal periods of development. For example, a study 
by Li et al. (Li et al., 2013) using the small-litter mouse model of early postnatal 
overnutrition, adult offspring from small-litters have reduced spontaneous physical 
activity and energy expenditure. In addition, hyperleptinemia during pregnancy in mice 
has been shown to increase locomotor activity in adult offspring, with female mice 
displaying greater responses to hyperleptinemia compared to male mice (Pollock et al., 
2015). Paradoxically, studies in rats show that both maternal food restriction and HFD 
decrease cage activity levels in adulthood (Cunha Fda et al., 2015; Vickers et al., 2003). 
In addition to nutrition, energy expenditure during pregnancy may also influence 
offspring physical activity levels. Recently, Eclarinal et al. (Eclarinal et al., 2016) 
demonstrated in mice that access to voluntary running wheels during pregnancy increases 
voluntary wheel running in the offspring up to 300 days of age. Surprisingly, while these 
findings collectively suggest that over/undernutrition during pregnancy affects physical 
activity levels in the offspring, the mechanisms remain largely unstudied.  
 One potential mechanism by which HFD during pregnancy in rodents may 
influence physical activity levels in offspring is via HFD-induced alterations in the 
mesolimbic DA system. Data from the Reyes lab shows that following HFD during 
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pregnancy and lactation, Drd1 and Drd2 mRNA expression in the NAc are reduced in 
adult offspring, while mRNA expression of dopamine transporter (Dat) and Oprm1 are 
increased (Vucetic et al., 2010). The differences in mRNA expression appear to be the 
result of altered epigenetic patterns leading to transgenerational dysfunction in the DA 
and opioid-related systems (Vucetic et al., 2012). Importantly, HFD effects on offspring 
DA and opioids appear age-dependent. Following maternal ‘junk-food’ (e.g. chocolate, 
peanut butter, biscuits, etc.) exposure during pregnancy and lactation, Ong & 
Muhlhausler (Ong and Muhlhausler, 2011) noted that Oprm1 mRNA was increased at 6 
weeks of age but decreased at 3 months of age compared to standard chow-fed offspring, 
while the inverse was observed for Dat mRNA. Along these lines, a number of 
laboratories have identified behavioral changes indicative of dopamine dysregulation 
following maternal HFD or junk-food. For example, offspring of HFD fed dams have 
increased preference for fatty and sugary foods (Ong and Muhlhausler, 2011), and 
increased operant responding (i.e. working harder) for high-fat pellets (Naef et al., 2011). 
Along these lines, leptin suppresses the rewarding effects of wheel running in 
mice via activation of signal transducer and activator of transcription-3 (STAT3) 
signaling in mesolimbic DA neurons, an effect which likely increases DA overflow and 
function in the NAc, suggesting that leptin may influence the motivational and rewarding 
effects of wheel running (Fernandes et al., 2015). Observations that serum leptin levels 
inversely correlate with marathon run-time, after adjusting for BMI (Bobbert et al., 2012) 
and running performance (time and speed) in mice bred for high voluntary running 
(Girard et al., 2007) further suggest that leptin may impact the motivational and 
rewarding effects of running. In addition, numerous studies have identified leptin as a key 
22 
 
determinant of physical activity levels. In leptin-deficient patients during the fed-state, 
acute leptin increases locomotor activity (Farooqi et al., 1999; Licinio et al., 2004). In 
leptin deficient ob/ob mice, acute subcutaneous leptin replacement increases wheel 
running during the fed state, while no effect is observed in wild-type mice (Morton et al., 
2011).  Although the previous examples describing the influences of leptin on physical 
activity are unrelated to maternal-offspring transmission, it suggests alterations in 
metabolism (such as HFD/WD consumption) could drive changes in VTA and NAc DA 
signaling, which in turn could change physical activity levels. 
Similarly, changes in the hypothalamic systems involved in the homeostatic 
regulation of feeding and spontaneous activity following maternal HFD during pregnancy 
and lactation are documented. Maternal HFD increases mRNA expression of the 
orexigenic peptides galanin, enkephalin, and dynoprphin in the paraventricular nucleus 
(PVN), as well as neurogenesis of orexigenic neurons, which may increase obesity risk 
through overeating or reduce physical activity (Chang et al., 2008). In addition, 
abnormalities in proopiomelanocortin (Pomc), neuropeptide Y (Npy), and melanocortin-4 
receptor (Mc4r) expression in the arcuate nucleus of the hypothalamus (Arc) have been 
reported in pups from obese dams (Chen and Morris, 2009; Grayson et al., 2010). 
Collectively, the above findings suggest that changes in reward-associated and/or 
homeostatic neurocircuitry could influence changes in physical activity levels following 
maternal HFD. 
 
A novel model of physical activity motivation: selective breeding for high or low 
voluntary running behavior 
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 A review by Bauman et al. (Bauman et al., 2012) identified 75 biological and 
demographic factors correlated with the motivation to be physically active. However, 
data from these cross-sectional and longitudinal studies have considerable variation in 
estimates of genetic heritability and do not present any evidence supporting causal roles 
by which candidate genes control physical activity levels. Further, complex behaviors, 
such as physical activity motivation, are likely mediated by a network of genes rather 
than single genes or allelic variations. This complexity makes selective breeding for a 
desired trait a more biologically-valid method to study the traits complex phenotype, 
rather than studying the effects of single gene knock-out or knock-in models (Rhodes et 
al., 2005). 
 In light of the roughly 97% of U.S. adults and 92% of adolescents not meeting US 
daily physical activity guidelines for 30 and 60 min, respectively (Troiano et al., 2008), 
our lab developed selectively bred lines of rats for low vs. high voluntary running 
distance, LVR and HVR, respectively. This selective breeding model was developed 
similar to that of Swallow et al. (Swallow et al., 1998) for HVR mice and that of Koch 
and Britton (Koch and Britton, 2001) for low and high aerobic capacity rats. In brief, this 
selection resulted in a founding population of 159 outbred Wistar rats (80 male and 79 
female) subsequently selected for high and low voluntary running distance in wheels. 
This selection resulted in a 13 family HVR and a 13 family LVR line (Roberts et al., 
2013). By Generation (G) 9, HVR rats ran ~10-fold greater distances, at a higher speed, 
than did LVR rats, as shown in Figure 1.4 (Roberts et al., 2013). Interestingly, minimal 
inherent differences in peripheral factors such as the skeletal musculature quality and 
body fat proportion exist between the HVR and LVR lines, suggesting differences in 
24 
 
brain circuitry may account for some of the drastic differences in running distance 
(Roberts et al., 2013). 
 
 Our labs’ previous findings using the HVR and LVR lines suggest intrinsic 
differences in NAc DA signaling pathways influence the ~10-fold differences in running 
behavior. By G 4-5, agonism and antagonism of Drd1 in the NAc decreased wheel 
running in HVR, but not LVR, rats, suggesting rats predisposed to run high nightly 
distances may quickly develop a rewarding response to exercise due to an optimal D1-
like receptor signaling pathway in the NAc (Roberts et al., 2012). Subsequent RNA-seq 
studies in G8 by Roberts et al. (Roberts et al., 2014) demonstrated that 6-days of wheel 
running produced marked increases in transcripts in the NAc related to DA signaling in 
HVR rats, while transcripts in the DA pathway of LVR rats were non-responsive to 
wheel running. HVR rats also inherently possess more mature MSNs than LVR which 
possibly contributes to high and low running distances in the HVR and LVR lines, 
 
Figure 1.4. Divergence of wheel running in HVR and LVR lines. Data are from 
days 5 and 6 (selection criteria) for male (left) and female (right) HVR (black) and 
LVR (white) rats from generations 1-9. Non-breeding founder Wistar rats (F; gray) 
were used as a template for comparison. Symbols: a-f denotes a significant difference 
from generation to generation (p < 0.05). * denotes statistical difference from non-
breeding founders (p < 0.05). † denotes statistical difference between HVR and LVR 
within a given generation (p < 0.05). Adapted from Roberts et al. (Roberts et al., 
2013). 
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receptively (Roberts et al., 2014).  Further, in the same study by Roberts et al. (Roberts et 
al., 2014), 13 transcripts in the NAc identified by RNA-sequencing and Ingenuity 
Pathway Analysis could represent inherent genetic differences between HVR and LVR 
lines, providing evidence for the inheritance of genes related to physical inactivity. 
Similarly, differences in opioids have been reported between the HVR and LVR lines. 
In a recent study, I determined that Oprm1 mRNA in the NAc was intrinsically 3-
fold greater in HVR compared to LVR rats (Ruegsegger et al., 2015). In the same study, 
agonism and antagonism of these receptors decreased running distance in HVR, but not 
LVR rats. While paradoxical, the results suggest HVR express high running levels 
mediated by an increase in motivation driven, in part, by elevated NAc opioidergic 
signaling. Additional findings from this study suggested the influences of Oprm1 
modulation on running distance could be dependent on NAc DA (Ruegsegger et al., 
2015). Likewise, my previous findings show that prodynorphin (Pdyn) and Drd1 mRNA 
expression are intrinsically increased in HVR vs. LVR rats. Together, my results imply 
the striatonigral “direct” pathway influences wheel running behavior, and the 
contributions of opioidergic signaling on wheel running could be mediated through DA. 
Like the findings described in previous sections, these data strongly suggest the 
importance of NAc DA and opioids for the motivation to be physically active. 
 
Aims of dissertation research 
Understanding the neuromolecular mechanisms contributing to the motivation to 
be physically active is highly important. Unraveling these mechanisms may have 
profound implications on our future lifestyle, and may potentially lead to strategies to 
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reduce sedentary behavior and its associated chronic disease that is acknowledged in the 
U.S. Federal Physical Activity Guidelines Advisory Committee Report, 2008 (US Dept. 
of Health and Human Services, 2008). Thus, the aims and general hypothesis of this 
dissertation were the following: 
 
Overall objective: to investigate the relationship between the mesolimbic reward 
pathway, specifically the NAc, and the motivation for physical activity, as assessed by 
voluntary wheel running, an accepted surrogate for motivation to be physically active. 
 
Overall hypothesis: reduced dopamine signaling in the NAc associates with/contributes 
to lower motivation for physical activity.  
 
This research objective and hypothesis was tested using three independent strategies, as 
described next: 
 
Study 1: assess the necessity of the dopaminergic system on µ-opioid receptor driven 
changes in voluntary running in HVR and LVR rats.   
Previously, our lab has shown that Oprm1 mRNA is elevated in HVR vs. LVR, 
and that modulation of Oprm1 in the NAc decreases wheel running in HVR without an 
effect in LVR. These prior data also suggest that the influence of Oprm1 on running 
behavior may be mediated potentially through DA action in the NAc. Therefore, the 
following original experiments were performed: 
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1) Extend previous findings on intrinsic Oprm1 mRNA differences between 
HVR vs. LVR to the protein and functional (electrophysiological) level 
2) Determine if intraperitoneal (ip) injection of the opioid receptor antagonist 
naltrexone (20mg/kg) decreases the expression of mRNAs indicative of DA 
action in the NAc and VTA in HVR and/or LVR rats. 
3) Determine if ip injection naltrexone (10, 20mg/kg) decreases wheel running in 
HVR and/or LVR rats. 
4) Determine if DA neuron lesion with 6-OHDA into the NAc reduced wheel 
running to similar extent as naltrexone in HVR rats. 
 
Study 2: determine the extent to which maternal Western diet (WD) (42% kcal from fat, 
27% kcal from sucrose) influences transgenerational offspring physical activity, and 
NAc, VTA, and Arc mRNA expression in juvenile and adult offspring.  
A previous report has identified changes in offspring physical activity in 
adulthood of HFD- and WD-fed dams (Cunha Fda et al., 2015); however, to my 
knowledge, no studies have attempted to identify molecular factors that associate with, 
and that may regulate, voluntary activity in these offspring. These effects have also never 
been assessed beyond the initial offspring generation. The following experiment was 
performed: 
 
1) Assessment of voluntary wheel-running and home-cage locomotor activity, 
NAc, VTA, and Arc mRNA expression, and NAc Drd1 and Drd2 protein 
levels in 6 wk-old (juvenile) and 18 wk-old (young adult) was performed in 
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offspring from ND or WD fed dams. Additionally, F1 generation rats within 
the ND or WD lines were bred, without treatment, and voluntary wheel 
running along with NAc and VTA mRNA expression were measured in F2 
generation offspring.  
 
Study 3: Aim 1: examine the NAc of wheel running and sedentary rats at 8 and 14 weeks 
of age to identify transcripts indicative of the inherent age-dependent decreases in 
voluntary physical activity. Aim 2: to determine the extent to which Cdk5 inhibition alters 
wheel-running behavior. 
The molecular factors that associate with or cause the onset of the lifetime decline in 
physical activity in adolescence are unknown; however, it is hypothesized NAc DA plays 
at least some role. The health ramifications of preventing or slowing age-related declines 
in physical activity are enormous. Therefore, I completed the following: 
 
1) Perform transcriptomic analysis of the NAc of wheel running at 8 and 14 wk rats, 
ages at which wheel running was at its maximum and had significantly declined 
from maximum, respectively. Bioinformatics was used to generate hypotheses for 
follow-up studies to test the relationships between specific molecules/structural 
measurements with the age-dependent decline in running. 
2) Determine if NAc infusion of the Cdk5 inhibitor roscovitine decreases running 
distance. 
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ABSTRACT 
The mesolimbic dopamine and opioid systems are postulated to influence the 
central control of physical activity motivation. We utilized selectively bred rats for high 
(HVR) or low (LVR) voluntary running behavior to examine 1) inherent differences in 
mu-opioid receptor (Oprm1) expression and function in the nucleus accumbens (NAc), 2) 
if dopamine-related mRNAs, wheel-running, and food intake are differently influenced 
by intraperitoneal (i.p.) naltrexone injection in HVR and LVR rats, and 3) if dopamine is 
required for naltrexone-induced changes in running and feeding behavior in HVR rats. 
Oprm1 mRNA and protein expression were greater in the NAc of HVR rats, and 
application of the Oprm1 agonist [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) to 
dissociated NAc neurons produced greater depolarizing responses in neurons from HVR 
versus LVR rats. Naltrexone injection dose-dependently decreased wheel running and 
food intake in HVR, but not LVR, rats. Naltrexone (20mg/kg) decreased tyrosine 
hydroxylase mRNA in the ventral tegmental area and Fos and Drd5 mRNA in NAc shell 
of HVR, but not LVR, rats. Additionally, lesion of dopaminergic neurons in the NAc 
with 6-hydroxydopamine (6-OHDA) ablated the decrease in running, but not food intake, 
in HVR rats following i.p. naltrexone administration. Collectively, these data suggest the 
higher levels of running observed in HVR rats, compared to LVR rats, are mediated, in 
part, by increased mesolimbic opioidergic signaling that requires downstream 
dopaminergic activity to influence voluntary running, but not food intake. 
 
  
31 
 
INTRODUCTION 
Identification of neuromolecular mechanisms influencing voluntary, physical 
activity behaviors is of paramount importance. Accelerometry measurements suggest 
~90% of American adults do not meet US physical activity guidelines (Troiano et al., 
2008). These statistics are concerning given that physical inactivity significantly 
increases risk for premature mortality, chronic disease, cognitive dysfunction, and 
diminished quality of life (Booth et al., 2012). While environmental factors influence 
physical activity, human and rodent studies show a robust genetic component for physical 
activity levels (Bauman et al., 2012; den Hoed et al., 2013; Lightfoot et al., 2004; 
Swallow et al., 1998). Therefore, elucidation of inherited genes that dictate physical 
activity levels will be key to developing more effective therapies to combat chronic 
ailments associated with sedentary lifestyles. To address initial needs for gene identities, 
we developed a polygenic selectively bred rat model to study the complex biology of 
high and low motivation for voluntary running. Here, we tested the hypothesis that 
inherited dopaminergic and mu-opioid systems mediate intrinsic voluntary running 
behavior in rats selectively-bred for high (HVR) or low (LVR) voluntary wheel-running 
(Roberts et al., 2014). 
 Mesolimbic system components, specifically dopaminergic signaling in the 
nucleus accumbens (NAc), are important modulators of voluntary running behavior 
(Knab and Lightfoot, 2010). The NAc acts as a ‘filter’ and/or ‘amplifier’ of information 
passing between various limbic, cortical, and motor areas, suggesting the NAc is 
instrumental in orchestrating behavioral processes related to motivation (Salamone and 
Correa, 2012). Indeed, we and others show that dopaminergic system modulation in the 
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NAc decreases wheel running (Rhodes and Garland, 2003; Roberts et al., 2012). 
Likewise, STAT3 knock-out in dopamine neurons in the ventral tegmental area (VTA) 
leads to reductions in dopamine overflow and function in the NAc and increased wheel 
running (Fernandes et al., 2015). 
As the mesolimbic dopamine system is regulated, in part, by opioidergic signaling 
(Pierce and Kumaresan, 2006), we hypothesized that divergence in voluntary running 
phenotypes between HVR and LVR rats is due to inherited differences within the 
opioidergic system. This hypothesis was based on other studies which demonstrated that 
increased striatal enkephalin mRNA is associated with reduced wheel running (Monroe et 
al., 2014), and that injection of the opioid receptor antagonist naloxone suppresses wheel 
running (Sisti and Lewis, 2001). Further, we have observed that our HVR rats are more 
responsive to opioid receptor modulation in the NAc, and that mu-opioid receptor 
(Oprm1) is up-regulated in the NAc of HVR compared to LVR rats (Ruegsegger et al., 
2015). 
Given that interactions between the opioid and dopamine systems may influence 
voluntary running, we further examined HVR and LVR rats to 1) corroborate and extend 
upon differences in Oprm1 expression and function, 2) assess the influence of systemic 
naltrexone injection on mRNA expression of transcripts essential for dopamine action, 3) 
determine the extent to which systemic naltrexone injection influences wheel running and 
free-feeding behavior, and 4) determine the extent to which 6-hydroxydopamine (6-
OHDA) lesion of dopaminergic neurons in the NAc influences natural, and naltrexone-
induced changes in, running distance of HVR rats. 
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MATERIALS AND METHODS 
Experimental Animals 
Development and proliferation of the HVR and LVR lines are previously 
described (Roberts et al., 2013). Female rats from the 12th-17th generations of HVR and 
LVR lines were used in this study. We used female rats due to the fact that females 
usually run further than males, and may thus have greater responses to experimental 
treatments (Jones et al., 1990; Pitts, 1984). Additionally, another advantage to using 
female rats is that their body mass plateaus, minimizing the effect of continued body 
mass growth in male rats; our recent publications have employed female rats; and using 
female rats balances the predominance of male rodents in the literature. Chow (Formulab 
5008, Purina) and water were provided ad libitum. Running distance was recorded using 
Sigma Sport BC 800 bicycle computers (Cherry Creek Cyclery, Foster Falls, VA). Given 
the potential influences of wheel running on our outcome measures, no screening 
strategies were used to verify phenotype in experiments conducted using sedentary rats. 
The Institutional Animal Care and Use Committee at the University of Missouri approved 
all procedures. Animals were housed in AAALAC-accredited research animal facilities. 
The authors used laboratory animals following the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1996). All 
efforts were made to minimize animals suffering and to reduce the number of animals 
used. 
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Experiment 1 
 Inherent differences in Oprm1 expression and function, and pain responses 
(primarily an opioid-derived outcome) were assessed in sedentary (group-housed without 
running wheels) HVR and LVR rats. At 8 wks of age, rats were sacrificed at 1700 h with 
carbon dioxide asphyxiation. This time-point was two hours prior to the onset of the dark 
cycle, and chosen to match previous findings (Ruegsegger et al., 2015). Estrous cycle 
was not controlled for in this experiment. Oprm1 mRNA (n = 6-7) was measured in the 
NAc (core and shell), VTA, medial prefrontal cortex (PFC), caudate putamen (here forth 
referred to as the dorsal striatum (DS)), arcuate nucleus of the hypothalamus (Arc), and 
hippocampus (Hippo). These regions were assessed due to their strong innervation by 
opioidergic and dopaminergic neurons (Mansour et al., 1995). Oprm1 protein levels (n = 
6-8) were measured in NAc (core and shell). Additionally, Oprm1 protein was assessed 
in HVR and LVR rats (n = 4) in regions with high [lateral and medial habenula (Hb)] and 
low [external cuneate nucleus (ECN)] Oprm1 expression (Erbs et al., 2015). These 
regions were selected to provide some additional validity to the selectivity of the Oprm1 
antibody. Electrophysiological (n = 6-11) responses to the mu-opioid receptor agonist [D-
Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) (Sigma) were ascertained in NAc 
neurons isolated from HVR and LVR rats. Additionally, paw-withdrawal latency (PWL) 
to thermal stimulation was examined in 6-wk-old sedentary HVR (n = 11) and LVR (n = 
12) rats. 
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Experiment 2 
The effects of opioid antagonism were determined on neuronal activation and 
dopaminergic gene expression in similar brain regions to those assayed in Experiment 1. 
Eight-week-old sedentary HVR and LVR rats were injected (i.p) with either saline 
vehicle or naltrexone (20 mg/kg) (Sigma) one hour into the dark-cycle (n = 6-7). NAc 
core, NAc shell, VTA, and Arc tissue were then collected from HVR and LVR rats 120-
min post-injection. Previous studies have shown that naltrexone influences neuronal 
activation, as measured by Fos induction, 90-120-min post-injection (Dayas et al., 2007). 
Further, to minimize the effects of cycling hormones on cell activation, vaginal cytology 
was performed to ensure all rats were injected on the night of proestrus. Differences for 
Fos, dopamine receptors (Drd1, Drd2, and Drd5), and tyrosine hydroxylase (Th) mRNAs 
were then assessed by qRT-PCR.  
 
Experiment 3 
This experiment determined opioid antagonism effects on wheel running and food 
intake. Five-week-old HVR (n = 14) and LVR (n = 13) rats were given free wheel access 
for 3 weeks. At 8 weeks, each rat was injected (i.p.) with vehicle (sterile saline) or 
naltrexone (10, 20mg/kg) one hour into the dark cycle. Injections were counterbalanced 
so that all rats were given each treatment on the night of proestrus (3 estrous cycles), as 
determined by vaginal cytology. An interesting characteristic of females rats is their 
display of voluntary running distance varying with their 4-day estrous cycle (i.e., running 
distance peaks every 4th night), with peak running occurring during proestrus 
(Anantharaman-Barr and Decombaz, 1989). Wheel running was monitored 120-min post-
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injection. Food hopper weights were recorded at 2000 and 2200 h (immediately prior to, 
and 2 h post-injection, respectively). 
 
Experiment 4 
 The effect of NAc dopaminergic neuron ablation on voluntary running was tested 
in HVR rats. Six week-old rats were introduced to running wheels. At 7 weeks, cannulae 
were bilaterally inserted to target the NAc shell. Following surgery, rats were injected 
with either 6-hyrdoxydopamine 6-OHDA (n = 9) to destroy dopaminergic nerve 
terminals or saline (n = 8). Given the high heterogeneity in running distances in the HVR 
line (unpublished observation), rats were matched-paired to vehicle or 6-OHDA 
according to running distance prior to surgery, with an additional rat assigned to the 6-
OHDA group. Counter-balanced naltrexone injection occurred 21 days after surgery to 
ensure the loss of retrograde cells. Running distance and food intake were measured as in 
Experiment 3. 
 
Tissue Extraction 
During sacrifices, brains tissue was extracted using a 2mm-thick punch tool and 
brain sectioning apparatus (Braintree Scientific). Tissue plugs from 2mm-thick coronal 
brain slices were identified per a rat brain atlas (Paxinos and Watson, 1998). 
 
Western Blotting 
Western blotting was performed as previously described (Roberts et al., 2014). 
Twenty microgram of protein was loaded onto SDS-PAGE gels, transferred onto 
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nitrocellulose membranes, and incubated with Ponceau S (Sigma) to verify equal lane 
loading. Primary antibody for Oprm1 (1:500, Santa Cruz Biotechnology) was diluted in 
TBST with 5% BSA and applied to membranes overnight at 4C. HRP-conjugated 
secondary antibody (1:1,000; Cell Signaling) was applied for 1 h at room temperature in 
TBST with 5% non-fat milk. Prior to exposure, ECL substrate (Pierce Biotechnology) 
was applied for 5 minutes. Band densitometry was obtained using a Kodak 4000R Imager 
and Molecular Imagery Software (Kodak Molecular Imaging Systems, New Haven, CT). 
 
Tissue Dissociation and Electrophysiology 
NAc punches were dissociated using a previously established procedure (Kuehl-
Kovarik et al., 2002). Electrophysiological recordings from HVR and LVR NAc neurons 
(n = 16/line) occurred 16-24 h following dissociation, as previously described (Kuehl-
Kovarik et al., 2002). Whole-cell recordings were obtained with thin-walled borosilicate 
glass micropipettes (World Precision Instruments), with a resistance of 2-3 M, filled 
with a potassium gluconate intracellular solution [in millimoles: 120 potassium 
gluconate, 1 CaCl2, 1 MgCl2, 10 HEPES, 1 NaCl, 5 EGTA, 2 ATP, and 0.2 GTP (pH 
7.2–7.4)]. The presence of 1 mM CaCl2 during isolation and trituration prevents the 
retention of presynaptic boutons on dissociated neurons (Drewe et al., 1988) and ensures 
recordings from post-synaptic neurons. Recordings were performed using a MultiClamp 
700B digitized with a Digidata 1440 and stored using pClamp 10 software (Molecular 
Devices). 
Whole-cell current-clamp recordings were used to examine depolarizing or 
hyperpolarizing responses in cells isolated from HVR and LVR rats. The majority of cells 
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were firing (resting membrane potential <−50 to −55 mV) when whole-cell, current-
clamp mode was achieved. Cells were hyperpolarized to −60 mV to prevent spontaneous 
activity. Given that medium spiny neurons (MSNs) represent 90-95% of neurons in the 
NAc (Yager et al., 2015), we assumed recordings were from MSNs, however 
characterizations of D1-type vs. D2-type MSNs were not made. MSNs were also 
identified by morphological analysis, as previously described (Calabresi et al., 1995; 
Calabresi et al., 1990). While recording in whole-cell current-clamp, each neuron was 
bathed in artificial cerebrospinal fluid (ACSF) (2 minutes), then ACSF + DAMGO (1 
µM) for 4-6 minutes, and finally washed with ACSF (5-10 minutes). Previous studies 
have indicated that the EC50 for DAMGO in the NAc of the normal rat pup is 0.1 µM, 
suggesting that 1 µM DAMGO may be a saturating concentration (Chieng and Bekkers, 
2001). Data were digitized at 20 kHz and low-pass filtered at 4 kHz. All amplitude 
measurements were taken in reference to the pre-pulse baseline. Latency and duration 
measurements were taken at the time of pulse initiation. 
 Each cell was analyzed as an individual data point. The amplitude of the response 
(depolarization or hyperpolarization) was determined in relationship to the baseline 
established before the application of DAMGO. Depolarization and hyperpolarization 
were treated as different responses and analyzed separately. Data were analyzed for 1) the 
percentage of cells that respond (with a >3 mV response) to DAMGO per rat line; and 2) 
the mean amplitude of response to DAMGO for each rat line. 
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Thermal Stimulation Test 
Paw-withdrawal latency (PWL) to radiant heat was examined according to the 
Hargreaves test (Dirig et al., 1997; Hargreaves et al., 1988) using a Model 390 Paw 
Stimulator Analgesia Meter (IITC/Life Science Instruments; Woodland Hills, CA). This 
test was performed to assess potential differences in peripheral opioid signaling. Rats 
were individually placed into Plexiglas chambers on an elevated glass floor and 
habituated to the environment for 30 minutes.  A beam of radiant heat at low (10%) 
stimulus intensity was applied to the plantar surface of each hind paw through the glass 
plate.  When the rat lifted its foot, the light beam was turned off.  The length of time 
between the start of the light beam and the foot lift was measured by the apparatus and 
defined as the PWL.  A cut-off time of 20 seconds was used to avoid tissue damage to the 
paw and there was a 5-minute interval between testing left and right paws. The trials were 
then repeated for increasing (20%, 40%, 60%, 80% and 100%) intensities with 5-minute 
intervals between intensities. 
 
RNA isolation, cDNA synthesis, and qRT-PCR 
 RNA isolation, cDNA synthesis, and qRT-PCR were performed as previously 
described (Ruegsegger et al., 2015). Gene-specific primers were constructed using 
PrimerExpress3.0 (Applied Biosystems) (Table 2.1). Twenty nanograms of cDNA from 
each sample were assayed in duplicate using SYBR Green Mastermix (Applied 
Biosystems). mRNA expression values were quantified using the 2ΔΔCt method, whereby 
ΔCT = 18S Ct – target gene Ct.  
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Table 2.1. Primer sequences for gene expression analyzed by qRT-PCR 
Gene Forward (5’- 3’) Reverse (5’- 3’) 
18S GCCGCTAGAGGTGAAATTCTTG CATTCTTGGCAAATGCTTTCG 
Fos GGAGCCGGTCAAGAACATTA ATGATGCCGGAAACAAGAAG 
Drd1 TCTCCTGGGCAATACCCTTGT GGACCTCAGGTGTCGAAACC 
Drd2 GTCCTGGTACGATGACGATCTG CCTTCCCTTCTGACCCATTG 
Drd5 CAACTCAATTGGCACAGAGACAA TTGGACAGCAGGCCCTCTT 
Th TGTTGGCTGACCGCACAT CCCAGAGATGCAAGTCCAATG 
 
Surgery and 6-OHDA administration 
Brain cannula were implanted as previously described (Ruegsegger et al., 2015). 
On the day of surgery, rats (165-215 g) were anesthetized with a mixture of 
ketamine/xylazine (87/13 mg/kg). Cannulae were bilaterally implanted 2.5 mm above the 
NAc shell using coordinates (relative to Bregma): 1.30 mm rostral, 0.80 mm from 
midline, 6.40 mm ventral. Infusions were performed using a 31-gauge injector attached to 
polyethylene tubing and 10-mm Hamilton syringes mounted to an infusion pump 
(Harvard Apparatus). 6-OHDA hydrobromide (12 μg/0.5 μl) (Sigma) or vehicle (0.2% 
ascorbic acid) were bilaterally infused over 2 min for a final volume of 0.5 μl. Injectors 
remained in place for 2 additional minutes to allow proper infusion. 30-gauge stylets 
were inserted into the guide cannulae to prevent occlusions. To spare noradrenergic 
terminals, desipramine (15 mg/2 ml/kg i.p.) was injected 30-min before 6-OHDA 
injections. Following initial recovery, rats were placed back into their home cages with 
running wheels and monitored for 21 days before beginning naltrexone or saline i.p. 
injections. 
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Immunohistochemistry for 6-OHDA dopamine neuron lesion 
6-OHDA depletion of dopamine neurons was assessed by tyrosine hydroxylase 
immunostaining (1:1000, EMD-Millipore), as previously described (Roberts et al., 2014). 
Micrographs were captured using an Olympus BX60 photomicroscope (Olympus), and 
photographed with a Spot Insight digital camera (Diagnostic Instruments). TH-positive 
neurons in the NAc and dorsal striatum were counted using Fiji (ImageJ) software 
(National Institutes of Health, Bethesda, MD). 
 
Statistical Analysis  
Data were analyzed with SigmaPlot 12.0 (Systat Software, Inc). Significance was 
set with an alpha-value of 0.05. Student’s t-test compared differences in Oprm1 mRNA, 
protein, and electrophysiological responses following DAMGO application between 
HVR and LVR rats. Differences in Oprm1 mRNA expression between brain regions was 
assessed by a one-way analysis of variance (ANOVA). For thermal stimulation, the 
average of the PWL was log transformed and analyzed via two-way ANOVA. Two-way 
ANOVA was used to assess the influences of naltrexone on mRNA expression. 
Repeated-measures ANOVA assessed incremental differences in running distance 
following the dose-dependent injection of naltrexone in Experiments 3 and 4. Repeated-
measures ANOVA compared differences in food intake in Experiments 3 and 4. Basal 
differences in running distance in Experiment 4 were assessed with paired-t-test. Holm-
Sidak analysis was used for all post-hoc analysis when appropriate.  
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RESULTS 
Experiment 1 
 Oprm1 mRNA was increased in the NAc (core and shell) (p = 0.014) and Arc (p = 
0.025) of HVR compared to LVR rats (Figure 2.1A). Additionally, one-way ANOVA 
inclusive of both HVR and LVR showed that Oprm1 mRNA expression was influenced 
by brain region (F5,78 = 36.2, p < 0.001) (Figure 2.1B). Oprm1 protein in the NAc was ~2-
fold greater in HVR rats (p = 0.020) (Figure 2.1C). Two-way ANOVA found that Oprm1 
protein was increased in the Hb compared to ECN (F1,12 = 74.2, p < 0.001), while Oprm1 
protein in the Hb (p = 0.15) or ECN (p = 0.96) was not different between HVR or LVR 
(Figure 2.1D). Whole-cell current-clamp recordings from NAc neurons showed no 
differences in capacitance (Cm) (HVR: 9.34 ± 0.68, LVR: 9.78 ± 1.23, p = 0.77) between 
isolated HVR and LVR NAc neurons (Figure 2.1E). Following administration of 1μM 
DAMGO, the mean average response (mV) for all neurons trended (p = 0.060) to be 
increased in HVR neurons (HVR: 4.82 ± 2.26, LVR: -0.13 ± 1.14) (Figure 2.1F). 
Additionally, ~45% of HVR neurons (7/16) produced depolarizing responses (>3mV 
response), compared to 25% of LVR neurons (4/16) depolarizing following DAMGO 
application (Figure 2.1G). Of depolarizing cells, the mean average response was greater 
in HVR than LVR NAc neurons (HVR: 13.08 ± 2.50, LVR: 4.90 ± 1.21, p = 0.044) 
(Figure 2.1H). Together, these results suggest Oprm1 function is inherently greater in the 
NAc of HVR compared to LVR rats. 
No significant differences between HVR and LVR rats in the PWL responses 
were present across stimulus intensities (F2,130 =1.23, p = 0.30) (Figure 2.2). 
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Figure 2.1. Oprm1 expression and functions differ between HVR and LVR. 
Oprm1 mRNA is increased in the NAc (core and shell) and arcuate nucleus (Arc) in 
sedentary HVR, versus LVR, rats (A). In analysis inclusive of both HVR and LVR 
rats, Oprm1 mRNA was differentially expressed depending on brain region [note: 
different letters denote different statistical significance (p < 0.05)] (B). Oprm1 
protein is greater in the NAc of HVR rats (C), and increased in the Hb compared to 
ECN in both HVR and LVR rats (D). We performed current-clamp electrophysiology 
on isolated NAc neurons from HVR and LVR rats (n = 16/line) (E). For all neurons 
analyzed, HVR neurons tended (p = 0.06) to have a greater mean average response 
(mV) to 1μM DAMGO treatment (F). Application of DAMGO produced 
depolarizing responses (> 3 mV) in 44% (7/16) and 25% (4/16) of HVR and LVR 
neurons, respectively (G). Of the neurons depolarized following DAMGO 
application, the mean average response was 2.7-fold greater in HVR neurons (H). 
Representative traces for HVR (I) and LVR (J) neurons. Scale bar in (J) also applies 
to (I). Values are presented as mean ± SEM. * indicates significant difference 
between HVR and LVR (p < 0.05). 
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Experiment 2 
 All qRT-PCR data are shown in Table 2.2. Two-way ANOVA of mRNA 
expression in the NAc core showed that naltrexone reduced Fos mRNA expression (F1,22 
= 8.06, p = 0.010), while Drd2 (F1,22 = 4.57, p = 0.044) and Drd5 (F1,22 = 8.09, p < 0.01) 
mRNA were higher in HVR compared to LVR rats. Analysis of mRNA expression in the 
NAc shell showed that naltrexone significantly reduced Fos (F1,22 = 6.54, p = 0.018) and 
Drd5 (F1,22 = 7.87, p = 0.010) mRNA expression. Post-hoc analysis revealed that 
naltrexone reduced Fos (p = 0.015) and Drd5 (p = 0.035) mRNA expression in HVR rats, 
but had no effect in LVR rats (Figure 2.3A, C). Analysis of mRNA expression in the Arc 
revealed that naltrexone reduced Fos mRNA expression (F1,22 = 5.66, p = 0.026), with 
post-hoc analysis determining Fos mRNA decreased following naltrexone in HVR rats (p 
= 0.014). Analysis of mRNA expression in the VTA identified a line x drug interaction 
(F1,22 = 5.97, p = 0.023) for Th mRNA expression, with post-hoc analysis showing 
 
Figure 2.2. Paw withdrawal latency is similar between HVR and LVR. Paw 
latency withdrawal in seconds at varied thermal intensities for HVR (closed circles) 
and LVR (open circles) rats (n = 11-12/line). Values are presented as mean ± SEM. 
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naltrexone reduced Th mRNA expression in HVR (p = 0.031) but not LVR rats (Figure 
2.3B, D), and Th mRNA was increased in HVR compared to LVR rats treated with saline 
(p = 0.028).   
 
 
  
 
Figure 2.3. NAc and VTA mRNA expression following naltrexone injection. 
Relative mRNA expression of Fos, Drd1, Drd2, Drd5, and Th 120-min post i.p. 
saline (black) or naltrexone (20 mg/kg) (white) injection for the nucleus accumbens 
shell (A) and ventral tegmental area (B) of HVR rats and for the nucleus accumbens 
shell (C) and ventral tegmental area (D) of LVR rats. Values are presented as mean ± 
SEM (n = 6-7/group). * indicates significant difference between saline and 
naltrexone (p < 0.05).  
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Table 2.2. Full qRT-PCR results following naltrexone injection 
  HVR-sal HVR-ntx LVR-sal LVR-ntx 
NAc core     
Fos† 1.00 ± 0.10 0.69 ± 0.09 0.90 ± 0.13 0.57 ± 0.12 
Drd1 1.00 ± 0.13 0.87 ± 0.14 0.78 ± 0.12 0.60 ± 0.07 
Drd2* 1.00 ± 0.09 0.95 ± 0.09 0.72 ± 0.12 0.69 ± 0.06 
Drd5* 1.00 ± 0.09 0.97 ± 0.17 0.78 ± 0.12 0.52 ± 0.09 
NAc shell     
Fos† 1.00 ± 0.13 0.58 ± 0.09‡ 0.85 ± 0.12 0.71 ± 0.12 
Drd1 1.00 ± 0.09 0.62 ± 0.13 0.73 ± 0.15 0.61 ± 0.10 
Drd2 1.00 ± 0.12 0.64 ± 0.13 0.90 ± 0.21 0.94 ± 0.12 
Drd5† 1.00 ± 0.08 0.67 ± 0.05‡ 0.74 ± 0.11 0.56 ± 0.08 
Arcuate nucleus     
Fos† 1.00 ± 0.08 0.76 ± 0.06‡ 0.78 ± 0.07 0.73 ± 0.06 
Drd1 1.00 ± 0.12 0.85 ± 0.10 0.85 ± 0.07 1.09 ± 0.13 
Drd2 1.00 ± 0.09 0.90 ± 0.09 0.80 ± 0.12 0.80 ± 0.11 
Drd5 1.00 ± 0.04 0.82 ± 0.06* 0.77 ± 0.07 0.75 ± 0.06 
VTA     
Th# 1.00 ± 0.35 0.14 ± 0.03‡ 0.33 ± 0.14‡ 0.37 ± 0.12 
Values are mean ± SEM. mRNA expression values are presented as 2ΔΔCT whereby ΔCT 
= 18S CT − gene of interest CT. Expression values were normalized to 1.0 for HVR-sal. 
Statistical comparisons were made with two-way ANOVA. Symbols: * denotes 
significant line (HVR vs. LVR) effect, † denotes significant drug (saline (sal) vs. 
naltrexone (ntx), # denotes significant line x drug interaction, ‡ denotes significant 
statistical difference from HVR-sal (p<0.05) (n = 6-7/group). 
 
Experiment 3 
 Running patterns and food intake following injection of either saline or 10 or 20 
mg/kg naltrexone are shown in Figure 2.4. Analysis of running and feeding behavior on 
the night of saline injection with one-way ANOVA determined that HVR rats ran (F1,25 = 
77.69, p < 0.001) significantly more than LVR rats, however no differences in food 
intake were present (F1,25 = 3.37, p = 0.079). Repeated-measures ANOVA showed a 
significant effect of naltrexone administration on running distance in HVR (F2,76 = 12.59, 
p < 0.001), but not LVR rats (F2,72 = 1.89, p = 0.17). Post-hoc analysis revealed wheel 
running was decreased in HVR rats following both 10 and 20 mg/kg naltrexone 
administration compared to saline (p < 0.05). Repeated-measures ANOVA showed that 
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naltrexone significantly decreased food intake in HVR (F2,18 = 7.90, p < 0.01), but not 
LVR (F2,23 = 0.79, p = 0.51) rats. Post-hoc analysis revealed that both 10 (p = 0.01) and 
20 mg/kg (p < 0.01) doses of naltrexone decreased food intake, compared to saline, in the 
HVR line. 
 
 
Figure 2.4. Wheel running following systemic naltrexone injection. Wheel 
running and food intake responses following intraperitoneal injection of saline (SAL) 
(black circle), 10 mg/kg naltrexone (NTX) (gray square), or 20 mg/kg NTX (open 
triangle). Panels A-C depict running distance in 30-min segments, running distance 
for the entire 120-min test session, and food intake for the entire 120-min test session 
in HVR rats, respectively. Panels D-F depict running distance in 30-min segments, 
running distance for the entire 120-min test session, and food intake for the entire 
120-min test session in LVR rats, respectively. Values are presented as mean ± SEM 
(n = 13-14/group). Symbols indicate significant difference from saline: * p < 0.05, ** 
p < 0.01, *** p < 0.001. 
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Experiment 4 
 6-OHDA infusion reduced TH-immunoreactivity 81% and 43% in the NAc and 
dorsal striatum, respectively, compared to saline injection (Figure 2.5A). No relationships 
between the size or location of the lesion and running distance or food intake were 
observed (data not shown). Paired t-test showed 6-OHDA decreased wheel running in the 
1st week following infusion (p < 0.01) (Figure 2.5B).  
 
 
 
Running patterns and food intake following injection of either saline or 5, 10 or 
20 mg/kg naltrexone in vehicle or 6-OHDA treated rats are shown in Figure 2.6. Analysis 
of running and feeding behavior on the night of saline injection with one-way ANOVA 
found no differences in running distance (F1,15 = 1.26, p = 0.280) or food intake (F1,25 = 
1.22, p = 0.287) between vehicle and 6-OHDA injected rats. Repeated-measures 
ANOVA showed a significant effect of naltrexone on running distance in vehicle (F3,63 = 
 
Figure 2.5. 6-OHDA influence on wheel running. Representative tyrosine 
hydroxylase (TH) stained coronal sections of the striatum from rats that received 
either vehicle (VEH) (left panel), or 6-hydroxydopamine (6-OHDA). 6-OHDA 
induced lesions ranged from mild (middle panel) to severe (right panel). 6-OHDA 
depletion of TH immunostaining was noted in the NAc and dorsal striatum (A). 
Paired t-test showed that 6-OHDA (open circles) infusion into the NAc decreased 
wheel running in the initial week following injection (B). Values are presented as 
mean ± SEM. * indicates significant difference between VEH and 6-OHDA (p < 
0.05). 
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11.158, p < 0.001), but not 6-OHDA-injected HVR rats (F3,72 = 1.068, p = 0.381). Post-
hoc analysis revealed wheel running was decreased in vehicle-treated HVR rats following 
10 and 20mg/kg naltrexone administration (p < 0.05). For the entire 120-min 
experimental session, repeated-measures ANOVA showed that naltrexone significantly 
decreased food intake in both vehicle (F3,20 = 4.96, p < 0.01) and 6-OHDA injected HVR 
rats (F3,24 = 9.732, p < 0.001). Post-hoc analysis revealed that 20 mg/kg (p < 0.01) and 10 
and 20 mg/kg (p < 0.001) naltrexone injections decreased food intake in vehicle and 6-
OHDA-treated HVR rats, respectively. 
50 
 
 
 
 
 
Figure 2.6. 6-OHDA influence on naltrexone-induced changes in wheel running. 
Wheel running and food intake responses following intraperitoneal injection of saline 
(SAL) (black circle), 5 mg/kg naltrexone (NTX) (dark gray diamond), 10 mg/kg 
NTX (gray square) or 20 mg/kg NTX (open triangle) in HVR rats. Panels A-C depict 
running distance in 30-min segments, running distance for the entire 120-min test 
session, and food intake for the entire 120-min test session in vehicle (VEH) treated 
rats, respectively. Panels D-F depict running distance in 30-min segments, running 
distance for the entire 120-min test session, and food intake for the entire 120-min 
test session in 6-hydroxydopamine (6-OHDA) treated rats, respectively. Values are 
presented as mean ± SEM (n = 8-9/group). Symbols indicate significant difference 
from saline: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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DISCUSSION 
To our knowledge, this is the first report to analyze how opioidergic and 
dopaminergic signaling work together to mediate wheel running behavior. Given the 
polygenic nature of human physical activity (Lippi et al., 2008), our unique model of 
high and low voluntary running provides a valuable tool to understand running 
neurobiology, and potentially why a large proportion of the U.S. population is not 
meeting physical activity guidelines (Troiano et al., 2008).We report the following novel 
findings: 1) Oprm1 expression and function are higher in the NAc of sedentary HVR than 
LVR rats, 2) blocking opioid-receptor function with naltrexone decreases mRNAs related 
to dopamine signaling in HVR, but not LVR, rats, 3) naltrexone reduces wheel running 
and food intake in HVR, but not LVR rats, and 4) HVR rats with ablated NAc 
dopaminergic neurons are refractory to naltrexone-induced reductions in wheel running, 
but not food intake. Together, these findings suggest that inherent differences in Oprm1 
action and downstream dopaminergic signaling may influence inherited physical activity 
behavior. Collectively with previous studies (Brown et al., 2015; Roberts et al., 2012; 
Roberts et al., 2014; Ruegsegger et al., 2015), a model by which inherent differences in 
the mesolimbic dopamine system may contribute to differing physical activity levels 
between HVR and LVR rats is presented in Figure 2.7. 
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Figure 2.7. Hypothesized, collective model summarizing how inherent differences 
in the mesolimbic dopamine system may influence physical activity levels in HVR 
and LVR rats. Previous evidence suggests endogenous opioids are increased in HVR 
compared to LVR rats. Despite no difference in Oprm1 expression in the VTA, we 
speculate elevated endogenous opioids may lead to inherent increases in DA release in 
the NAc of HVR rats indirectly via disinhibition of GABAergic neurons in the VTA. 
The effect of DA in HVR rats on down-stream cAMP production and DA-related gene 
transcription may be further amplified by increased dopamine receptor expression in 
the NAc, together with similar levels of DAT, compared to LVR rats. Increased Oprm1 
expression in the NAc of HVR rats may enhance DA-related gene transcription. In 
total, we speculate these adaptations may lead to the drastic divergence in wheel 
running between HVR and LVR rats. Abbreviations: DA: dopamine; DxR: dopamine 
receptor; DAT: dopamine transporter; MSN: medium spiny neuron; OPRM1: mu 
opioid receptor 1. 
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 At least some of the rewarding effects of physical activity are caused by the 
stimulation of the same brain circuits that are activated by drugs of abuse, including 
opioidergic and dopaminergic systems (Knab and Lightfoot, 2010). In the current study, 
we focused on opioidergic signaling due to our observations that HVR rats express 
elevated amounts of Oprm1 mRNA and protein in the NAc (core and shell) compared to 
LVR rats, and because Oprm1 expression is associated with various rewarding behaviors 
(Mansour et al., 1995). We demonstrated that NAc neurons from HVR rats are more 
sensitive to mu-opioid receptor-stimulated depolarization than NAc neurons isolated 
from LVR rats. While opioid receptors often work by disinhibition, Ma et al. (Ma et al., 
2012) demonstrated that DAMGO induces depolarizations in D1 cells of the NAc and 
hyperpolarized the threshold for action potential generation in D2 cells of the NAc, 
indicating increased excitability of NAc medium spiny neurons (MSN)s by DAMGO. 
Given that Oprm1 is primarily expressed by dynorphin- and D1-expressing cells 
(Georges et al., 1999), we posit that greater activation of the striatonigral pathway could 
lead to disinhibition of motor circuits that facilitate the motivation for voluntary running 
in HVR rats. However, the current lack of D1 vs. D2 MSN comparisons and recording 
Oprm1 responses only on the postsynaptic membrane limit our interpretation. For 
example, our results could represent a difference in the proportion of Opm1 expressing 
(direct-pathway) neurons in each group. Additionally, these results could be the effect of 
DAMGO indirectly effecting dopamine terminals or off-target effects of DAMGO. 
Nonetheless, our results imply heightened Oprm1 action in the NAc of HVR compared to 
LVR rats.  
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 Pharmacological and transgenic animal studies show that Oprm1 is important for 
responses to thermal pain (Chen and Pan, 2006; Gendron et al., 2007). Interestingly, our 
data show that although HVR rats express higher levels of Oprm1 than LVR rats, we did 
not observe differences in sensitivity to thermal pain between HVR and LVR rats. These 
findings differ with those from rats selectively bred for high and low forced treadmill 
running distance (Geisser et al., 2008). This comparison suggests that pain sensitivity 
may carry a stronger co-selected genetic inheritance in selective breeding models based 
on forced-exercise rather than voluntary running behavior. 
 Our results suggest that HVR rats may have elevated baseline opioidergic activity 
compared to LVR rats and may be hypersensitive to endogenous opioid action. 
Naltrexone reduces ethanol-induced increases in Th mRNA to baseline levels (Lee et al., 
2005; Navarrete et al., 2014), an effect which may contribute to an increase in dopamine 
synthesis. However, we did not observe Oprm1 mRNA differences in the VTA of HVR 
compared to LVR rats, suggesting other factors could influence Oprm1 function in HVR 
rats. Further, a prior report shows no influence of naltrexone on Fos mRNA expression in 
the NAc of naïve rats (Rasmussen et al., 1995); however, naltrexone does increase Fos 
mRNA in morphine-dependent rats (Georges et al., 2000; Rasmussen et al., 1995). Thus, 
naltrexone-induced decreases in Th and Fos mRNA expression in the VTA and NAc 
shell of HVR rats suggests that they may have an elevated basal level of opioidergic 
signaling similar to those in opioid-related addiction phenotypes. However, these data 
have several limitations. Home cage activity was not measured in the current study, thus 
it is possible that diverging levels of home cage activity, rather than inherent genetic 
differences, influence the observed results. Given the high dose of naltrexone (20 mg/kg) 
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used in this experiment, the observed changes in mRNA expression may also be 
influenced by kappa and delta opioid receptor activity. Future studies using low-dose 
subcutaneous (s.c.), rather than i.p., naltrexone injection should be performed given the 
~30-times more potent effect of naltrexone with s.c. injection (Williams and Broadbridge, 
2009). 
We demonstrate that opioidergic inhibition modifies dopaminergic signaling in 
HVR, but not LVR, rats. Opioidergic modification of dopamine action is well described 
(Mansour et al., 1995). Several reports show that opioid-receptor antagonism suppresses 
ethanol-induced dopamine-release in the NAc, a behavior well characterized to involve 
Oprm1 in the NAc (Benjamin et al., 1993; Gonzales and Weiss, 1998). Additionally, 
Oprm1 influences other dopamine-dependent processes such as cocaine self-
administration (Mathon et al., 2005). Likewise, our results suggest that naltrexone 
influences expression of neurons expressing D1-like receptors, which is in agreement 
with the notion that Oprm1 is primarily expressed on D1-like neurons (Georges et al., 
1999). Thus, blocking endogenous opioid action in HVR rats likely reduces contributions 
from neurons in striatonigral “direct” pathway, which express dynoprphin and D1-like 
dopamine receptors, for the promotion of rewarding behavior. We previously noted that 
dynorphin mRNA is intrinsically increased in the NAc of HVR rats versus LVR rats 
(Ruegsegger et al., 2015). Further, our findings show that naltrexone influences 
dopamine receptor expression in the NAc shell but not NAc core. In contrast, a previous 
finding suggests the NAc core, and not shell, likely mediates voluntary running behavior 
(Werme et al., 2002). Future research is needed to clarify the specific contributions of the 
NAc core and shell to wheel running behavior. 
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 We demonstrate that opioid antagonism decreases wheel-running behavior in 
HVR rats. These results are in agreement with previous rat (Li et al., 2004; Sisti and 
Lewis, 2001) and hamster (Schnur and Barela, 1984) studies. In contrast, voluntary 
running of LVR rats is not influenced by opioid antagonism. We posit that the inability of 
LVR rats to respond to naltrexone is a result of lower opioid receptor expression and, 
therefore, depressed opioid signaling. This may at least partially account for the lower 
volume of running exhibited by LVR rats compared to HVR and outbred rats. However, 
we did not observe differences in fecal excretion between HVR and LVR rats following 
naltrexone injection suggesting naltrexone did not change basal levels of endogenous 
opioids (observer observation). Given changes in gene expression in the VTA and NAc 
shell following naltrexone injection, we predict that the NAc and VTA may be the sites 
of action where systemic naltrexone injection influences wheel running behavior in HVR 
rats. Further, while naltrexone did not impact running in LVR rats, the possibility of a 
“floor effect” not allowing a decline in running given the low basal running distance of 
LVR rats must remain viable and still be considered.  
We observed a reduction in running of HVR rats following 6-OHDA infusion into 
the NAc shell. This suggests the mesolimbic dopamine system partially contributes to the 
heightened wheel running performed by HVR rats. However, as the effect disappeared 
two weeks post-lesion, it is possible that neuro-adaptive changes may have taken place to 
compensate for the disrupted dopaminergic system and thus masked the effects of 
dopaminergic lesion on wheel running. However, the above results of the initial decreases 
in wheel running are in agreement with Robbins & Koob (Robbins and Koob, 1980), who 
demonstrated that 6-OHDA lesion in the NAc decreases voluntary wheel running. In the 
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present study, catecholamine loss in the dorsal striatum following 6-OHDA infusion may 
have also contributed to the acute decrease in wheel running in HVR rats. Dopamine 
concentrations in the dorsal striatum are increased in mice bred for high voluntary wheel 
running (Mathes et al., 2010), and ΔFosB in striatal neurons influences wheel running 
(Werme et al., 2002).   
Given that dopamine depletion produced a small change in running, these results 
also suggest that dopamine is important for the motivational, but not locomotor, 
components of wheel running. Thus wheel running may not be a direct index of physical 
activity motivation. Nevertheless, many studies have associated the mesolimbic 
dopamine system with the motivation for voluntary wheel running [see (Knab and 
Lightfoot, 2010) for additional refs]. The finding that 6-OHDA transiently decreases 
running in HVR rats also extends upon several previous studies by our lab showing the 
HVR rats are sensitive to both Drd1 agonism and antagonism in the NAc compared to 
LVR rats (Roberts et al., 2012). Therefore, we speculate that an inherent increased 
potential to respond to dopamine may drive the high running phenotype in the HVR line. 
Given the response of HVR rats to 6-OHDA with current and past data showing LVR rats 
are unresponsive to opioid or dopamine modulation, we posit that LVR rats are 
insensitive to changes in dopamine, potentially due to an inherent reduction in MSNs and 
immature neuron number in the NAc compared to HVR rats (Roberts et al., 2014). 
However, previous unpublished observations from G12 HVR and LVR rats found no 
difference in TH-immunoreactivity, suggesting dopamine projections to the NAc are 
unchanged between HVR and LVR rats (unpublished data). Additionally, the potential 
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ablation of noradrenergic neurons by 6-OHDA may have also contributed to the 
phenotypes observed in the current study. 
Ablation of NAc shell dopaminergic neurons by 6-OHDA blocked naltrexone-
induced decreases in voluntary running by HVR rats. This observation suggests that 
naltrexone influences wheel running by blocking the natural reward from running rather 
than other mechanisms which dictate physical activity reward which could include 
reducing pain perception during exercise (Tierney et al., 1991), β-endorphin-mediated 
glucose uptake in skeletal muscle (Evans et al., 1997), or by inhibiting the ability of β-
endorphin to delay fatigue (Khan and Smith, 1995). Given these results, we speculate an 
interaction between the opioidergic and dopaminergic systems in the NAc may be critical 
for perceiving reward from physical activity. However, given the far-reaching effect of 6-
OHDA on retrograde neurons, it is possible other brain regions may mediate this 
interaction as well. 
 The findings of this study have important implications for dissecting out the 
unique neural-circuitry that drive energy intake and physical activity-associated energy 
expenditure. 6-OHDA infusion in the NAc shell did not block naltrexone-induced 
decreases in food intake by HVR rats. This suggests that opioids may influence wheel 
running and free-feeding behavior in dopamine-dependent and independent mechanisms, 
respectively. This observation is in agreement with our previous study following intra-
NAc infusion of DAMGO which showed that wheel running behavior was altered 
independent of feeding behavior, and together these results suggest the localized site of 
action for wheel running in the current experiment may be the NAc (Ruegsegger et al., 
2015). Additional studies support a disconnect between dopaminergic and opioidergic 
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action for controlling food intake. For example, pretreatment with dopamine D1 and D2 
antagonists does not blunt free feeding following DAMGO infusion into the NAc (Will et 
al., 2006). Additionally, dopamine is a strong mediator of tasks requiring varying degrees 
of effort and motivation to seek reward, such as voluntary wheel running, rather than free 
feeding behavior (Baldo and Kelley, 2007). Taken together, these intriguing findings 
imply opioidergic influences on wheel running behavior require dopamine transmission, 
and changes in effort and motivation for reward, while opioidergic regulation of free 
feeding may not. 
Given the pandemic rates of physical inactivity and its associated comorbidities, 
understanding the molecular mechanisms that control physical activity is of great 
importance. These novel results suggest inherent reductions in Oprm1 signaling may 
contribute to lower physical activity. Similarly, mesolimbic dopamine signaling is 
essential to opioid-reward for voluntary exercise, but not for food intake. These data 
encourage future investigation into leveraging opioidergic and dopaminergic systems 
together to elevate physical activity in sedentary individuals. 
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ABSTRACT 
Prenatal overnutrition affects development into adulthood and influences obesity 
risk. Given the increasing prevalence of obesity during pregnancy, we assessed the 
transgenerational effect of maternal Western diet (WD) consumption on offspring 
physical activity. Voluntary wheel running was increased in juvenile (4-7 weeks of age), 
but decreased in adult (16-19 weeks of age), F1 female WD offspring. In contrast, no 
wheel running differences in F1 male offspring were observed. Intriguingly, increased 
voluntary running in juvenile, female, WD offspring associated with up-regulated Drd1 
and Drd2 in the nucleus accumbens (NAc) and with down-regulated Lepr in the ventral 
tegmental area (VTA). Conversely, decreased voluntary running by adult, female, WD 
offspring associated with down-regulated Drd1 in the NAc and with up-regulated Lepr in 
the VTA. Surprisingly, body fat, leptin, and insulin were increased in male, but not 
female, F1 WD offspring, suggesting changes in wheel running in female WD offspring 
were independent of metabolic disease risk. However, wheel running attenuated 
metabolic changes in male WD offspring. Analysis of F2 offspring found no differences 
in wheel running or adiposity in male or female offspring, suggesting changes in the F1 
generation were likely due in utero somatic reprogramming rather than stable germline 
inheritance. Our findings indicate prenatal WD exposure leads to age-specific changes in 
voluntary physical activity in female offspring that are associated with changes in 
dopamine and leptin signaling in mesolimbic brain nuclei. 
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INTRODUCTION 
The incidence of obesity during pregnancy, which ranges from 20-38% (Yogev 
and Catalano, 2009), increases the risk for obesity and metabolic diseases in both child 
(Mehta et al., 2012) and adult (Lawlor et al., 2011) offspring. In utero overnutrition 
exposure is postulated to influence physical activity levels, an important preventer of at 
least 35 chronic diseases (Booth et al., 2012). Rowland (Rowland, 1998) proposed that an 
“activity-stat” may be influenced by environmental factors during critical pre- and post-
natal periods to regulate the propensity for physical activity. For example, a small-litter 
mouse model of early postnatal overnutrition reduces spontaneous activity and energy 
expenditure in adult females (Li et al., 2013). Paradoxically, both maternal food 
restriction and high-fat feeding in rats also decrease offspring locomotor activity in 
adulthood (Cunha Fda et al., 2015; Vickers et al., 2003). While these findings collectively 
suggest that excess nutritional status during pregnancy detrimentally affects offspring 
physical activity, the mechanisms remain largely unstudied. Specifically, understanding 
how maternal overnutrition influences voluntary physical activity (e.g. wheel running) is 
paramount given the often profound impact of exercise on fat loss (Garland et al., 2011). 
One mechanism by which maternal overnutrition could influence offspring 
physical activity levels is via dysregulation of mesolimbic dopaminergic pathway, which 
at least partially regulates wheel-running (Knab and Lightfoot, 2010). Several reports 
demonstrate that maternal high-fat feeding alters dopamine-related mRNA expression 
and DNA methylation patterns in the nucleus accumbens (NAc) and ventral tegmental 
area (VTA) (Vucetic et al., 2011; Vucetic et al., 2010). Furthermore, expression patterns 
of dopamine and opioid receptors and ligands are up-regulated in juvenile, but down-
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regulated in adult, offspring of “junk food” fed dams (Ong and Muhlhausler, 2011). 
Moreover, recent evidence from dopamine receptor 2 (Drd2) knockdown mice suggests 
decreased mesolimbic dopamine function reduces physical activity, in turn promoting 
obesity (Beeler et al., 2016). 
Leptin receptor signaling is well characterized in VTA dopaminergic neurons 
(Domingos et al., 2011; Fulton et al., 2006; Hommel et al., 2006). Recent findings 
suggest leptin action on mesolimbic DA neurons decreases the motivational and 
rewarding effects of wheel running (Fernandes et al., 2015). However, hyperleptinemia 
during pregnancy in mice increases spontaneous activity in adult offspring, with female 
mice displaying greater responses to hyperleptinemia compared to male mice (Pollock et 
al., 2015). Additionally, pups from diabetic and obese mothers display characteristics of 
peripheral and central leptin resistance (Chen et al., 2008; Steculorum and Bouret, 2011). 
From the above observations, we hypothesized maternal overnutrition before and during 
pregnancy would alter physical activity levels of offspring, potentially through alterations 
in mesolimbic dopaminergic and leptin action. 
Therefore, in the offspring of female rats fed a Western diet (WD) high in fat and 
sucrose before and during pregnancy we examined the extent to which maternal WD 
reprograms the “activity-stat” to alter voluntary physical activity levels, and influences 
dopamine and leptin signaling in mesolimbic brain nuclei. 
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MATERIALS AND METHODS 
Animals and experimental design 
Virgin female Wistar rats (8 weeks old, n = 8 per group) were subjected to a 
standard chow (SD, Purina Formulab Diet 5008) or Western (WD, Teklad TD.88137, 
42% kcal from fat, 27% kcal from sucrose) diet for 5 weeks before and throughout 
pregnancy. For mating, a male rat (14-16 weeks old, n = 16) eating a SD was placed in 
the cage for up to four days. Pregnancy was confirmed by copulatory plug formation. 
Female rats continued the same diet intervention until term, at which time all rats 
received a SD. All offspring consumed a SD for the study duration. Following birth, litter 
sizes were culled to 10 pups (5 males, 5 females) when possible. Body weight was 
recorded weekly from 3 to 18 weeks of age. Male and female offspring were randomly 
selected from each litter (n = 5-7) and euthanized by CO2 asphyxiation at 6 or 18 weeks 
of age between 1200-1500 h, prior to body fat assessment and tissue collection.  
Additionally, 14 week-old SD and WD F1 offspring (n = 5 per diet and sex) were 
bred to generate F2 ND and WD offspring. As with F1 offspring, F2 offspring body 
weight was recorded weekly, and subsets of F2 offspring (n = 5-7 per age and sex) were 
euthanized at 6 or 18 weeks of age for body fat assessment and tissue collection. All F2 
offspring consumed standard chow until sacrifice. 
Rats maintained a 12:12-h light/dark cycle at 21-22°C, with food and water 
provided ad libitum. The Institutional Animal Care and Use Committee of the University 
of Missouri approved all procedures. 
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Offspring voluntary wheel running 
 Juvenile (4-7-weeks of age) and adult (16-19-weeks of age) F1 and F2 offspring (n 
= 4-7 per age and sex) were given access to voluntary running wheels (circumference = 
1.08 m). Voluntary wheel running distance was monitored daily using Sigma Sport BC 
800 bicycle computers. 
 
Offspring spontaneous activity and indirect calorimetry 
In 6- and 18-week-old male and female F1 offspring (n = 4-6), a multi-
dimensional beam break and indirect calorimetry system measured total energy 
expenditure, spontaneous activity, and food intake over a 72-hr period (Promethion, 
Sable Systems Int., Las Vegas, NV). Rats acclimated to chamber environment for 24 h 
before data collection. Data were analyzed as 24-hr averages for each animal to calculate 
group means. 
 
Submaximal exercise run to exhaustion test 
Run to exhaustion tests were performed in 6- and 18-week-old F1 SD and WD 
offspring (n = 3-4 per age and sex). Beginning at 5 or 17 weeks of age, rats were 
familiarized with the treadmill for at least 5 days prior to the experiment by exposure to a 
5-minute run at a speed of 15-20 m/min at a grade of 10% on a motorized treadmill 
(Quinton Instruments, Seattle, WA). The testing procedures in 6- and 18-week-old rats 
are shown in Tables 3.1 and 3.2, respectively. Exercise testing was performed between 
1200 – 1400 h. An electrical shocker and blasts of air from the rear of the treadmill were 
used to stimulate running. Volitional exhaustion was determined as the third time a rat 
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remained on the electrical shocker for at least 2 seconds and could not keep pace with the 
speed of the treadmill, as previously described by Koch and Britton (Koch and Britton, 
2001). At the moment of volitional exhaustion, the rat was removed from the treadmill 
and immediately sacrificed by CO2 asphyxiation.  
 
 
 
Body composition 
Body composition was measured in 6- and 18-week-old offspring using a Hologic 
QDR-1000/w dual-energy X-ray absorptiometry machine calibrated for rats. Body 
composition was assessed in SD and WD F0 dams just prior to breeding using isoflurane 
anesthesia.  
 
Serum leptin and insulin 
 During sacrifice, whole blood samples were removed via heart stick, centrifuged 
at 1300 xg for 10 min in serum separator tubes, and stored at -20°C. Serum from non-
fasted animals were assayed in duplicate for leptin concentration using a mouse/rat leptin 
quantitative ELISA assay (R&D Systems, Minneapolis, MN). Insulin levels were 
Table 3.1. Run to exhaustion protocol used in 6-week-old rats. 
Treadmill belt speed (mph) Grade (%) Time (min) 
20 10 60 
25 10 40 
30 10 Until exhaustion 
 
 
Table 3.2. Run to exhaustion protocol used in 18-week-old rats. 
Treadmill belt speed (mph) Grade (%) Time (min) 
15 10 50 
20 10 20 
25 10 25 
30 10 Until exhaustion 
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assessed by a clinical lab. 
 
Brain tissue extraction 
NAc, VTA, and arcuate nucleus of the hypothalamus (Arc) tissues were extracted 
using a 2mm-thick punch tool and brain sectioning apparatus (Braintree Scientific, 
Braintree, MA). Tissue plugs from 2mm-thick coronal brain slices were identified per a 
rat brain atlas (Paxinos and Watson, 1998). 
 
RNA isolation, cDNA synthesis, and qRT-PCR 
 NAc, VTA, and Arc RNA isolation, cDNA synthesis, and qRT-PCR were 
performed using Trizol (Qiagen) as previously described (Ruegsegger et al., 2015). Gene-
specific primers were constructed using PrimerExpress3.0 (Applied Biosystems) (Table 
3.3). Fifteen nanograms of cDNA from each sample were assayed in duplicate using 
SYBR Green Mastermix (Applied Biosystems). mRNA expression values were 
quantified using the 2ΔΔCt method, whereby ΔCT = 18S Ct – target gene Ct.  
 
Table 3.3. qRT-PCR primer sequences. 
Gene Forward (5’- 3’) Reverse (5’- 3’) 
18S GCCGCTAGAGGTGAAATTCTTG CATTCTTGGCAAATGCTTTCG 
Dat CCCCTCTGTCCACTAGCTGATG TCCGGGAGAAACTGGCCTAT 
Drd1 TCTCCTGGGCAATACCCTTGT GGACCTCAGGTGTCGAAACC 
Drd2 GTCCTGGTACGATGACGATCTG CCTTCCCTTCTGACCCATTG 
Drd5 CAACTCAATTGGCACAGAGACAA TTGGACAGCAGGCCCTCTT 
Lepr TGGGTTTGCGTATGGAAGTC GGTGCTTTTGTTTGGCTGTC 
Oprd1 TGGTATGCACGCTCCAGTTC GAACACGCAGATCTTGGTCACA 
Oprk1 GCAATTCGCGATCGGAGC TCCGCGGAAAATCTGGATGG 
Oprm1 CGATTCCAGAAACCACATTTCA TGTTCGTGTAACCCAAAGCAAT 
Th TGTTGGCTGACCGCACAT CCCAGAGATGCAAGTCCAATG 
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Western blotting 
  NAc samples were pulverized and homogenized as previously described, and fifty 
micrograms of protein was resolved on SDS-PAGE gels for Western blotting, as 
previously described (Roberts et al., 2014). Primary antibodies for Drd1 (ABN20; 
Millipore), Drd2 (ab85367; Abcam), and Gapdh (14C10; Cell Signaling) was diluted in 
TBST with 5% BSA and applied to membranes overnight at 4C. HRP-conjugated 
secondary antibody (7074; Cell Signaling) was applied for 1-h at room temperature in 
TBST with 5% non-fat milk. Prior to exposure, ECL substrate (Pierce Biotechnology) 
was applied, and band densitometry was obtained using a Kodak 4000R Imager and 
Molecular Imagery Software (Kodak Molecular Imaging Systems). Drd1 and Drd2 levels 
were normalized to Gapdh within each sample. 
 
Statistical analysis 
All analytical procedures were performed using SigmaPlot 12.0 (Systat Software, 
Inc., Chicago, IL). A two-way analysis of variance (ANOVA) assessed changes in body 
weight, food intake, body fat, leptin, insulin, spontaneous activity, energy expenditure, 
and wheel running in male and female offspring. Student’s t-test assessed between group 
differences in mRNA and protein levels within male or female offspring at 6- or 18-
weeks-old, and differences in dam characteristics. Holm-Sidak post-hoc analyses were 
applied when necessary. Pearson’s correlation analysis was used to compare variables of 
interest. Full statistics from ANOVA tests are presented in Table 3.4. Significance was 
set at p < 0.05. 
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RESULTS 
Maternal WD causes age- and sex-specific effects on F1 offspring body composition, 
body weight, and serum leptin and insulin 
 Characteristics of SD and WD dams are shown in Figure 3.1. Of note, WD dams 
had 80% greater body fat percentage immediately prior to breeding (p < 0.001). 
 
 Maternal WD decreased body weight in male and female F1 offspring up to 5 and 
8 weeks of age, respectively (p < 0.05) (Figure 3.2A, H). However, maternal WD 
exposure increased body weight by 18 weeks of age in male offspring (p < 0.05). 
Additionally, maternal WD increased body fat percentage, serum leptin, and serum 
insulin in 18-week-old male, but not female, F1 offspring (p < 0.01) (Figure 3.2B-D, I-K). 
However, these maternal WD-induced increases in body fat, insulin, and leptin in male F1 
offspring were reduced by voluntary wheel running from 16-19 weeks of age (p < 0.01) 
 
Figure 3.1. WD was obesogenic in dams. Following 5 weeks of SD or WD 
consumption, and just prior to breeding, body fat percentage (A) and food intake relative 
to body weight (B) were increased in WD compared to ND. No differences in litter size 
were observed between SD and WD dams. Data are mean ± standard deviation. 
Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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(Figure 3.3A-C). Body fat and insulin levels were greater at 18, compared to 6, weeks of 
age in male F1 offspring (p < 0.001)  while leptin was greater 18, compared to 6, weeks 
of age in both male and female F1 offspring (p < 0.01). Metabolic chamber analysis, 
without wheel access, suggested that adulthood increases in body fat, leptin, and insulin 
levels in male WD F1 offspring were likely the result of increased food intake (p = 
0.004), rather than reductions in locomotor activity (p = 0.71) or energy expenditure (p = 
0.089) (Figure 3.2E-G). In female F1 offspring no differences in spontaneous activity (p = 
0.23) or total energy expenditure (p = 0.67) were observed when housed without running 
wheels, while food intake trended to be increased in WD offspring (p = 0.056) (Figure 
3.2L-N). 
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Figure 3.2. Effect of maternal WD on F1 offspring phenotype. Maternal WD male 
offspring had decreased body weight up to 5 weeks of age and increased body weight at 
18 weeks of age (A). Body fat (B), serum leptin (C), and serum insulin (D) were increased 
at 18 weeks of age in WD male offspring, despite no differences being present at 6 weeks 
of age. In male offspring, metabolic chamber analysis at 6 and 18 weeks of age found 
increased food intake relative to bodyweight in WD offspring (E), but no differences in 
spontaneous physical activity (SPA) (F), or total energy expenditure (TEE) (G). As 
observed in male offspring, Maternal WD female offspring had decreased body weight up 
to 7 weeks of age (H). No between diet differences in body fat (I), serum leptin (J), and 
serum insulin (K) were observed in 6- and 18-week-old old female WD compared to SD 
offspring. Metabolic chamber analysis at 6- and 18-week-old female offspring found no 
differences in food intake relative to bodyweight (L), SPA (M), or TEE (N) between SD 
and WD offspring. Data in bar graphs are mean ± standard deviation while data in line 
graphs are mean ± SEM. Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Maternal WD increases voluntary wheel running in juvenile female F1 offspring 
Previous studies show that developmental programming sex-specifically affects 
physical activity (both home cage activity and voluntary wheel running (Baker et al., 
2015; Eclarinal et al., 2016; Li et al., 2013). In juvenile F1 offspring, maternal WD did 
 
Figure 3.3. Effects of voluntary running on adiposity. Voluntary wheel running reduced 
body fat (A), serum leptin (B), and serum insulin (C) in adult (18 week old) male SD and 
WD F1 offspring. Of note voluntary wheel running in male offspring of WD-fed dams 
rescues levels to to those of sedentary offspring from SD-fed dams. However, similar 
reductions in adult female offspring body fat (D), serum leptin (E), and serum insulin (F) 
were not observed following voluntary wheel running. Different letters denote statistically 
significant differences. Abbreviations: SD-sed: standard diet + sedentary, SD-Ex: standard 
diet + voluntary running wheel, WD-sed: Western diet + sedentary, WD-Ex: Western diet 
+ voluntary running wheel. Data are mean ± standard deviation. 
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not influence wheel running distance in male offspring (p = 0.194) (Figure 3.4A). 
Similarly, no differences in mRNA expression or Drd1 and Drd2 protein levels in the 
NAc were observed in 6-week-old male F1 offspring (Figure 3.4B-D). However, in 
female F1 offspring, maternal WD increased wheel running in juvenile offspring (p = 
0.003) (Figure 3.4E), consistent with previous literature demonstrating female-specific 
influences of developmental programming on physical activity levels (Baker et al., 2015; 
Li et al., 2013). Additionally, Drd1 and Drd2 mRNA was up-regulated, while Dat mRNA 
was down-regulated, in 6-week-old female F1 WD offspring (p < 0.05) (Figure 3.4F). 
Furthermore, Drd1 and Drd2 protein levels were greater in 6-week-old female WD 
offspring (p < 0.05) (Figure 3.4G-H), corroborating previous findings that increased Drd1 
and Drd2 expression in the NAc may be predictive of increased wheel running behavior 
(Ruegsegger et al., 2015). Interestingly, VTA Lepr mRNA was down-regulated in 6-
week-old female, but not male, WD F1 offspring (p < 0.01) (Figure 3.4I-J), despite no 
differences in Arc Lepr mRNA in 6-week-old male and female offspring (Figure 3.4K). 
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Figure 3.4. Legend is on following page. 
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Maternal WD decreases voluntary wheel running in adult female F1 offspring 
 Like in juvenile F1 offspring, maternal WD did not influence wheel running 
distance in adult male F1 offspring (p = 0.400) (Figure 3.5A). Only NAc Dat mRNA was 
down-regulated in 18-week-old WD, compared to SD, male F1 offspring (p < 0.05) 
(Figure 3.5B), and NAc Drd1 and Drd2 protein levels did not differ between SD and WD 
male F1 offspring (Figure 3.5C, D). Contrary to findings in juvenile offspring, maternal 
WD decreased wheel running in adult female F1 offspring (p = 0.003) (Figure 3.5E). Of 
note, differences in voluntary wheel running were independent of differences in exercise 
endurance during a submaximal treadmill run to exhaustion test, suggesting systems 
controlling exercise motivation and capacity could be dissimilar and do not contribute to 
differences in wheel running accompanying maternal WD (Figure 3.6). The decrease in 
wheel running in female WD F1 offspring was accompanied by the down-regulation of 
Drd1 and Dat mRNA and up-regulation of Drd5 mRNA in the NAc of 18-week-old 
female WD F1 offspring (p < 0.05) (Figure 3.5F). NAc Drd1 protein was decreased (p < 
0.05) in 18-week-old female WD F1 offspring (p < 0.05) without any difference in Drd2 
Figure 3.4. Effects of maternal WD on voluntary wheel running in juvenile F1 
offspring. Maternal WD did not influence voluntary wheel running distance in 4-7-
week-old male offspring (A). Maternal WD had no effect on NAc mRNA expression 
(B) or Drd1 (C) or Drd2 (D) protein levels in the NAc. Maternal WD increased 
voluntary wheel running distance in 4-7-week-old female offspring (E). This increase 
in wheel running in WD female offspring was accompanied by an increase in Drd1 
and Drd2 mRNA expression and a decrease in Dat mRNA expression in the NAc (F). 
Similarly, Drd1 (G) and Drd2 (H) protein levels were increased in the NAc of female 
WD offspring compared to SD offspring. No differences in VTA mRNA expression 
were observed in male offspring (I), while Lepr mRNA expression in the VTA was 
reduced in female WD offspring (J). In analysis inclusive of both male and female 
offspring, no difference in Arc Lepr mRNA expression was observed between SD and 
WD offspring (K). Data in bar graphs are mean ± standard deviation while data in line 
graphs are mean ± SEM. Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
76 
 
protein (p = 0.72) (Figure 3.5G-H). Also opposite to 6-week-old offspring results, VTA 
Lepr mRNA was up-regulated in 18-week-old female, but not male, WD F1 offspring (p 
< 0.05) (Figure 3.5I-J), while Arc Lepr mRNA in male and female 18-week-old WD F1 
offspring was down-regulated (p < 0.001) (Figure 3.5K). Previous findings demonstrated 
that interactions between leptin and the mesolimbic dopamine pathway influence wheel-
running behavior (Fernandes et al., 2015). Here, serum leptin was negatively correlated 
with running distance in WD (p = 0.03), but not SD (p = 0.79), adult F1-female offspring, 
suggesting variations in leptin sensitivity could associate with adulthood differences in 
wheel running following maternal ND or WD (Figure 3.5L). Similarly, analysis inclusive 
of both SD and WD female 18-week-old F1 offspring demonstrated that NAc Drd1 
mRNA negatively correlated with VTA Lepr mRNA (p < 0.01) (Figure 3.5M). 
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Figure 3.5. Legend is on following page. 
78 
 
 
 
 
Figure 3.5. Effects of maternal WD on voluntary wheel running in adult F1 
offspring. Maternal WD did not influence voluntary wheel running distance in 16-19-
week-old male offspring (A). Dat mRNA expression in the NAc was decreased in 
male WD offspring (B), while Drd1 (C) and Drd2 (D) protein levels in the NAc were 
unchanged between SD and WD male offspring. Maternal WD decreased voluntary 
wheel running distance in 16-19-week-old female offspring (E). This decrease in 
wheel running in WD female offspring was accompanied by a decrease in Drd1 and 
Dat mRNA expression and an increased in Drd5 mRNA expression in the NAc (F). 
Drd1 (G), but not Drd2 (H), protein was decreased in the NAc of female WD 
offspring compared to SD offspring. No differences in VTA mRNA expression were 
observed in male offspring (I), while Lepr mRNA expression in the VTA was 
increased in female WD offspring (J). In analysis inclusive of both male and female 
offspring, Arc Lepr mRNA expression was decreased in WD offspring (K). 
Additionally, Pearson’s correlation analysis showed a negative relationship between 
voluntary wheel running distance and serum leptin in female WD offspring (L), and a 
negative relationship between VTA Lepr mRNA expression and NAc Drd1 mRNA 
expression in SD and WD female offspring (M). Data in bar graphs are mean ± 
standard deviation while data in line graphs are mean ± SEM. Symbols: * p < 0.05, ** 
p < 0.01, *** p < 0.001. 
 
 
Figure 3.6. Run to exhaustion performance. Maternal WD during gestation did not 
influence submaximal run to exhaustion distance in 6-week-old male (A), 6-week-old 
female (B), 18-week-old male (C), or 18-week-old female (D) F1 offspring. Data are 
mean ± standard deviation. 
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Maternal WD does not influence F2 offspring voluntary wheel running 
 Links between maternal high-fat feeding and obesity predisposition have been 
observed as late as the third (F3) generation (Dunn and Bale, 2011). However, sex-
specific differences in body weight, body fat, leptin, and insulin were not present between 
SD and WD F2 offspring in either male or female offspring (Figure 3.7A-D, F-I). 
Additionally, selective breeding experiments show transgenerational selection for 
voluntary running behavior (Rhodes et al., 2005; Roberts et al., 2013). However, in the 
present study no differences in voluntary running were present in juvenile (4-7 weeks of 
age) and adult (16-19 weeks of age) SD and WD F2 male and female offspring (Figure 
3.7E, J). Analysis of mRNA expression in the NAc and VTA of 6- and 18-week-old F2 
female offspring found that Dat mRNA in the NAc was decreased in WD offspring at 6 
weeks of age (p < 0.05), while no differences in NAc Drd1, Drd2, Drd5, or VTA Lepr 
mRNA were observed at 6 or 18 weeks of age (Figure 3.7K, L). 
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Figure 3.7. Legend is on following page. 
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Figure 3.7. Effect of maternal WD on F2 offspring phenotype and voluntary 
wheel running. No differences in body weight (A), body fat (B), serum leptin (C), or 
serum insulin (D) were reported between male F2 SD and WD offspring. Similarly, 
maternal WD did not influence voluntary wheel running distance in 4-7-week-old or 
16-19-week-old male F2 offspring (E).  Furthermore, no differences in body weight 
(F), body fat (G), serum leptin (H), or serum insulin (I) were reported between female 
F2 SD and WD offspring. Contrary to the F1 generation, maternal WD did not 
influence voluntary wheel running distance in 4-7-week-old or 16-19-week-old female 
F2 offspring (J). Analysis of mRNA expression showed that Dat mRNA was 
decreased in the NAc, while no differences were present in the VTA of 6-week-old 
female F2 WD offspring (K). Analysis of mRNA expression in 18-week-old female F2 
offspring found no differences in NAc or VTA mRNA expression between SD and 
WD offspring (L). Data in bar graphs are mean ± standard deviation while data in line 
graphs are mean ± SEM. Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Table 3.4. Statistical information 
Measurement Graph Main effects/interactions F value P value 
F1 male body weight 2A Age 
Diet 
Age x Diet 
F(15.380) = 627.14 
F(1,380) = 35.94 
F(15,380) = 5.59 
< 0.001 
< 0.001 
< 0.001 
F1 male body fat 2B Age 
Diet 
Age x Diet 
F(1,20) = 43.94 
F(1,20) = 13.13 
F(1,20) = 5.49 
< 0.001 
0.002 
0.03 
F1 male leptin 2C Age 
Diet 
Age x Diet 
F(1,20) = 47.87 
F(1,20) = 6.95 
F(1,20) = 2.95 
< 0.001 
0.016 
0.10 
F1 male insulin 2D Age 
Diet 
Age x Diet 
F(1,20) = 34.53 
F(1,20) = 4.52 
F(1,20) = 2.21 
< 0.001 
0.046 
0.15 
F1 male relative food intake 2E Age 
Diet 
Age x Diet 
F(1,16) = 1359.44 
F(1,16) = 11.35 
F(1,16) = 4.34 
< 0.001 
0.004 
0.054 
F1 male spontaneous activity 2F Age 
Diet 
Age x Diet 
F(1,16) = 2.57 
F(1,16) = 0.14 
F(1,16) = 1.15 
0.13 
0.71 
0.30 
F1 male total energy expenditure 2G Age 
Diet 
Age x Diet 
F(1,14) = 6.02 
F(1,14) = 3.33 
F(1,14) = 0.26 
0.028 
0.089 
0.62 
F1 female body weight 2H Age 
Diet 
Age x Diet 
F(15.437) = 452.74 
F(1,437) = 10.99 
F(15,437) = 0.322 
< 0.001 
< 0.001 
0.99 
F1 female body fat 2I Age 
Diet 
Age x Diet 
F(1,19) = 1.81 
F(1,19) = 0.27 
F(1,19) = 0.24 
0.20 
0.60 
0.63 
F1 female leptin 2J Age 
Diet 
Age x Diet 
F(1,19) = 11.89 
F(1,19) = 0.17 
F(1,19) = 1.03 
0.003 
0.69 
0.32 
F1 female insulin 2K Age 
Diet 
Age x Diet 
F(1,19) = 0.09 
F(1,19) = 0.20 
F(1,19) = 0.81 
0.77 
0.66 
0.38 
F1 female relative food intake 2L Age 
Diet 
F(1,16) = 390.78 
F(1,16) = 4.27 
< 0.001 
0.056 
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Age x Diet F(1,16) = 5.06 0.039 
F1 female spontaneous activity 2M Age 
Diet 
Age x Diet 
F(1,16) = 1.72 
F(1,16) = 1.55 
F(1,16) = 1.54 
0.21 
0.23 
0.23 
F1 female total energy expenditure 2N Age 
Diet 
Age x Diet 
F(1,16) = 35.17 
F(1,16) = 0.19 
F(1,16) = 0.17 
< 0.001 
0.67 
0.69 
F1 18-wk Sed vs. Ex. male body fat 3A Diet 
Exercise 
Diet x Exercise 
F(1,20) = 13.32 
F(1,20) = 13.64 
F(1,20) = 1.31 
0.002 
0.001 
0.27 
F1 18-wk Sed vs. Ex. male leptin 3B Diet 
Exercise 
Diet x Exercise 
F(1,20) = 20.47 
F(1,20) = 12.85 
F(1,20) = 0.76 
< 0.001 
0.002 
0.39 
F1 18-wk Sed vs. Ex. male insulin 3C Diet 
Exercise 
Diet x Exercise 
F(1,20) = 7.29 
F(1,20) = 11.35 
F(1,20) = 0.064 
0.014 
0.003 
0.80 
F1 18-wk Sed vs. Ex. female body fat 3D Diet 
Exercise 
Diet x Exercise 
F(1,20) = 1.23 
F(1,20) = 0.82 
F(1,20) = 0.52 
0.28 
0.38 
0.48 
F1 18-wk Sed vs. Ex. female leptin 3E Diet 
Exercise 
Diet x Exercise 
F(1,20) = 1.74 
F(1,20) = 1.95 
F(1,20) = 0.44 
0.20 
0.18 
0.52 
F1 18-wk Sed vs. Ex. female insulin 3F Diet 
Exercise 
Diet x Exercise 
F(1,20) = 0.011 
F(1,20) = 2.20 
F(1,20) = 0.20 
0.92 
0.15 
0.66 
F1 6-wk male voluntary run dist. 4A Age 
Diet 
Age x Diet 
F(3,28) = 0.77 
F(1,28) = 1.78 
F(3,28) = 0.08 
0.50 
0.19 
0.97 
F1 6-wk female voluntary run dist. 4E Age 
Diet 
Age x Diet 
F(3,28) = 12.71 
F(1,28) = 10.36 
F(3,28) = 0.79 
< 0.001 
0.003 
0.51 
F1 18-wk male voluntary run dist. 5A Age 
Diet 
Age x Diet 
F(3,40) = 2.94 
F(1,40) = 0.72 
F(3,40) = 0.19 
0.045 
0.40 
0.90 
F1 18-wk female voluntary run dist. 5E Age 
Diet 
Age x Diet 
F(3,40) = 14.17 
F(1,40) = 10.23 
F(3,40) = 0.28 
< 0.001 
0.003 
0.84 
F2 male body weight 7A Age F(1,318) = 1419.44 < 0.001 
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Diet 
Age x Diet 
F(1,318) = 1.79 
F(1,318) = 0.39 
0.18 
0.98 
F2 male body fat 7B Age 
Diet 
Age x Diet 
F(1,20) = 37.09 
F(1,20) = 1.54 
F(1,20) = 1.31 
< 0.001 
0.23 
0.27 
F2 male serum leptin 7C Age 
Diet 
Age x Diet 
F(1,20) = 32.51 
F(1,20) = 0.30 
F(1,20) = 0.83 
< 0.001 
0.59 
0.37 
F2 male serum insulin 7D Age 
Diet 
Age x Diet 
F(1,20) = 9.95  
F(1,20) = 0.68 
F(1,20) = 0.09 
 0.005 
0.42 
0.77 
F2 6-wk male voluntary run dist. 7E Age 
Diet 
Age x Diet 
F(3,44) = 10.39 
F(1,44) = 1.84 
F(3,44) = 1.03 
< 0.001 
0.18 
0.39 
F2 6-wk female voluntary run dist. 7E Age 
Diet 
Age x Diet 
F(3,44) = 16.75 
F(1,44) = 0.53 
F(3,44) = 0.29 
< 0.001 
0.47 
0.84 
F2 female body weight 7F Age 
Diet 
Age x Diet 
F(1,176) = 290.13 
F(1,176) = 2.54 
F(1,176) = 0.15 
< 0.001 
0.11 
1.00 
F2 female body fat 7G Age 
Diet 
Age x Diet 
F(1,20) = 20.96 
F(1,20) = 2.40 
F(1,20) = 1.85 
< 0.001 
0.14 
0.19 
F2 female serum leptin 7H Age 
Diet 
Age x Diet 
F(1,20) = 11.08 
F(1,20) = 2.94 
F(1,20) = 1..77 
0.003 
0.10 
0.20 
F2 female serum insulin 7I Age 
Diet 
Age x Diet 
F(1,20) = 3.42 
F(1,20) = 0.002 
F(1,20) = 2.19 
0.079 
0.96 
0.16 
F2 18-wk male voluntary run dist. 7J Age 
Diet 
Age x Diet 
F(3,40) = 6.11 
F(1,40) = 0.23 
F(3,40) = 0.64 
0.002 
0.63 
0.60 
F2 18-wk female voluntary run dist. 7J Age 
Diet 
Age x Diet 
F(3,44) = 20.93 
F(1,44) = 1.17  
F(3,44) = 0.08 
< 0.001 
0.29 
0.97 
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DISCUSSION 
 Here we report that prenatal WD consumption increases voluntary physical 
activity in juvenile, but decreases voluntary physical activity in adult, female F1 
offspring. These changes in voluntary physical activity were associated with age-
dependent directional alterations in Drd1 mRNA and protein levels in the NAc as well as 
Lepr mRNA in the VTA. Conversely, no differences in voluntary physical activity or 
NAc Drd1 and VTA Lepr mRNA or protein levels were present in male F1 offspring of 
WD fed dams, despite increases in body weight and adiposity by adulthood. Collectively, 
these findings support the hypothesis that maternal WD consumption causes age-
dependent changes in mesolimbic nuclei that may influence voluntary physical activity 
levels in female F1 offspring independent of changes in adiposity, as presented in Figure 
3.8. 
 We observed that maternal WD decreased body weight in juvenile F1 offspring. 
While increased body weight at weaning following maternal high-fat feeding has been 
observed (Vucetic et al., 2010), other studies demonstrate maternal high-fat feeding can 
decrease offspring body weight at weaning and post-weaning (Ferezou-Viala et al., 2007; 
Howie et al., 2009; Ong and Muhlhausler, 2011). Given that the WD was lower in protein 
than the SD in the current study (15.2% kcal vs. 26.5% kcal), the reduced postnatal 
growth in WD offspring could be the result of a lack of essential amino acids in dam milk 
production. This hypothesis is supported by findings that low protein intake during 
pregnancy reduces offspring body weight in early postnatal life (Bellinger et al., 2004; 
Bhasin et al., 2009). Additionally, maternal low protein intake during pregnancy 
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increases male offspring body weight by adulthood (Bhasin et al., 2009), a response very 
similar to that observed in F1 male offspring in the current study. 
 
 
Figure 3.8. Hypothesized model by which impaired leptin and dopaminergic 
signaling alter physical activity in F1 female WD offspring. Left: summary of the 
reward circuitry in the brain. The blue projection illustrates dopaminergic projections 
from the ventral tegmental area (VTA) that release dopamine (DA) onto post-synaptic 
neurons in the nucleus accumbens (NAc). Right:  Expanded, but simplified, 
illustration of this dopaminergic VTA to NAc projection as it is hypothesized to relate 
to physical activity in F1 SD and WD female offspring. In juvenile WD offspring, 
dopamine receptor (DxR), particularly Drd1, expression is decreased in the NAc 
Similarly, a reduction of VTA leptin receptor (LEPR) may enhance downstream DA 
production and release, leading to more DA in the synapse. On the contrary, in adult 
WD offspring , reduced NAc DxR expression and increased VTA LEPR levels could 
collectively lead to diminished down-stream DA function. Collectively, these 
impairments in dopaminergic signaling may lead to exacerbated levels of physical 
inactivity in adulthood.. Other abbreviations: Amyg, amygdala, PFC, prefrontal 
cortex. 
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In our model, maternal WD increased body fat, leptin, and insulin in adult male, 
but not female, F1 offspring. This result supports a previous report following high-fat 
(60% lipids) consumption during pregnancy in Wistar rats, 9-month-old male offspring 
displayed mild glucose intolerance, hyperleptinemia, hyperinsulinemia, and increased 
visceral adiposity, while similar observation were not present in female offspring 
(Lecoutre et al., 2016). However, our findings are in disagreement with findings that 
high-fat (58%) and high-sucrose (25%) consumption during pregnancy and lactation 
increases body fat and decreases glucose tolerance in adult female, but not male, 
offspring (Dearden and Balthasar, 2014), and that high-fat diet (45%) during pregnancy 
and lactation increases body fat, leptin, and insulin in adult male and female offspring 
(Howie et al., 2009). These discrepancies highlight the potential variability that the 
duration of maternal high-fat/WD feeding, diet content (e.g. percentage of lipids vs 
carbohydrates), lipid composition (saturated vs unsaturated), and diet palatability, and 
thus food consumption and obesity severity, may have on fetal and/or postnatal 
programming. Furthermore, our finding that increased adiposity in male WD offspring is 
likely due to hyperphagia supports findings that maternal high-fat consumption increases 
food intake to a greater extent in male, than female, offspring (Desai et al., 2014). 
Additionally, our observation that voluntary wheel running ~1.2 km/day in adult male 
WD offspring reduced body fat, leptin, and insulin levels to those of sedentary SD 
offspring has significant clinical importance and suggests that maternal WD-induced 
metabolic dysfunction is malleable to voluntary exercise. 
Despite its widespread importance, our understanding of how environmental 
factors influence voluntary physical activity remains limited. Here, wheel running was 
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increased in juvenile, but decreased in adult, F1 female WD offspring, while no 
differences in wheel running were present in F1 male offspring at either age assessed. Our 
observation that maternal WD influences physical activity in female offspring supports 
several prior publications in which spontaneous physical activity was reduced specifically 
in female offspring following prenatal and/or postnatal overnutrition (Baker et al., 2015; 
Khan et al., 2003; Li et al., 2013) or undernutrition (Vickers et al., 2003). Surprisingly, 
however, in the current study maternal WD did not alter spontaneous activity in female 
offspring. This discrepancy from previous reports could be attributed to the lack of body 
fat difference between SD and WD female offspring. Of the previously mentioned 
reports, two studies detected that maternal overnutrition resulted in increased adiposity 
which associated with reduced spontaneous activity in female offspring (Baker et al., 
2015; Li et al., 2013), while adiposity was not measured in the other studies (Khan et al., 
2003; Vickers et al., 2003). Collectively, these reports and our data suggest that 
alterations in body fat may be necessary for changes in spontaneous activity that 
accompany maternal overnutrition, but not for changes in voluntary physical activity, and 
that regulatory mechanisms controlling spontaneous and voluntary physical activity 
following maternal or postnatal WD are dissimilar, as has been previously speculated 
(Garland et al., 2017).  
In the present study, increased Drd1 and Drd2 mRNA and protein in the NAc 
accompanied increased wheel running in juvenile, female F1 WD offspring. This 
observation was reserved in adult, female WD F1 offspring, where decreased Drd1 
mRNA and protein in the NAc complemented decreased wheel running. Other (Rhodes 
and Garland, 2003) and our (Roberts et al., 2012) labs have shown that Drd1 antagonism 
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reduces wheel running. Furthermore, Drd1 mRNA is increased in rats selected for high, 
compared to low, wheel running (Ruegsegger et al., 2015). Therefore, we posit that one 
mechanism possibly explaining alterations in wheel running with maternal WD stems 
from increased and decreased Drd1 protein in 6- and 18-week-old female F1 offspring, 
respectively. Similarly, Friend et al. (Friend et al., 2016) reported that chronic high-fat 
exposure in mice reduces striatal Drd2 binding and consequently reduces wheel running. 
Equally fascinating are results that Drd2 knockdown in mice produces an obese 
phenotype compared to wild-type littermates that is primarily due to decreased physical 
activity (Beeler et al., 2016). Future studies should determine the potential contributions 
of individual dopamine receptors to altered wheel running accompanying maternal WD. 
Unexpectedly, Dat mRNA was decreased in juvenile female and adult male and female 
WD F1 offspring. However, given the consistent, and non-sex-specific, down-regulation 
of Dat, we speculate dopamine receptor function, rather than reuptake, could more likely 
influence altered running in female WD F1 offspring. Additionally, our observations are 
in line with previous findings that maternal high-fat and junk food consumption affect 
dopamine-related mRNA expression in young (6-weeks-old) and adult (18-24-weeks-old) 
offspring; however, these results were observed in both male and female offspring (Ong 
and Muhlhausler, 2011; Vucetic et al., 2012; Vucetic et al., 2010).  
Leptin receptors colocalize with dopamine neurons in the VTA, where leptin in 
turn inhibits dopamine activity (Fulton et al., 2006; Hommel et al., 2006). Fernandes et 
al. (Fernandes et al., 2015) demonstrated that intra-VTA injection leptin suppresses the 
rewarding effects of wheel running in mice via STAT3 activation in dopamine neurons. 
Intriguingly, maternal hyperleptinemia in mice increases spontaneous activity in adult 
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female, but not male, offspring, (Pollock et al., 2015). These observations support the 
next notions. Reductions in VTA Lepr mRNA in juvenile female WD F1 offspring might 
enhance dopamine activity increasing voluntary wheel running, while the elevation of 
Lepr in adult female WD F1 offspring could reduce dopamine activity, and in turn reduce 
voluntary wheel running. In contrast, similar observations in the Arc were absent, 
suggesting that Lepr expression in the VTA rather than hypothalamus may more strongly 
predict voluntary physical activity. The finding that VTA Lepr mRNA negatively 
correlates with NAc Drd1 mRNA in female F1 offspring also suggests that common 
regulatory factors could influence leptin and dopamine function. Our observation that 
serum leptin levels inversely correlate with running distance in adult, female WD 
offspring supports findings that leptin levels inversely associate with human marathon 
run-time, after adjusting for BMI (Bobbert et al., 2012), further demonstrating leptin as a 
potential regulator of voluntary physical activity in female WD F1 offspring. Future 
experiments performing intra-VTA leptin or leptin antagonist injection in SD and WD 
offspring will certainly further our understanding of how genetic predisposition for 
altered mesolimbic leptin signaling influences voluntary physical activity.  
Interestingly, no differences in adiposity, leptin, insulin, or voluntary physical 
activity were observed in F2 offspring. Dunn et al. (Dunn et al., 2011) proposed that 
changes in health outcomes in the first generation are the result of acute somatic tissue  
reprograming and that if germline cells are not directly impacted by prenatal 
overnutrition the phenotype will terminate after the first generation. Therefore, 
differences in adiposity and voluntary wheel running in male and female F1 offspring, 
respectively, may be attributed to dysfunction in somatic tissue, rather than changes in 
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primordial germ cells, following direct placental exposure to maternal WD. White et al. 
(White et al., 2009) suggest that maternal obesity is necessary for increases in offspring 
body fat and insulin resistance. While we did not measure body fat percentage in F1 
breeders no differences in body fat, or serum leptin were present between SD and WD F1 
female offspring, suggesting that F1 WD female breeders were not obese. Thus, maternal 
obesity may be necessary for somatic tissue reprograming in offspring. In contrary, the 
down-regulation of Dat mRNA in juvenile F2 females suggest that primordial germ cell 
reprogramming may accompany gestational WD, although future research is needed to 
discern factors contributing to transgenerational differences in Dat compared to dopamine 
or leptin receptor expression. Furthermore, our results disagree with previous reports 
demonstrating that maternal HFD during pregnancy increases body size (Dunn and Bale, 
2011) and insulin resistance (Dunn and Bale, 2009; Huypens et al., 2016) as late as F3 
offspring. However, these discrepancies likely stem from difference in diet duration and 
content. 
 In summary, our data are the first to show that maternal WD sex-specifically and 
age-specifically influences the propensity for voluntary physical activity in F1 offspring, 
and importantly that this propensity associates with the reprogramming of leptin and 
dopamine systems in mesolimbic brain nuclei.  Given the increasing levels of physical 
inactivity (Kohl et al., 2012) and maternal obesity (Yogev and Catalano, 2009), these 
novel insights provide valuable insight into how prenatal nutrition affects voluntary 
physical activity. 
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ABSTRACT 
Increases in age are often associated with reduced levels of physical activity, 
which, in turn, associates with the development of numerous chronic diseases. We aimed 
to assess molecular differences in the nucleus accumbens (NAc), a specific brain nucleus 
postulated to influence rewarding behavior, of wheel running and sedentary female 
Wistar rats at 8 and 14 wks of age. RNA-sequencing was used to interrogate 
transcriptomic changes between 8 wk and 14 wk-old wheel running rats, and select 
transcripts were later analyzed by qRT-PCR in age-matched sedentary rats. Voluntary 
wheel running was greatest at 8 wks and had significantly decreased by 12 wks. From 
619 differentially expressed genes, bioinformatics suggested that cAMP-mediated 
signaling, DARPP-32 feedback, and synaptic plasticity were greater in 8 compared to 14 
wk-old rats. In depth analysis of these networks showed significant (~20-30%; p < 0.05) 
decreases in Cadm4 and p39 mRNAs, as well as their proteins from 8 to 14 wks of age in 
running and sedentary rats. Further, Cadm4, Cdk5, and p39 mRNAs were significantly 
correlated with voluntary running distance. Analysis of dendritic spine density in the 
NAc showed that wheel access increased spine density (p < 0.001), while spine density 
was lower in 14 wk compared 8 wk-old sedentary rats (p = 0.03). Intriguingly, intra-NAc 
injection of the Cdk5 inhibitor roscovitine, dose-dependently decreased wheel running. 
Collectively, these experiments suggest that an age-dependent loss in synaptic function 
and Cdk5/p39 activity in the NAc may be partially responsible for age-related declines in 
voluntary running behavior. 
 
  
95 
 
INTRODUCTION 
Physical inactivity has reached pandemic levels in the United States and rest of 
the developed world. Strong evidence shows that physical inactivity is associated with 35 
chronic diseases, including major non-communicable diseases such as type 2 diabetes 
(T2D) and coronary heart disease (CHD), and premature mortality (Booth et al., 2012). 
Strikingly, the World Health Organization has declared physical inactivity as the fourth 
leading risk factor for death worldwide, responsible for ~6% of the deaths worldwide in 
2008 (Lee et al., 2012; Organization, 2010). 
 Several studies demonstrate that physical activity levels first fall at young ages. 
Troiano et al. (Troiano et al., 2008) reported a ~34% decline in physical activity between 
6-11 and 12-17 years of age. A similar report observed a 40% decline in time spent 
performing moderate-vigorous physical activity in grade school children (Trost et al., 
2002). In one analysis of 3,700 U.S. youth from the age of 6- to 11-years old, the minutes 
of physical activity in girls and boys dropped ~67% and ~60%, respectively (Wolff-
Hughes et al., 2014). Taken together, these reports show that by ~9-11 years of age, 50% 
of U.S. youth are not undertaking sufficient daily physical activities for health according 
to U.S. Physical Activity Guidelines. 
 Findings from rodent studies provide similar results. Jakubczak (Jakubczak, 1969) 
demonstrated that declines in free wheel running activity begin early in the life of rats (66 
d of age). In addition, our lab has shown voluntary wheel running initially declines at ~8 
weeks of age (Ruegsegger et al., 2016). Interestingly, increases in age are associated with 
declining levels of physical activity in C. elegans (Herndon et al., 2002; Kirkwood and 
Finch, 2002), flies (Marden et al., 2003), and dogs (Siwak et al., 2003) suggesting that the 
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decrease in physical activity with ageing is fundamental to many species. Thus, it is 
imperative to understand the neuromolecular mechanisms that control the maturation-
associated decline in physical activity motivation. 
 Studies in animals and humans estimate the genetic component for physical 
inactivity to be between 20-80% (Festing, 1977; Kaprio et al., 1981; Lauderdale et al., 
1997; Lerman et al., 2002; Lightfoot et al., 2004; Lightfoot et al., 2008) and analysis 
from twins suggests that 31% of sedentary behavior is heritable (den Hoed et al., 2013).  
Substantial evidence suggests the mesolimbic dopaminergic pathway, specifically 
the nucleus accumbens (NAc), plays a significant role in determining voluntary running 
behavior (Knab et al., 2009; Knab et al., 2012; Knab and Lightfoot, 2010). Since its 
characterization as the neural interface between the limbic ‘motivation’ and motor 
systems (Mogenson et al., 1980), the NAc, and its associated circuitry, has been shown to 
mediate many motivating and rewarding behaviors. Further, a loss of dopaminergic 
action has been postulated to drive age-related declines in physical activity in humans 
(Ingram, 2000).  
 In the current study we sought to examine the NAc transcriptome of wheel-
running rats at 8 and 14 weeks of age to identify transcripts associated with the initial 
age-related decline in voluntary physical activity. This ‘omics’ approach was used to 
generate testable hypotheses by which possible NAc features may be contributing to 
running motivation. Based on RNA-sequencing (RNA-seq) and bioinformatics analysis 
suggesting that NAc neuronal function decreases from 8 to 14 weeks, follow-up studies 
in sedentary and wheel running rats were conducted to test this hypothesis. Additionally, 
in light of our RNA-seq and initial follow-up experiments, the Cdk5 inhibitor roscovitine 
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was infused into the NAc to assess the role it may play in determining wheel running 
motivation. 
 
MATERIALS AND METHODS 
Experimental animals 
All animal protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Missouri and complied with the National Institutes of 
Health’s Guide for the Care and Use of Laboratory Animals. Female, Wistar rats were 
used in this study (Charles River, Raleigh, NC). Thus, a limitation of our study is the 
inability to analyze sex differences. We employed female rats in this study due to the 
findings that females usually run further than males (Jones et al., 1990; Pitts, 1984). 
Further rationale for the use of female rats is their body mass plateau, minimizing the 
effect of continued body growth in male rats, and our usage of female rats balances the 
predominance of literature utilizing male rats. 
Rats were maintained on a 12:12-h light/dark cycle at 21-22°C, with food 
(Formulab Diet 5008, Purina) and water provided ad libitum throughout all experiments.  
 
Experiment 1: analysis of voluntary running behavior 
Female, Wistar rats were weaned at 21 days of age, and were provided with 
access to a voluntary-running wheel beginning at 5 weeks of age (circumference: 
1.062m) (Tecniplast 2154, Tecniplast, Italy), and running distance and time were 
monitored using Sigma Sport BC 800 bicycle computers (Cherry Creek Cyclery, Foster 
Falls, VA). Evidence from our laboratory suggested that voluntary-wheel running peaks 
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at 8 weeks of age (Ruegsegger et al., 2016). Therefore, in order to assess the 
hypothesized neuromolecular-reshaping that may regulate the decrease in wheel-running 
behavior at this age, we sacrificed rats at either: a) 8 weeks of age (8 wk; n = 7) or b) 14 
weeks of age (14 wk; n = 5). We selected 14 weeks of age, after we noted a significant 
drop in running distance at 12 weeks of age. NAc samples from these rats were submitted 
for RNA-seq and protein analysis. Given that rats in the 14 wk group ran for 6 weeks 
more than rats in the 8 wk group, it is just as likely that differences between 8 and 14 wks 
are due to duration-dependent effects of chronic exercise rather than age or nightly 
running distance. However, our objective was to associate molecular differences at the 
time when wheel running first declines during the life course, thus approaches to match 
exercise duration were not feasible. Due to financial limitations and because our primary 
objective was to identify mRNAs associated with changes in wheel-running behavior, we 
could only perform RNA-seq only on wheel running rats. Additionally, separate groups 
of sedentary rats were sacrificed at 8 wk (n = 8), and 14 wk (n = 8) to assess mRNA and 
protein levels in target molecules identified by RNA-seq independent of voluntary wheel 
running. Thus, a limitation of the current study is data for many comparisons were 
obtained from different methods, and thus not statistically compared. 
At each experimental time point, rats were sacrificed between 1700-1900, which 
is up to two hours prior to the dark cycle, with carbon dioxide asphyxiation. This 
sacrificial point was chosen as a basal observational time-point in order to avoid acute 
running-induced differences in mRNA expression that likely exist upon the onset of the 
dark cycle. Similarly, an interesting characteristic of females is the presence of the 4-day 
estrous cycle influencing voluntary running distance, with peak running in the 4-day 
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running rhythm occurring at proestrus (Anantharaman-Barr and Decombaz, 1989). 
Therefore, to minimize the effects of cycling hormones rats were sacrificed on the night 
of proestrus as determined by the peak running night in the 4-day running rhythm or 
vaginal cytology. 
 
Nucleus accumbens RNA isolation and cDNA library preparation for RNA-seq 
 At the time of sacrifice, brains were quickly removed and NAc tissue was 
extracted using a 2-mm punch tool and brain sectioning apparatus (Braintree Scientific, 
Braintree, MA). Tissue plugs from 2-mm thick coronal brain slices, which were 
identified as NAc per a rat brain atlas (Paxinos and Watson, 1998), were stored at -80°C 
until processing. An objective of the present study was to compare RNA-seq results with 
a previous RNA-seq experiment analyzing the NAc of rats selectively bred for high and 
low motivation for wheel running (Roberts et al., 2014), which analyzed both the NAc 
shell and core. Thus, a limitation of our RNA-seq data is the lack of explicit distinction 
between the NAc shell and core. During tissue processing, samples were lyzed in 
NucleoSpin XS lysis (Macherey-Nagel, Bethlehem, PA, USA) buffer using a high-speed 
shaking apparatus (Tissuelyser, LT, Quiagen) with RNase-free stainless steel beads. RNA 
was subsequently extracted using the NucleoSpin XS RNA extraction kit according to the 
manufacturer’s instructions (Macherey-Nagel, Bethlehem, PA, USA). RNA was eluted in 
40 μL of RNase-free water. High integrity of each sample was confirmed using 
BioAnalyzer 2100 automated electrophoresis system (Bio-Rad) prior to cDNA library 
construction. 
100 
 
 cDNA library preparation was performed at the University of Missouri DNA Core 
using the manufacturer’s protocol and reagents supplied in Illumina’s TruSeq RNA 
sample preparation kit v2, and have been previously described (Roberts et al., 2014). 
 
Illumina sequencing and statistical analysis of RNA-seq data 
The University of Missouri DNA Core performed all RNA-seq procedures, which 
have been described in detail elsewhere (Rustemeyer et al., 2011). Briefly, following 
cDNA library construction, samples were loaded into flow cells where clusters of each 
oligo were replicated. Following this procedure, flow cells were placed in the sequencer 
and fluorescently labeled bases were attached to the complementary bases of each 
sequence. The Illumina Genome Analyzer recorded 50 base pair reads.  Reads were 
trimmed to ensure adaptor sequence removal and tiled to a custom reference library that 
had been modified and updated from the publically available rattus norvigecus NCBI 
library (method described elsewhere (Roberts et al., 2014) using NextGENe v2.4.1 
(SoftGenetics, State College, PA). 
mRNA expression patterns were analyzed for annotated genes using reads per 
kilobase per million mapped reads (RPKM) values. To examine mRNA expression 
differences associated with the decreased wheel-running behavior, our analysis compared 
the transcriptomes of 8 wk and 14 wk-old wheel-running rats. Data processing and 
statistical analyses were performed using Microsoft Excel v.2013. We implemented the 
following filters based on previous publications (Heruth et al., 2012; Roberts et al., 2013; 
Song et al., 2012; Zhang et al., 2012); unique mRNA sequences with: counts per million 
reads (CPM) minus 2-standard deviations > 0, reads per kilobase per million reads 
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(RPKM) > 1, fold-change value of > ± 1.2-fold, and a false discovery rate (FDR) < 0.05. 
Additionally, mRNAs input into bioinformatics software had a Student’s t-test p-value < 
0.05. While a ±1.2-fold cut-off may seem liberal compared to other recent RNA-seq 
publications which have used a 1.5-to-2.0 fold-change cut-off (Heruth et al., 2012; Song 
et al., 2012; Zhang et al., 2012), we contend that subtle mRNA differences within the 
NAc of 8 wk- and 14 wk-old rats exist given that a) our model is a physiological, 
polygenic, in vivo model whereby rats are being observed in an unperturbed state, and b) 
only 67 and 3 transcripts differed between groups at ±1.5 and  ±2.0-fold change 
thresholds, respectively. An overview of our filtering process is shown in Figure 4.1A. 
Our approach in the current study was to identify differentially expressed 
transcripts at time points which were at and after the observed peak lifetime, nightly 
voluntary wheel running distance, in order to elucidate initial transcriptomic changes that 
may contribute to decreases in running phenotype during the early life course. Therefore, 
all transcripts were correlated with running distance in order to further explore whether a 
given gene was associated with running behavior (r > ±0.70). While correlation does not 
represent causation, a high correlation between the expression of a transcript and running 
distance could signify the following, and warrant future interrogation: a) the transcript of 
interest may be a contributor to running motivation; or b) the transcript of interest is 
altered by attenuated running volumes.   
 
Bioinformatics analysis of RNA-seq data 
 Ingenuity Pathway Analysis (IPA; Ingenuity Systems Inc., Redwood, CA, USA) 
was used to examine gene networks and physiological system functions in the NAc that 
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differed between 8 wk- and 14 wk-old wheel-running rats. In addition, the Gene 
Ontology (GO) Consortium database (http://www.geneontology.org) was used to 
examine biological, cellular, and molecular functions differing between the 8-wk and 14-
wk-old wheel running rats. 
 
qRT-PCR for RNA-seq validation and follow-up analysis in sedentary rats 
 Gene primers were constructed using PrimerExpress 3.0 software (Applied 
Biosystems) and efficiency curves were produced for all primers. Primer efficiencies 
ranged between 90-110% for all genes. Twenty-five nanograms of cDNA from each 
sample were assayed in duplicate for each of the target genes shown in Table 4.1 using 
SYBR Green Mastermix (Applied Biosystems, Carlsbad, CA). mRNA expression values 
were quantified using the 2ΔΔCt method, whereby ΔCT = 18S Ct – gene of interest Ct.  
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Figure 4.1. Characteristics of RNA-seq dataset and transcript filtering. (A) 
Overview of filtering process used to generate differentially expressed transcripts 
between 8 and 14 wk wheel running rats. For each group, a transcript was omitted if 
it was not a known transcript. (B) RNA-seq data was highly reliable as 
demonstrated by the high correlation (r = 0.995) of RPKM values from a single rat 
compared to RPKM average values from all rats. Both 8 and 14 wk groups 
expressed high amounts of Grd1 (C) and Grd2 (D), which is indicative of NAc 
MSNs. Abbreviations: False Discovery Rate (FDR); Reads per Kilobase per Million 
Reads (RPKM); and Differentially Expressed Transcripts (DETs). 
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Table 4.1. Primer sequences for gene expression analyzed by qRT-PCR 
Gene Forward (5’- 3’) Reverse (5’- 3’) 
18S GCCGCTAGAGGTGAAATTCTTG CATTCTTGGCAAATGCTTTCG 
Adcy1 GAAGTCCACCGACTGCTGAA TAGCATCTCTCCCTTGCCCT 
Birc5 TGAAGGGAGGGTTGTGCAAG ACCAACACCTACACATGGGC 
Cadm4 CTGAGATCACCTGCCGTCTG GGCTGGGTTCTGAATGACGA 
Cdk5 TCTGTCACAGCCGTAACGTG CAGCGGACTGGGATACCAAA 
Cdk5r2  CCGCGGTGTCTGGATAAACT CAGACGGAAAGGGTGAACGA 
Znf238 GATGATGACCCCAGAGAGCG CACAGGGGGCACATGAAGAT 
 
Western blotting confirmation of RNA-seq targets up-regulated in 8 wk compared to 14 
wk rats 
From the same rats in which samples were submitted for RNA-seq (n = 5-
7/group), and age-matched sedentary rats (n = 8/group), approximately 5-10 mg of NAc 
tissue was homogenized on ice in RIPA buffer [50 mM Tris-HCl (pH 8.0), 150 mM 
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1% SDS, 1x protease inhibitor cocktail] 
using a Tissuelyser at 25 Hz for 1 minute. The homogenate was centrifuged at 12,000xg 
for 10 minutes and the resultant supernatant was obtained. The BCA assay (Pierce 
Biotechnology, Rockford, IL) was used to determine protein concentrations. 20 µg of 
protein in loading buffer was loaded onto 10 or 18% SDS-PAGE gels. Proteins were 
transferred onto nitrocellulose membranes and incubated with Ponceau S (Sigma) to 
verify equal loading in all lanes. Primary antibodies [rabbit polyclonal for Cadm4 
(1:1,000 Abcam), p39 (1:1000, Cell Signaling), p35/25 (1:1000, Cell Signaling), and 
Darpp-32 (1:1000, Cell Signaling)] were diluted in TBST with 5% bovine serum albumin 
and applied to membranes overnight at 4C. HRP-conjugated secondary antibody 
(1:1,000; Cell Signaling) was then applied to membranes for 1 hour at room temperature 
in TBST with 5% non-fat milk. Prior to exposure, ECL substrate (Pierce Biotechnology) 
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was applied for 2 minutes. A Kodak 4000R Imager and Molecular Imagery Software 
(Kodak Molecular Imaging Systems, New Haven, CT) were used to obtain band 
densitometry.  
 
Golgi staining for MSN dendritic spine determination  
For rapid Golgi staining, 8 wk- and 14 wk-old sedentary and wheel running rats 
(n=6/group) were sacrificed using carbon dioxide asphyxiation and brains were rapidly 
removed from the skull and briefly rinsed in distilled water. Golgi staining was 
performed using the FD rapid GolgiStain kit (FD NeuroTechnologies, Inc.) according to 
manufacturer’s protocol. Coronal sections (200 μm) were cut with a vibrotome 
(Vibrotome 3000, Vibrotome Company Inc., MO). Slices were mounted on 3% gelatin-
coated microscope slides (Fisher Scientific). Spine density was assessed on 10-12 
dendritic segments (sampled from the entire medial NAc shell and similar rostrocaudal 
levels of the NAc core) per rat, sampled equally between hemispheres, resulting in the 
analysis of 70-72 segments per treatment condition. These dendritic segments were 
collected from two to three neurons per hemisphere. We restricted our study to dendritic 
segments of 2nd order branches, and spine density was assessed by manual labeling spines 
~50 μm from the soma. Spine density was counted along the entire length of the branch 
and results were expressed as spine/10μm. Mean spine number per dendritic length was 
calculated from measurements on 2D digital images, and thus likely represent 
underestimates. Distinct spine morphologies were manually scored as thin, stubby, or 
mushroom types on dendrite segments as defined previously (Peters and Kaiserman-
Abramof, 1970). For counting, images were coded and counted by a blinded individual. 
106 
 
Sections were visualized using an Olympus BX60 photomicroscope (Olympus, Melville, 
NY) at an overall magnification of 1000x and photographed with a Spot Insight digital 
camera (Diagnostic Instruments, Sterling Heights, MI). ImageJ Fiji software (National 
Institutes of Health, Bethesda, MD) was used to assess dendritic spine density. 
 
Experiment 2: Follow-up intra-accumbens cannula injection 
 Based upon the results of the above mentioned experiment, an additional set of 
female, Wistar rats was used to determine if intra-accumbens injection of the Cdk5 
inhibitor roscovitine (APExBIO, Houston, TX) influences voluntary running behavior. 
Rats were weaned at 21 days of age, and provided access to voluntary running wheels 
beginning at 10 weeks of age. After acclimating to the running wheels, brain cannulae 
were surgically inserted at 13-wks of age, and injections began at ~14 wks of age. This 
age was chosen based on preliminary data suggesting running behavior is level between 
14 and 18 weeks of age (data not shown), allowing for a ‘cleaner’ experimental 
interpretation free of natural age-related declines in voluntary running. Additionally, 
while results from experiment 1 suggest mRNAs and proteins central to Cdk5 function 
decrease from 8 to 14 wks, expression levels are still robust at 14-15 wks allowing for 
pharmacological inhibition of Cdk5 effects on running to be determined. 
 
Surgery and injection protocol 
On the day of the surgery, animals (250-275g) were anesthetized with an 
intraperitoneal injection of a ketamine (87mg/kg) and xylazine (13mg/kg) mixture. The 
surgical procedures used have been described previously (Roberts et al., 2012; 
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Ruegsegger et al., 2015). Briefly, 10-mm, 23-gauge guide cannulae were bilaterally 
positioned 2.5mm above the NAc core using the coordinates as follows (in mm relative to 
Bregma): anteroposterior (AP) 1.30, mediolateral (ML) ± 1.85 mm, dorsoventral (DV) -
4.63mm (Whishaw et al., 1977). We chose to target the NAc core given previous findings 
suggest that the core, and not shell, is associated with wheel running behavior (Werme et 
al., 2002). Following surgery, animals were warmed on a 32˚C heating pad for two hours 
and topical Neosporin was applied around the surgical area. Following recovery from 
surgery, rats were placed back into their home cages with running wheels and monitored 
for 7 days to ensure running patterns returned to pre-surgical values. Note that the 
running pattern of each rat was monitored prior to surgery to determine a voluntary 
running periodicity and to establish anticipated high running nights for drug injections. 
The injection protocol is shown in Figure 2.2A. Because of the cyclic effects of 
the estrous cycle on running behavior, we chose to take measurements during the night of 
proestrus, which is the night of peak running distance (Anantharaman-Barr and 
Decombaz, 1989). Roughly one week after NAc core cannulation, bilateral intra-NAc 
infusion of 0.5 μl of vehicle (PBS/50% DMSO) was performed to acclimatize rats to the 
injection protocol. An additional vehicle injection was performed four days later. This 
injection served as a baseline for all rats. Four days after baseline injection, rats were 
bilaterally injected with either vehicle (n = 8), or roscovitine: 40 nmol/0.5 μl (n = 8) or 80 
nmol/0.5 μl (n = 9). Drug concentrations were determined from previous studies 
suggesting intra-NAc roscovitine injection influences locomotor activity (Massart et al., 
2015; Taylor et al., 2007). This injection scheme was maintained for 5 days. On the 
‘baseline’ and 1st and 5th day of continuous vehicle or roscovitine injection, running 
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distance (km) was recorded in 30-min increments up to 120-min post-injection. Injections 
took place immediately prior to the onset of the dark cycle. We chose this timeframe 
because running patterns are more homogeneous during this period as compared to later 
time periods. Unpublished observations suggest that rats immediately begin voluntary 
wheel running upon the start of the dark cycle, compared to an intermittent and random 
running pattern later in the dark cycle.  
To perform the injections, rats were gently hand-restrained for 90 s and 10-mm 
Hamilton syringes were mounted to an infusion pump (Harvard Apparatus, Holliston, 
MA). 12.5-mm, 30-gauge injector cannulae were connected to Hamilton syringes with 
PE-10 tubing that were used to deliver vehicle or roscovitine at a rate of 0.32μl/min. The 
injectors remained in place for 60 s following injection completion to ensure that 
vehicle/drug was properly infused, and upon completion of the injections, rats were 
returned to their home cages to monitor nightly wheel running. 
109 
 
 
 
Figure 4.2. Overview of the study design for intra-NAc vehicle or roscovitine 
injection. (A) The schematic illustration of ascending distances of voluntary 
running to the peak 4th night mimics the 4-day running cycles of female rats 
employed in the experiment. Rats were introduced to running wheels at 10 wks of 
age, had cannulae surgically implanted bilaterally in the NAc core at 13 wks of age, 
and began the injection protocol at ~14 wks of age (wheel running was monitored 
for 8 days post-surgery to ensure that surgery did not disrupt running pattern). 
Baseline vehicle (VEH) injection was performed in all rats. Rats were then 
randomly administered VEH, 40 nmol roscovitine, or 80 nmol roscovitine for 5 
continuous days ~10-15 min before the beginning of the dark cycle. Running 
distance was monitored for 120-min post-injection for the baseline injection and on 
the 5th night of VEH or roscovitine injection. (B) Coronal section of rat brain, as per 
a rat brain atlas (Paxinos and Watson, 1998), which shows the cannulae location as 
determined by cresyl violet staining (with position of each section given in mm 
relative to Bregma). Black dots represent the location of injector tips. 
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Verification of cannulae placement 
 The methods of Parker et al. (Parker et al., 2010) were used to determine cannulae 
placement. In brief, sections containing tracks from injectors were mounted on charged 
microscope slides, stained with cresyl violet, and examined using a light microscope to 
determine if correct cannulae placement had been made. The endpoint of each injector 
were mapped on a rat brain atlas (Paxinos and Watson, 1998) as presented in Figure 
4.2B. 
 
Statistical analysis 
All analytical procedures were performed using SigmaPlot 12.0 (Systat Software, 
Inc., Chicago, IL). All values are presented as mean ± SE. Significance for all analyses 
was set with an α-value of 0.05. Student’s t-test was used to assess between group 
differences in mRNA expression. Statistical analyses on band densities and dendritic 
spine measurements were conducted using a two-way analysis of variance (ANOVA) 
[Age (8wk vs. 14wk) x Treatment (Sed vs. Wheel)] with Holm-Sidak post hoc analyses 
when appropriate. One-way repeated measures ANOVA was used to assess age-related 
changes in wheel running. Two-way repeated-measures ANOVA using treatment and 
time as the repeated variables followed by Holm-Sidak post-hoc analyses, when 
necessary, was used to assess the influence of roscovitine on running distance, and 
percent running distance compared to baseline injection. Deviations to these statistical 
analyses are reported in figure legends. 
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RESULTS 
Voluntary wheel running peaks at 8 wks of age 
 One-way repeated-measures ANOVA showed a significant effect of age on 
running distance (F8,46 = 14.14, p < 0.001) (Figure 4.3A). Post-hoc analysis revealed 
running distance was lower at 6 and 7 wks (p < 0.001), and at 12, 13, and 14 wks of age 
(p < 0.05), compared to 8wks. Similar results were obtained for running time (F8,46 = 
22.95, p < 0.001) (Figure 4.3B). Repeated-measures ANOVA also showed a significant 
effect of running velocity (F8,46 = 4.21, p < 0.001), however post-hock analysis revealed 
differences in velocity from 8 wks only at 6 wks (p < 0.01) (Figure 4.3 C). 
 
Characterization of RNA-seq data from 8 wk and 14 wk wheel running rats 
A summary of the total number of reads as well as the percentage of reads aligned 
to the reference genome is presented in Table 4.2.  We observed a high correlation (r = 
0.995) between RPKM values from an individual rat versus the mean RPKM values from 
all 12 rats assessed, demonstrating a high reliability of transcript detection using our 
RNA-seq methods (Figure 4.1B). High enrichment of glutamic acid decarboxylase 1 
(Gad1) and Gad2 transcripts (RPKM, log2 values of 7-8), has been associated with NAc 
MSNs following laser capture microdissection (Chen et al., 2011). Our data showed high 
 
Figure 4.3. Voluntary wheel running characteristics. Average nightly running (A) 
distance (km), (B) time (min), (C) velocity (m/min) over the course of the study. 
Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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enrichment, based on RPKM values, of Gad1 and Gad2, suggesting NAc MSNs were 
present in our assayed brain tissue (Figure. 4.1C, D). Additionally, differently expressed 
transcripts of interest were verified by qRT-PCR (Table 4.3). 
 
Table 4.2. Summary of RNA-seq reads mapped to reference library 
Group Average total reads 
Reads aligned to 
reference library 
Total annotated 
transcripts expressed* 
8 wk 45,040,967 84.3% 25,898 
14 wk 41,524,614 83.7% 26,088 
According to Chen et al. (Chen et al., 2011), 20-30 million total reads per sample in the 
nucleus accumbens are sufficient to provide gene expression data that correlate well with 
microarray and qRT-PCR data. To ensure uniform tiling across the reference genome, 
tiled reads from each sample were analyzed using NexGen v2.4 software. Symbols: * = 
RPKM > 0 in all animals within each group, as performed by Song et al. (Song et al., 
2012) 
 
Table 4.3. qRT-PCR validation of select RNA-seq transcripts 
 RNA-seq qRT-PCR 
Transcript Fold Change 
(8wk/14 wk) 
p-value Fold Change 
(8wk/14wk) 
p-value 
Adcy1 1.64 0.006 1.78 0.005 
Birc5 1.62 0.03 1.50 0.007 
Cadm4 1.23 0.01 1.16 0.06 
Cdk5r2 (p39) 1.28 0.004 1.42 0.03 
Znf238 1.68 0.03 1.54 0.02 
 
mRNA differences in 8 wk and 14 wk wheel running rats 
 Using the aforementioned thresholds (8 wk/14 wk ±1.2-fold, p < 0.05) we 
determined 619 NAc mRNAs were differentially expressed between 8 wk and 14 wk 
wheel running rats, of which 263 were up-regulated at 8 wk and 356 down-regulated at 8 
wk (Figure 4.1A). Of these mRNAs, the top 10 up- and down-regulated at 8 wk/14 wk 
are presented in Table 4.4. Of these transcripts, Znf238 (Diotel et al., 2015), Birc5 
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(Survivin) (Jiang et al., 2005), Tnfaip6 (Bhattacherjee et al., 2007), and Vamp7 (Bal et 
al., 2013) have been associated with adult neurogenesis, brain regeneration, neural repair, 
survival, and development, and neurotransmission. 
 Transcripts meeting our filtering criteria and strongly positively or negatively 
correlated (r > ± 0.70) with running distance during the week of sacrifice are presented in 
Table 4.5. Of note, the top positively correlated transcripts, Cadm2 and Cadm4, and other 
cell adhesions molecule family proteins, are associated with synaptic plasticity and 
motivation-based behaviors (Biederer et al., 2002; Robbins et al., 2010), Fa2h is essential 
for proper spatial learning, memory, and myelination (Potter et al., 2011), and Vamp7, 
which also strongly up-regulated at 8 wks, directs synaptic transmission (Bal et al., 
2013). 
 
Bioinformatics reveals up-regulation of networks pertaining to nervous system function 
in 8 wk vs. 14 wk running rats 
 IPA was used to examine pathways and networks different between 8 wk and 14 
wk running rats. Of the top associated gene networks defined by IPA, the following 
networks were up-regulated at 8 wk vs 14 wk: 1) ‘nervous system and function, organ 
morphology, and organismal development’ (Figure 4.4) and 2) ‘cellular assembly and 
organization, nervous system development and function, and tissue morphology’. IPA 
analysis of the top scoring physiological system functions also revealed up-regulation of 
functions pertaining to nervous system function, as well as CREB and cAMP signaling, 
at 8 wk vs. 14 wk (Table 4.6). Enrichment analysis of GO categories also revealed an up-
regulation of functions related to nervous system function and synaptic transmission. 
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Table 4.4. Top ten up- and down-regulated NAc transcripts between 8 wk/14 wk 
Transcript 
8 wk 
RPKM 
14 wk 
RPKM 
Fold Change 
(8 wk/14 wk) 
p-value 
Run 
distance 
r-value 
Up-regulated in 8 wk/14 wk 
Titin cap protein (Tcap) 2.16 1.23 1.75 0.04 0.75 
Zinc finger protein 238 (Znf238) 28.09 16.67 1.68 0.03 0.62 
Adenylate cyclase 1 (brain) (Adcy1) 74.38 45.21 1.65 0.001 0.68 
Receptor (G protein-coupled) activity modifying protein 3 
(Ramp3) 
5.22 3.19 1.63 0.02 0.68 
Calcium binding protein 1, transcript variant 3 (Cabp1) 34.63 21.41 1.62 0.02 0.75 
Baculovirus IAP repeat containing 5 (Birc5) 1.80 1.12 1.62 0.03 0.31 
Tumor necrosis factor, alpha-induced protein 6 (Tnfaip6) 2.71 1.68 1.61 0.03 0.76 
Vesicle-associated membrane protein 7 (Vamp7) 6.57 4.08 1.61 0.01 0.78 
Trophoblast glycoprotein (Tpbg) 9.10 5.74 1.58 0.01 0.57 
Sterile alpha motif domain containing 9 (Samd9) 7.61 4.87 1.56 0.02 0.69 
Down-regulated in 8 wk/14 wk 
Keratin 77 (Krt77) 1.21 2.65 -2.19 0.009 -0.63 
BAI1-associated protein 3 (Baiap3) 7.06 14.82 -2.10 0.01 -0.49 
von Willebrand factor A domain containing 5A (Vwa5a) 3.97 8.00 -2.01 0.005 -0.61 
Fibronectin type III domain containing 9 (Fndc9) 1.52 3.03 -1.99 0.01 -0.59 
Delta-like 1 homolog (Drosophila) (Dlk1) 5.16 10.28 -1.99 0.02 -0.56 
Major histocompatibility complex, class I, A (Hla-a) 7.29 13.88 -1.90 0.001 -0.81 
Huntingtin-associated protein 1 (Hap1) 2.93 5.48 -1.87 0.003 -0.59 
Glutathione peroxidase 3 (Gpx3) 6.06 11.22 -1.85 0.01 -0.57 
Neuropeptide Y receptor Y2 (Npy2r) 1.25 2.23 -1.85 0.006 -0.57 
Family with sequence similarity 70, member A (Fam70a) 8.13 14.93 -1.84 0.02 -0.40 
These transcripts were the top ten up- and down-regulated NAc transcripts from the 619 transcripts that were differentially expressed 
between animals sacrificed at 8 and 14 wks of age. Note: Run distance r-value = the Pearson correlation coefficient between distance 
ran in the 8wk and 14wk rats versus the RPKM value of each gene; note that a bold value signifies a strong correlation (r > ±0.70). 
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Table 4.5. Top NAc transcripts correlated with running distance between 8 wk and 14 wk 
Transcript 
Run distance 
r-value 
p-value 
Fold Change 
(8 wk/14 wk) 
Positively correlated 
Cell adhesion molecule 2 (Cadm2) 0.87 < 0.001 1.42 
Cell adhesion molecule 4 (Cadm4) 0.84 < 0.001 1.22 
Fatty acid 2-hydroxylase (Fa2h) 0.83 < 0.001 1.27 
UDP glycosyltransferase 8 (Ugt8) 0.82 < 0.01 1.33 
Deiodinase, iodothyronine, type II (Dio2) 0.82 < 0.01 1.32 
Ras viral oncogene homolog 2 (Rras2) 0.81 < 0.01 1.22 
Calcium/calmodulin-dependent protein kinase II inhibitor 1 (Camk2n1) 0.79 < 0.01 1.34 
Proteolipid protein 1 (Plp1) 0.78 < 0.01 1.21 
Vesicle-associated membrane protein 7 (Vamp7) 0.78 < 0.01 1.61 
Rab11 family interacting protein 2 (class I) (Ran11fip2) 0.77 < 0.01 1.26 
Negatively correlated 
Threonine synthase-like 2 (Thnsl2) -0.90 < 0.001 -1.24 
Erythrocyte membrane protein band 4.1 like 4b (Epb41l4b) -0.87 < 0.001 -1.31 
Major histocompatibility complex, class I, H (pseudogene) (Hla-h) -0.84 < 0.001 -1.31 
dCMP deaminase (Dctd) -0.83 < 0.01 -1.27 
Kelch domain containing 8b (Klhdc8b) -0.82 < 0.01 -1.26 
Major histocompatibility complex, class I, A (Hla-a) -0.81 < 0.01 -1.90 
Monooxygenase, DBH-like 1 (Moxd1) -0.80 < 0.01 -1.24 
Filamin C, gamma (Flnc) -0.80 < 0.01 -1.28 
Major histocompatibility complex, class I, C (Hla-c) -0.79 < 0.01 -1.78 
Pygopus homolog 1 (Drosophila) (Pygo1) -0.79 < 0.01 -1.21 
These transcripts were the top ten positively and negatively correlated NAc transcripts from the 619 transcripts that were differentially 
expressed between animals sacrificed at 8 and 14 wks of age. Run distance r-value and p-value determined Pearson correlation 
coefficient between distance ran in the 8 wk and 14 wk rats versus the RPKM value of each gene. 
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Table 4.6. Top scoring Ingenuity Pathway Analysis biological functions and Gene Ontology terms identified as up-regulated in 8 wk 
vs 14 wk running rats 
Term Number of 
molecules 
p-value z-score / q-
value 
Ingenuity Pathway Analysis    
Top Physiological System Development and Functions 
Nervous System Development and Function 135 4.71E-3 – 2.14E-10 NA 
Tissue Development 139 4.44E-3 – 2.14E-10 NA 
Behavior 70 3.04E-3 – 9.19E-8 NA 
Top Nervous System Development and Function Categories 
Neuritogenesis 43 9.64E-10 2.258 
Development of neurons 53 2.14E-10 2.201 
Morphogenesis of neurons 29 1.00E-6 2.023 
Long-term potentiation 19 6.14E-6 2.004 
Branching of neurites 16 5.63E-4 1.748 
Select Activated Canonical Pathways Associated with Nervous System Development and Function 
CREB signaling in neurons 10 0.003 2.121 
Dopamine-DARPP32 feedback in cAMP signaling 7 0.04 0.816 
cAMP-mediated signaling 11 0.006 0.302 
Gene Ontology 
Top Biological Processes    
GO:0007268 – synaptic transmission 20 6.6E-5 1.0E-3 
GO:0019226 – transmission of nerve impulse 20 7.1E-6 6.0E-3 
GO:0007267 – cell-cell signaling 23 4.9E-4 1.5E-1 
Top Cellular Components 
GO:0044459 – plasma membrane part 62 1.9E-5 5.1E-3 
GO:0045202 – synapse 18 8.9E-5 7.9E-3 
GO:0030054 – cell junction 22 1.4E-4 9.6E-3 
Top Molecular Functions 
GO:0000287 – magnesium ion binding 17 4.4E-3 8.9E-1 
GO:0046873 – metal ion transmembrane transporter activity 13 1.0E-2 9.2-1 
GO:0009055 – electron carrier activity 10 1.2E-2 8.6E-1 
For IPA generated data, the z-score is used to reflect the predicted activation state of a given network or pathway. For GO generated 
data, the far right column displays q-values. For GO terms, only terms inclusive of at least 10 molecules per function where included 
in for analysis. NA: not applicable
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Cadm4 and Cdk5-associating molecules inherently decrease from 8 wk to 14 wk and are 
correlated with running 
 Following the aforementioned IPA and GO analysis, we analyzed our RNA-seq data 
for mRNAs that a) associate with the IPA and GO predicted up-regulated networks, and b) 
have been previously associated with a low voluntary running phenotype (Roberts et al., 
 
Figure 4.4. Top IPA generated network up-regulated in 8- vs. 14-week old wheel 
running rats. For NAc mRNAs differently expressed in 8 and 14 wk wheel running rats, the 
top up-regulated network at 8 wks included ‘nervous system and function, organ 
morphology, and organismal development’ (Focus molecules: 24/35, Score: 35). Nodes 
represent genes/molecules. Shading is proportional to fold change size (red: up-regulated, 
green: down-regulated). Direct and indirect relationships are denoted with solid and dashed 
lines, respectively. White nodes denote network members that were not altered in the 
network. Lines ending in an arrow or blunt end indicate known direction of molecular 
activation or inhibition, respectively.  
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2014). In doing so, we identified Cadm4 as a transcript differentially expressed between 8 wk 
and 14 wk running rats (p < 0.01) (Figure 4.5A) that 1) associates with the predicted up-
regulated networks, and 2) whose expression in NAc is intrinsically greater, and correlated 
with running behavior, in rats selectively bred for high vs. low voluntary running (Roberts et 
al., 2014). Follow-up qRT-PCR between sedentary 8 wk and 14 wk rats revealed Cadm4 
mRNA expression decreases from 8 wk to 14 wks of age independent of wheel running (p = 
0.026) (Figure 4.5B). Cadm4 mRNA was also highly correlated with wheel running distance 
(r = 0.84, p < 0.001) (Figure 4.5C). Additionally, Western blot analysis confirmed Cadm4 
protein was increased at 8 wk vs. 14 wk. independent of wheel running (F1,24 = 12.10, p < 
0.01) (Figure 4.5D). 
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 Others suggest that Cdk5 is a downstream regulator of Cadm signaling pathways and 
promotes synaptic formation and specialization (Lai and Ip, 2009; Samuels et al., 2007). 
Given the role of Cdk5 in modifying cocaine-induced locomotor activity (Taylor et al., 
2007), we next assessed other transcripts potentially critical for Cdk5 function. Of these 
transcripts, mRNA expression of the Cdk5 regulatory subunit Cdk5r2 (p39) was decreased in 
14 wk vs. 8 wk wheel running (p < 0.01) (Figure 4.6A) and sedentary (p < 0.01) (Figure 
4.6B) rats. p39 mRNA was also strongly correlated with running distance (r = 0.71, p < 0.01) 
(Figure 4.6C). Follow-up Western blot analysis revealed an age-dependent decrease in p39 
protein from 8 wk to 14 wk that was independent of wheel running (F1,24 = 9.54, p < 0.01) 
 
Figure 4.5. Cadm4 mRNA and protein are up-regulated at 8- vs. 14-weeks of age 
independent of wheel running. Cadm4 mRNA is up-regulated at 8 vs. 14 wks of age in 
wheel running (A) and sedentary (B) rats. Note the units in panels (A) and (B) differ due to 
(A) being determined by RNA-seq and (B) by qRT-PCR. Cadm4 mRNA is strongly correlated 
with running distance during the final week of the study (C). Similarly, Cadm4 protein 
decreases from 8 to 14 wks of age independent of wheel running (data normalized to 8-wk 
wheel running group) (D). Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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(Figure 4.6D). Assessment of a homologous Cdk5 regulatory subunit Cdk5r1 (p35) with 
Western blotting revealed no differences in p35 between 8 wk and 14 wk (F1,24 = 0.052, p = 
0.81) or wheel status (F1,24 = 0.25, p = 0.62) (Fig. 4.6E). However, Western blotting showed 
an increase in p25, the cleavage product of p35, in wheel running vs. sedentary rats (F1,24 = 
20.98, p < 0.01) suggesting increased Cdk5 activity with wheel running (Figure 4.6F). 
Finally, analysis of Cdk5 mRNA expression revealed a decrease between 8 wk and 14 
wk wheel running (p < 0.05) but not sedentary rats (p = 0.34) (Figure 4.6G, H). Cdk5 mRNA 
was also significantly correlated with wheel running distance (r = 0.58, p = 0.047) (Figure 
4.6I). Together, these results suggest an age-related decline in select molecules controlling 
Cdk5 function may influence/modulate wheel running behavior, and that Cdk5 function may 
be enhanced by, and/or possibly regulate, wheel running, as previously hypothesized (Werme 
et al., 2002).  
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Figure 4.6. Cdk5-associated mRNA and protein differences in 8- vs. 14-week old wheel 
running and sedentary rats. Cdk5r2 (p39) mRNA is higher at 8 vs. 14 wks of age in wheel 
running (A) and sedentary (B) rats. Note the units in panels (A) and (B) differ due to (A) being 
determined by RNA-seq and (B) by qRT-PCR. p39 mRNA is strongly correlated with running 
distance during the final week of the study (C). Similarly, p39 protein decreases from 8 to 14 
wks of age independent of wheel running (data normalized to 8-wk wheel running group) (D). 
Wheel running and age had no effect on Cdk5r1 (p35) protein level (E); however, wheel 
running increased protein expression of the p35 cleavage product p25 (F). Cdk5 mRNA was 
modestly, but significantly, greater in 8 vs. 14 wk wheel running rats (G), but was not different 
between 8 and 14 wk sedentary rats (H). Cdk5 mRNA was significantly correlated with 
running distance during the final week of the study (I). Symbols: * p < 0.05, ** p < 0.01, *** p 
< 0.001. 
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Neuronal maturation and dendritic density 
 Given the resultant IPA and GO gene networks and functions, we hypothesized that a 
decrease in MSN number may associate with the decrease in wheel running observed 
between 8 and 14 wks. Dopamine- and cAMP-regulated neuronal phosphoprotein of 32kDa 
(Darpp-32) protein is predominantly expressed in differentiated striatal MSNs, comprising 
95% of neurons in the NAc (Arlotta et al., 2008), which we used as a marker of NAc MSN 
content in the current study. Western blotting showed no differences in the levels of Darpp-
32 protein in 8 wk vs. 14 wk-old rats (F1,24 = 1.48, p = 0.24) or in wheel vs. sedentary rats 
(F1,24 = 0.06, p = 0.81) (Figure 4.7A). 
 Additionally, we hypothesized decreases in dendritic spine density were associated 
with age-related declines in wheel running. Assessment of NAc MSNs showed that the total 
number of dendritic spines was greater at 8 wk compared to 14 wk (F1,282 = 24.28, p < 0.001) 
and was increased by wheel running (F1,282 = 51.12, p < 0.001) (Figure 4.7B). We also 
observed a trend for an age x wheel status interaction (F1,282 = 3.48, p = 0.063). No 
differences in dendritic spine density where observed between NAc subregions (data not 
shown). Post-hoc analysis found a modest, but significant, decrease in dendritic spine density 
in sedentary rats from 8 to 14 wks, suggesting dendritic spine density in the NAc inherently 
decreases from 8 to 14 wks of age (p = 0.031). Analysis of spine type composition showed 
that wheel running reduced the percentage of stubby spines (F1,282 = 5.94, p = 0.015) while 
tending to increase the percentage of thin spines (F1,282 = 3.84, p = 0.051) (Figure 4.7C). 
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Intra-NAc roscovitine injection decreases voluntary wheel running 
 Total running distance was significantly reduced following intra-NAc infusion of 
roscovitine at 40 nmol/0.5μl (F2,42 = 4.93, p = 0.024) and 80 nmol/0.5μl (F2,48 = 19.41, p > 
0.001) (Fig. 8A and C). Post-hoc analysis revealed total running over 120-min test session 
was decreased compared to baseline after 40 and 80 nmol roscovitine on both days 1 and 5 of 
drug injection (p < 0.05). Additionally, following 80 nmol roscovitine injection, running 
 
Figure 4.7. Dendritic spine density is increased in 8- vs. 14-week old wheel running and 
sedentary rats. (A) Darrp-32 protein was not different between any of the four experimental 
groups assessed. (B) Analysis of dendritic spine density showed that wheel running increased 
spine density, while increases in age from 8 to 14 wks was associated with a decrease in 
dendritic spine density. (C) Analysis of spine type showed that wheel running decreased the 
percentage of stubby spines and trended to increase the percentage of thin spins. (D) 
Representative images for the four experimental groups assessed. Scale bar = 5μM. Symbols: 
* p < 0.05, ** p < 0.01, *** p < 0.001. 
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distance was decreased in each 30-minute interval recorded during the 120-minute trial on 
both days 1 and 5 (p < 0.05) (Fig. 4.8A). 
 A repeated measures ANOVA examining of the effect of roscovitine on percent 
change in running distance from baseline showed significant decreases in running after 40 
nmol (F2,41 = 5.58, p = 0.016) and 80 nmol roscovitine (F2,46 = 37.07, p < 0.001) after the 
exclusion of 2 outlier points (> ± 2 SD) (Fig. 4.8B). Post-hoc analysis revealed decreased 
percent running 0-30 and 30-60 min. post-injection following 40 and 80 nmol infusion on 
days 1 and 5, respectively (p < 0.05). Likewise, following 80 nmol roscovitine injection, 
percent running from baseline was decreased in each 30-minute interval recorded during the 
120-minute trial on both days 1 and 5 (p < 0.05). 
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DISCUSSION 
 In this study, our two-fold aims were: 1) to analyze molecular transducers in the NAc 
that may initiate and are associated with decreases in voluntary wheel running in young rats 
and, 2) to assess how the inhibitor of Cdk5, a molecule highlighted in our first aim, impacts 
wheel running behavior. We report that decreasing levels of voluntary wheel running 
between 8 and 14 wks are associated with declines in 1) MSN dendritic spine density, 2) 
gene networks critical for synaptic communication and neuron development, and 3) several 
transcripts central to these functions are highly correlated with wheel running distance. 
Additionally, declines in key mRNAs and proteins related to the above functions and 
 
Figure 4.8. Intra-NAc roscovitine infusion decreases voluntary wheel running. (A) 
Running distance (km) displayed in 30-min. increments for baseline injection and on the 1st 
and 5th nights of vehicle (black) or 40 nmol (gray) or 80 nmol (white) roscovitine (ROS) 
injection. (B) Percent running distance on the 1st and 5th nights of vehicle or drug injection 
compared to baseline injection values. Note: two outlier points (± 2 SD) were removed from 
this analysis (not shown). (C) Total running distance over the 120-min. test session for the 
baseline injection and for the 1st and 5th night of vehicle or drug injection. All data was 
analyzed with repeated-measures ANOVA. Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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dendritic spine density were observed in analysis in age-matched sedentary rats, suggesting 
decrements in these functions may be the result of age, rather than from the reduction in 
physical activity. Finally, pharmacological inhibition of Cdk5, a molecule central to some 
functions described above, dose-dependently decreased wheel running. Taken together, these 
findings suggest, for the first time, that decreases in molecules associated with Cdk5 function 
in the NAc may regulate the initial decrease in wheel running behavior that begins after 8 
wks of age.  
Human physical inactivity is strongly associated with increased chronic disease and 
mortality later in life (Booth et al., 2012). Surprisingly, few studies, to our knowledge, have 
investigated any of the underlying biological mechanisms occurring in youth that may 
account for early reductions in physical activity. Furthermore, effective public health-related 
strategies to combat physical inactivity are relatively non-existent. Intriguingly, our 
observation that wheel running is greatest at 8 wks of age in female, Wistar rats matches our 
previous publications in male rats given wheel access at 4, rather than 6, wks of age 
suggesting inherent changes at 8 wks mediate running behavior in both males and females 
(Ruegsegger et al., 2016).  
 
Factors associated with MSN structure are associated with age-dependent reductions in 
voluntary wheel running 
Relationships between enhanced striatal MSN architecture and wheel running 
behavior have been previously established (Roberts et al., 2014). In the present study, 
bioinformatics using IPA and GO revealed extensive up-regulation of gene networks with 
functions in neuron development, dendritic spine density, and cAMP signaling in 8 wk- 
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compared to 14 wk-old wheel running rats; however, these results could represent alterations 
to reduced levels of wheel running, rather than age-induced adaptations. The extensive up-
regulation of mRNAs, which have nervous system function, included ~22% of all transcripts 
meeting our bioinformatics-filtering criteria. Additionally, several of the top up-regulated 
mRNAs at 8 wks have functions specific to nervous system function, as described in the 
results. Likewise, one transcript only expressed at 8 wk, Arhgef7, has been implicated in the 
assembly of functional synapses (Zhang et al., 2003; Zhang et al., 2005), further suggesting 
neural plasticity and function is higher in 8-wk compared to 14-wk wheel running rats (data 
not shown). These findings are similar to previous findings by Roberts et al. (Roberts et al., 
2014), who reported that high intrinsic levels of mRNAs indicative of increased neuronal 
maturation and synaptic function in the NAc are associated with high voluntarily running 
distances. Thus, assuming that NAc mRNA expression is an indicator of molecular 
transducers that are associated with voluntary wheel running behavior, we posit that these 
identified transcripts provide candidates that may ‘predict’ running behavior, and therefore 
begin to offer a neuromolecular basis for declining physical activity seen between 8 and 14 
wks of age. 
The above led us to identify molecules located at the synapse. Specifically, cell 
adhesion molecule 4 (Cadm4) and Cadm2 were identified as being higher at 8 vs. 14 wks, 
and they had high positive, strong correlations between their transcript levels and running 
distance. Cadm4 has been shown to promote synaptogenesis (Tanabe et al., 2013), and 
Cadm4 can drive the assembly of glutamatergic synapses (Biederer et al., 2002). Lower 
levels of Cadm4 protein have been previously associated with a low voluntary running 
phenotype (Roberts et al., 2014). Importantly, the overexpression of the Cadm family 
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member Cadm1 in mice promotes an increase in excitatory synapse number and synaptic 
plasticity, while loss of Cadm1 results in fewer excitatory synapses (Robbins et al., 2010). 
Therefore, given that synapse formation within the NAc has been attributed to addictive-like 
behaviors (Russo et al., 2010), we posit that the ~20% decreases in Cadm4 mRNA and 
protein levels could decrease the formation of specific synapses between NAc neurons and 
other brain regions (i.e., the ventral tegmental area, prefrontal cortex, and hippocampus as 
examples); an effect which may influence the reduced running behavior observed in 14 wk-
old rats. Further, this decrease in Cadm4 mRNA and protein appears independent of running, 
and provides a potential mechanism by which age may influence the decline in wheel 
running between 8 and 14 wks. While a major limitation of the present study is the lack of 
RNA-seq on age-matched sedentary rats, the decrease in Cadm4 mRNA by qRT-PCR in the 
sedentary group supports a hypothesis that similar decreases in mRNAs related to synaptic 
function and neural plasticity decrease independent of wheel running occur between 8 and 14 
wks of age; however, this must be assessed in future studies.  
Previous reports suggesting that Cadm proteins regulate Cdk5 signaling pathways led 
us to assess Cdk5 mRNA expression in 8- and 14-wk wheel running and sedentary rats (Lai 
and Ip, 2009; Samuels et al., 2007). However, the Cdk5 results were not completely 
confirmatory. While we observed a correlation between Cdk5 mRNA and running distance in 
NAc, Cdk5 mRNA was only lower at 14 weeks of age, compared to 8 weeks of age, in the 
voluntary wheel running group. In addition, literature indicates that Cdk5 protein without its 
co-factors does not exhibit enzyme activity. Cdk5 co-factors Cdk5r2 (p39) (Cai et al., 1997) 
and Cdk5r1 (p35) (Lew et al., 1994; Tsai et al., 1994) are indispensable for Cdk5 activity. 
They have been shown to have similar affinity and ability to activate Cdk5 (Tang et al., 
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1995). One of these, Cdk5r2 (p39) decreased at 14 wks, as compared to 8 wks, at both its 
mRNA and protein levels, independent of wheel running. In addition, p39 in the wheel 
running group was strongly positively correlated to running distance. Concerning the other 
Cdk5 co-factor, no differences were noted in the p35.  However, wheel running increased 
protein expression of its cleavage product p25, suggesting that wheel running increases p35 
activity. Immunohistochemical localization analysis suggests that p39 and p35 could have 
different functional roles in regulating Cdk5 activity, particularly in the basal ganglia 
(Honjyo et al., 1999). Further, Wu et al. (Wu et al., 2000) demonstrated that Cdk5 activity is 
~40% less in the striatum at 6 months compared to 3 months age despite no difference in 
Cdk5 protein level, and this decrease was attributed to decrements in p35 and p39 expression. 
Together with data from the current study, these findings suggest the notion that the age-
dependent declines in p39 in the striatum may drive age-related declines in Cdk5 activity.  
To interim summarize the above, findings that p39 is decreased by age is particularly 
interesting given that Cdk5 was hypothesized to mediate increases in running behavior 
associated with increased expression of its transcription factor ΔFosB. Wheel running 
increases ΔFosB expression, likely increasing Cdk5 activity (Werme et al., 2002). Thus, it is 
possible that p39 decreases age-related changes in Cdk5 activity while p35/25 increases 
exercise-induced changes in Cdk5 activity. Finally, while Cadm and other synaptic proteins, 
and p39 and/or p35 likely influence Cdk5 signaling by independent mechanisms, together 
these findings highlight the plausibility of Cdk5 as a promising target molecule to regulate 
age-related declines in voluntary physical activity.  
Dendritic spine density in MSNs was measured to assess whether structural 
differences could offer future leads to explain the aforementioned gene and network 
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differences. Intriguingly, we observed significant increases in spine density with wheel 
running. To our knowledge, this is the first report to show increases in dendritic spines in the 
NAc in response to wheel running. Precedence for increased spine density exists. Several 
reports by Stranahan et al. (Stranahan et al., 2007; Stranahan et al., 2009) have shown that 
wheel running increases dendritic spine density in the hippocampus. Together with findings 
from the present study, justification exists to assess how physical activity influences dendritic 
density in additional brain regions. Others have shown that increases in dendritic spine 
density in dopaminoceptive NAc MSNs are associated with long lasting addictive behaviors, 
and increases in dendritic spine density in the NAc have been observed in response to 
cocaine (Lee et al., 2006; Norrholm et al., 2003).  
We also observed subtle changes in dendritic spine composition following wheel 
running, Wheel access tended to increase, and to significantly decrease the percentage of thin 
and stubby dendritic spines, respectively. While a non-significant trend (p = 0.051), the 
increase in thin spines following in wheel running is intriguing given their important 
functions in excitatory synaptic activity and dictating rapid responses to changes imposed by 
salient stimuli (Bourne and Harris, 2007). Similarly, LePlant et al. (LaPlant et al., 2010) 
demonstrated that chronic cocaine use increased the percentage of thin spines in the NAc. 
Hence, wheel running produces alterations in the quality of dendritic spine density in the 
NAc that is similar to better-characterized addictive behaviors.  
We also observed significant reductions in dendritic spine density in 14 wk compared 
to 8 wk sedentary rats. Anderson (Anderson, 1982) observed higher dendritic densities in the 
medial preoptic area of the hypothalamus (MPOA), at 55 d (~8 wks of age) compared to 75 d 
(~11 wks of age) in rats. Like the NAc, the MPOA is highly responsive to dopamine (Hull et 
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al., 1995). Likewise, a recent study by Madison et al. (Madison et al., 2012) reported a ~20% 
reduction in dendritic spine density in the MSNs from 13 to 16 wk-old mice, further 
supporting the plasticity of the MSNs at relatively young ages.  
Cdk5 has been implicated in many biochemical processes that influence structural 
and functional changes in synaptic plasticity (Cheung et al., 2006). Injection of the Cdk5 
inhibitor roscovitine into the NAc reduces dendritic spine density in the NAc (Norrholm et 
al., 2003), further highlighting Cdk5 as a candidate target that could mediate age-dependent 
reductions physical activity. These differences in dendritic density in the current experiments 
were independent of differences in the amount of mature NAc MSNs, as assessed by Darpp-
32 Western blot. However, that the ~8% drop in Darpp-32 protein between 8 and 14 weeks is 
comparable to the 5-10% rate of decline in the number of dopaminergic neurons in the NAc 
and striatum per decade in humans (Naoi and Maruyama, 1999). 
 
Cdk5 inhibition dose-dependently decreases wheel running 
 To expound upon the data generated in the first experiments, we tested our notion that 
pharmacological inhibition of Cdk5 in the NAc core would decrease voluntary running. To 
our knowledge, this is the first report to observe a dose-response decrease in wheel running 
following infusion of the Cdk5 inhibitor roscovitine into the NAc core. The novel response to 
roscovitine presents important evidence that Cdk5 function in the NAc core is at least 
partially necessary for chronic adaptations that influence the motivation for voluntary wheel 
running, however voluntary wheel running is likely under polygenic control. This 
observation also extends our findings from the first experiment by potentially localizing a 
site of action for these changes to the NAc core.  Together, the above add to the growing 
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body of literature suggesting Cdk5 activity in the NAc may be an important modulator of 
reward-related behaviors and highlight the neuro-chemical parallels between wheel running 
behavior and drug addiction.  
 Dopamine neurotransmission is important to multiple reward-related processes in 
addition to those involved in drug addiction. In the striatum, Cdk5 controls dopamine 
neurotransmission through the regulation of the presynaptic components of dopamine 
synthesis and release (Chergui et al., 2004; Kansy et al., 2004; Moy and Tsai, 2004), and 
Cdk5 appears to interface dopamine signaling with several downstream targets thought to 
mediate reward-related behavior including PKA and DARPP-32 (Bibb, 2003). Several 
investigations have shown that both agonism and antagonism of dopamine signaling in the 
NAc reduces voluntary wheel running (Knab et al., 2012; Roberts et al., 2012). Cdk5 is a 
natural, negative-regulator of dopamine signal transduction (Bibb et al., 1999). Rats find 
voluntary wheel running rewarding (Brene et al., 2007), and inhibition of Cdk5 could 
promote a ‘substitution of reward’ by replacing the reward derived through wheel running 
with the reward derived through potential increases in dopamine signaling. Similarly, drug 
intake studies blocking mesolimbic dopamine receptors have shown increased nicotine and 
cocaine intake (Arnold and Roberts, 1997; Corrigall and Coen, 1991), suggest that 
decreasing NAc dopamine may promote reward-seeking behavior and vice versa. 
Importantly, reductions in running following roscovitine infusion occurred on both the first 
and fifth night of injection. Acute roscovitine treatment evokes dopamine release (Chergui et 
al., 2004), suggesting that roscovitine-induced alterations in dopamine may decrease wheel 
running via hedonic substitution, rather than Cdk5-induced plasticity. The notion that Cdk5 
influences wheel running by altering dopamine action is also similar to findings suggesting 
133 
 
that Cdk5 inhibition in the NAc enhances the behavioral responses to cocaine in a manner 
dependent of dopamine signaling in the NAc (Benavides et al., 2007; Taylor et al., 2007). 
Interestingly, while behavioral responses to drugs of abuse are often enhanced following 
roscovitine treatment, we observed a reduction in wheel running behavior, suggesting that the 
neuromolecular mechanisms controlling voluntary wheel running and behavioral responses 
to drugs of abuse are similar, but not identical.  
 Our finding that Cdk5 inhibition decreases wheel running also extends previous 
research by Werme et al. (Werme et al., 2002) showing that ∆FosB overexpression in 
dynorphin neurons in the striatum increases wheel running distance to suggest that Cdk5, a 
∆FosB target gene, may mediate the influences of ∆FosB on wheel running. Additionally, 
when extending these results to age-related changes, considerable decreases between 7 and 
14 weeks of age in cAMP production in NAc and striatum parallel declines in locomotor 
activity (Andersen, 2002), further suggesting that decreases in PKA-cAMP signaling 
between 8 and 14 wks may influence wheel running. Our results are also in agreement with 
analysis by Benavides (PhD Dissertation, UT Southwestern, 2010) who used Cdk5 
conditional knockout (CKO) mice to show that after acquisition of running behavior, Cdk5 
CKO mice displayed dramatically reduced steady-state levels of voluntary wheel running 
compared to controls. Our findings extend upon the unpublished finding to suggest that the 
loss of Cdk5 activity, as well as expression, mediates running behavior; however, further 
work is needed to identify more precisely how changes in Cdk5 activity/expression alter 
voluntary wheel running.  
 Our usage of the Cdk5 inhibitor roscovitine is limited by the possibility of 
nonspecific pharmacological effects and its inability to localize the effects of Cdk5 inhibition 
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to either presynaptic or postsynaptic compartments. An additional limitation is that inhibition 
of Cdk5 catalytic activity may not affect the described structural or activity-independent roles 
of the protein (Hawasli et al., 2007).  
  
Conclusions 
 Here, we show that age-related decreases in Cadm4, p39, and MSN dendritic density 
are associated with age-related decreases in voluntary running, and that repeated infusion of 
the Cdk5 inhibitor roscovitine decreases wheel running. Our data provide guidance for future 
investigation into how synaptic plasticity, dopaminergic signaling, and Cdk5 function in the 
NAc impact voluntary wheel running. Given the epidemic levels of physical inactivity 
significant efforts should be taken to unravel the neuromolecular mechanisms underlying the 
biological motivation for voluntary physical activity. 
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CHAPTER 5: Conclusions and future directions 
 
The overall aim of this dissertation was to investigate the relationship between the 
mesolimbic reward pathway, primarily via molecular mechanisms in the NAc, and the 
motivation for physical activity. This relationship was investigated using three distinct 
models to assess the involvement of the mesolimbic reward pathway on wheel running. In 
Chapter 2, I utilized rats selectively bred from high or low voluntary wheel running distance 
to assess differences in endogenous opioid and DA activities, and to determine the necessity 
of DA to influence opioid-mediated changes in physical activity in HVR rats. In Chapter 3, I 
assessed the effects of maternal WD on physical activity of F1 and F2 offspring, mRNA 
expression, and protein levels of DA-related genes. Similarly, in Chapter 4, I used 
transcriptomic, histological, and pharmacological approaches to assess how alterations in DA 
action in the NAc may influence declining physical activity levels present during 
adolescence. Collectively, the results of these experiments suggest that alterations in 
dopaminergic signaling in the NAc undoubtedly associate with and/or influence voluntary 
physical activity, as shown in Figure 5.1. While the mechanisms by which the DA system 
was potentially influenced in each study likely differ (e.g. receptor expression in Chapters 2 
and 3, and dendritic spine density and Cdk5 activity in Chapter 4), I find this a somewhat 
startling, and important, conclusion given the drastic differences among the three 
experimental approaches used in this dissertation. Given the potential implications by which 
understanding the neuromolecular mechanisms contributing to physical activity may improve 
the quality of life, I hope these results lead to further discoveries in this area of research. 
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Figure 5.1. Hypothesized model summarizing how findings in this dissertation may 
collectively influence physical activity. 1) Endogenous opioids act on the mu opioid 
receptor (OPRM1) in ventral tegmental area (VTA) and nucleus accumbens (NAc). In the 
VTA, opioid binding to OPRM1 hyperpolarizes GABAergic neurons, in turn lowering 
GABA release and action on VTA dopamine (DA) neurons. This disinhibition of VTA 
DA neurons by OPRM1 action on GABAergic neurons increases DA synthesis in the 
VTA and downstream release in the NAc, where DA acts on dopamine receptors (DxR) to 
depolarize NAc medium spiny neurons (MSNs) and increase cAMP concentrations and 
PKA signaling. Activation of the PKA signaling cascade increases gene expression of 
immediate early genes that may enhance wheel running. Similarly, opioids bind to post-
synaptic OPRM1 in NAc MSNs, producing depolarizing responses, in turn increasing 
cAMP/PKA signaling and downstream gene expression and wheel running. Note that 
opioid signaling requires interactions with dopaminergic signaling to influence wheel 
running, however whether these interactions are downstream of opioid action in VTA or 
NAc is unclear (Chapter 2). 2) In a non-resistant state, leptin binding to leptin receptor 
(LEPR) hyperpolarizes VTA DA neurons, decreasing DA release on downstream NAc 
MSNs. The reduction in NAc DA decreases NAc cAMP/PKA signaling, potentially 
decreasing wheel running by lowering gene expression of immediate early genes (Chapter 
3). 3) Cyclin dependent kinase 5 (Cdk5) in the NAc phosphorylates DARPP-32, 
ultimately inhibiting PKA signaling. Paradoxically, data in Chapter 4 suggests that 
inhibiting Cdk5, and therefore increasing PKA signaling, decreases wheel running. I 
hypothesize, the activation of Cdk5, and subsequent inhibition of PKA signaling, may 
lead to hypo-responsiveness to rewarding stimuli, such as wheel running. Thus, following 
Cdk5 activation higher levels of wheel running may be performed to achieve the same 
level of reward. Given that my data suggest both activation (Chapters 2 and 3) and 
inhibition (Chapter 4) of NAc PKA signaling associate with increased wheel running, the 
mechanisms controlling wheel running appear finely controlled and highly complex. 
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Selective breeding highlights inherent elevations in opioid and dopamine signaling in high 
voluntary running rats  
Physical activity is a complex, polygenic behavior in which multiple molecular 
adaptions likely contribute to the phenotype. Therefore, selective breeding for high and low 
voluntary running behavior provides a unique opportunity to study how divergences in 
physical activity propensity lead to the development of enriched gene signatures. In addition, 
knowledge of how these gene signatures associate with the polarization of extremely high 
and low running phenotypes provides a unique insight into heritable factors that may 
influence physical activity levels. In Chapter 2, I hypothesized that elevations in Oprm1 
expression and function in the NAc would associate with greater reductions in wheel running 
following opioid receptor antagonism in HVR, compared to LVR, rats. Additionally, I 
hypothesized the influences of opioid receptor antagonism on wheel running were dependent 
on the mesolimbic dopamine system. These hypotheses were based on multiple lines of 
evidence showing opioids and DA are independent strong influencers of voluntary wheel 
running behavior (Knab and Lightfoot, 2010; Rhodes et al., 2005; Roberts et al., 2012; 
Ruegsegger et al., 2015; Schnur and Barela, 1984).  
From the experiments in Chapter 2, I conclude 1) Oprm1 mRNA, protein, and 
function are increased in the NAc of HVR compared to LVR rats; 2) the opioid receptor 
antagonist naltrexone reduces wheel running to a greater extent in HVR than LVR; 3) 
systemic naltrexone injection decreases DA-related mRNAs in mesolimbic brain regions; and 
4) naltrexone effects require dopaminergic nerve terminals in the NAc, and likely VTA, to 
influence wheel running in HVR rats. Collectively, these results suggest that inherent up-
regulations in NAc opioidergic function may lead to increased physical activity levels, while 
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the down-regulation of opioidergic function in the NAc may promote physical inactivity, as 
shown in Figure 2.7. Interestingly, these results were independent of differences in peripheral 
pain sensitivity, an opioid-mediated function, suggesting that pain tolerance is not co-
selected with the selection for voluntary running motivation in healthy rats.  Additionally, 
given the postulate that elevated opioidergic function in ‘reward-controlling’ brain regions 
may be the driver of the elusive ‘runner’s high’ (Boecker et al., 2008), it is possible that HVR 
rats are merely running to obtain a ‘runner’s high.’ This idea is supported by my findings in 
Chapter 2, as well as previous findings that 1) antagonizing Oprm1 signaling locally in the 
NAc decreases running, suggesting the involvement of downstream Oprm1 activity in the 
acquisition of wheel running reward; and paradoxically 2) agonizing Oprm1 locally in the 
NAc decreases running, suggesting that rats may run to achieve an ‘opioid high’ that when 
artificially provided partially discourages the rat from running. Nonetheless, inherent 
differences in Oprm1 function may provide clues as to why certain humans repeatedly find 
pleasure in performing outlandish amounts of physical activity, while others seem to obtain 
no reward from physical activity. This hypothesis has been presented to explain running 
addiction in humans (Boecker et al., 2008). 
The results from Chapter 2 also suggest that HVR and LVR lines may display 
differing preferences for drugs of abuse. It is well recognized that the neuromolecular 
pathways influencing wheel running also influence addiction and drug usage. For example, 
rats with a high avidity for wheel running are more motivated to self-administer cocaine than 
outbred rats with a low avidity for voluntary running (Larson and Carroll, 2005). However, 
the addition of a running wheel reduces cocaine self-administration compared to sedentary 
rats, highlighting the ability of physical activity to substitute for the reward derived from 
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cocaine (Zlebnik et al., 2012). With reference to Oprm1, naltrexone injection reduces ethanol 
consumption in a DA-dependent mechanism, as determined by measuring extracellular DA 
measurements in vivo in the NAc (Valenta et al., 2013). Likewise, drug-induced locomotor 
activity has long been known to be the result of elevated DA in the NAc following repeated 
drug injection, and drug-induced locomotor activity serves as a simple screening tool for 
testing the sensitivity of rodents to drugs of abuse (Wise and Bozarth, 1987) (Delfs et al., 
1990). Similarly, my findings in Chapter 4 also support commonalties between molecular 
and structural changes that regulate drug addiction also mediate wheel-running behavior. 
Collectively, I believe a major outcome from this research could be to encourage future 
research into using exercise to prevent and/or treat drug addiction in patient populations. The 
concept of treating addicts with exercise has been extensively discussed, with the general 
census supporting future strategies to implement select exercise protocols to addicts 
recovering from various stages of addiction (Lynch et al., 2013). Ultimately, I speculate that 
the efficacy of exercise to treat drug addiction may relate to its ability to facilitate DA 
transmission as well as its ability to normalize dopaminergic and glutamatergic signaling and 
drug-induced epigenetic changes in chromatin structure in the cells of the reward system 
once addiction develops. The strong parallels between wheel running and drug addiction may 
make the HVR/LVR model an enticing model to study addiction and mental health. 
While much of my discussion has focused on the inherent divergence in opioid and 
DA-related signaling between HVR and LVR rats, it is also important to consider the 
polygenic nature by which this model is built. For example, in Chapter 2 the lesion of DA 
neurons in the NAc of HVR rats with 6-OHDA only produced minor reductions in wheel 
running following injection. Further supporting, running distance had returned to level of 
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vehicle treated rats by two-weeks post-injection (Figure 2.5). While this finding again 
highlights the role of DA in contributing to the wheel running behavior in HVR rats, it also 
suggests DA is not essential to maintain high voluntary running levels. The ability of other 
neuromodulators to compensate for the loss of DA highlights the complex, polygenic control 
of voluntary physical activity. Nonetheless, these findings may have translational implication 
for uncovering the control of physical activity motivation as well as for developing strategies 
to help recovering drug addicts. 
Future directions from this study include addressing opioidergic and dopaminergic 
contributions to wheel running with genetic manipulation models (e.g. overexpression of 
knockdown of Oprm1 or opioid ligands in the NAc or other mesolimbic brain nuclei in HVR 
or LVR rats) to study the direct contributions of opioid- and DA-related gene expression to 
high and low voluntary running phenotypes. For example, I hypothesize that knockdown of 
Oprm1 in the NAc will reduce wheel running in HVR rats, while overexpression of the 
Oprm1 ligand β-endorphin in the NAc will increase wheel running in LVR rats. Experiments 
in which opioid and DA receptors are simultaneously agonized and antagonized, 
respectively, in the NAc would further my conclusions about the necessity of the DA system 
for opioidergic influence on wheel running behavior. As mentioned previously, the 
neuromolecular mechanisms governing wheel running and addictive behaviors appear 
comparable. This suggests that HVR rats may be more prone to various drugs of abuse (e.g. 
ethanol, cocaine, etc). For example, our lab has identified parallelisms in cocaine-induced 
locomotor activity and anxiety-like behavior between HVR and LVR rats (Brown et al., 
2015). Future experiments using HVR and LVR rats investigating the propensity for various 
drugs of abuse, and the ability of voluntary wheel running to compete with the reward 
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derived from drugs of abuse may further associate running and addictive neurocircuitry, and 
suggest exercise may be part of a viable treatment for recovering addicts. The assessment of 
dendritic density in the NAc and other brain regions in sedentary and wheel running HVR 
and LVR rats may also draw further parallels between running motivation and drug 
motivation. 
 
Maternal Western diet and obesity may be key drivers of offspring physical activity  
 Further conjecture relates to an important clinical condition. Since the initial 
observations by Garrod during the turn of the last century that conferred the existence of 
inherited biochemical characteristics from family histories of alkaptonuria (Garrod, 1902), it 
has been increasingly appreciated that most common diseases involve not only discrete 
genetic and environmental causes, but also gene-environment interactions (Hunter, 2005). 
For example, Garrod proposed that the influences of diet and disease may mask some of the 
“inborn errors in metabolism” that were initially proposed as causes of disease. Indisputable 
evidence shows that genetic and environmental underpinnings cause obesity (Qi and Cho, 
2008). Importantly, these genetic and environmental contributions to obesity are posited to 
cause transgenerational alterations in dopamine signaling and metabolic dysfunction 
(Heerwagen et al., 2010; Ong and Muhlhausler, 2011; Vucetic et al., 2012; Vucetic et al., 
2010). Given that maternal obesity prevalence during pregnancy is as high as 38% (Yogev 
and Catalano, 2009), in Chapter 3 I sought to examine how environmental factors 
contributing to obesity during pregnancy potentially contribute to transgenerational genetic 
and behavioral changes in juvenile and young-adult offspring. Based upon previous findings 
that Oprm1 mRNA is increased and decreased in male and female juvenile and adult rats fed 
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a cafeteria-style diet, respectively (Ong and Muhlhausler, 2011) and upon my previous 
findings that Oprm1 mRNA positively associates with running distance (Ruegsegger et al., 
2015), I hypothesized that male and female offspring of dams fed WD prior to and during 
pregnancy would have increased voluntary wheel running distance at juvenile ages but 
decreased wheel running distance by young adulthood. Additionally, I hypothesized changes 
in offspring wheel running would associate with increased and decreased Oprm1 mRNA 
expression during juvenile and adult ages, respectively. These hypotheses were the basis for 
the experiments performed in Chapter 3 of my dissertation. 
 Contrary to my hypothesis, maternal WD had no influence on offspring Oprm1 
mRNA expression. Instead, my results from Chapter 3 suggest that gestational WD and 
maternal obesity lead to: 1) increased and decreased voluntary physical activity (i.e. wheel 
running) levels in juvenile and adult female offspring, respectively, while voluntary physical 
activity levels are unaltered in male offspring; 2) changes in the directionality of voluntary 
physical activity levels are complemented by changes in dopamine receptor mRNA and 
protein levels in the NAc and Lepr mRNA in the VTA; 3) differences in voluntary physical 
activity levels between SD and WD offspring appear independent of metabolic disease risk 
(e.g. increases in body fat and serum leptin and insulin); and 4) the lack of differences in F2-
offspring voluntary wheel running, adiposity, and dopamine receptor mRNA expression 
suggests the above differences are the result of direct in-utero exposure to maternal 
WD/obesity, rather than permanent transgenerational (potentially epigenetic) changes. 
The link between enhanced DA action in the NAc and greater wheel-running 
behavior is well-established (Knab and Lightfoot, 2010). Therefore, I posit that this link may 
provide one basis by which gene-environment interactions influence voluntary physical 
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activity. Interestingly, a recent publication by Friend et al. (Friend et al., 2016) reported that 
chronic HFD exposure in mice reduces striatal Drd2 binding, which in turn leads to reduced 
wheel running. Thus, mechanistic links explaining alterations in wheel running behavior in 
response to direct or maternal overnutrition may stem from ‘dysfunctional’ dopaminergic 
signaling. Equally fascinating are similar findings that Drd2 knockdown in mice produces an 
obese phenotype compared to wild-type littermates that is primarily due to decreased energy 
expenditure rather and increased food intake (Beeler et al., 2016). Future studies in which 
dopamine receptor expression is restored in knockdown or knockout mice fed a WD or HFD 
may be fruitful in better providing a direct causal link between dopamine receptor function 
and abnormal wheel-running patterns following overnutrition. 
Interestingly, I observed strong sex-specific differences in voluntary wheel running of 
offspring, with females from maternal WD fed dams having increased and decreased wheel 
running at juvenile and adult ages, respectively. Paradoxically, this observation is in line with 
human “quasi-experimental observations” such as the Dutch Hunger Study and Biafra famine 
(Hult et al., 2010; Stein et al., 2007; Yang et al., 2008) in which maternal and fetal 
undernutrition and growth restriction reprogram physical activity levels, specifically in 
females. Recent human epidemiologic data of Cameroonian children (Said-Mohamed et al., 
2012) and Nordic adults (Andersen et al., 2009) also suggests that early-life nutritional status 
(both over- and undernutrition) can decrease physical activity in adulthood. Additionally, 
numerous pre-clinical rodent studies show that prenatal and postnatal nutritional status can 
lead to persistent changes in physical activity. In Wistar rats fed either ad libitum or at 30% 
of ad libitum intake, Vickers et al. (Vickers et al., 2003) observed consistently decreased 
locomotor behavior at 35, 145, and 420 days of age despite the presence of a healthy diet 
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during postnatal life. However, findings from Vickers et al. are severely limited in that 
activity was monitored for only 15 minutes in each animal and no data on body weight or 
body fat were reported. Bellinger et al. (Bellinger et al., 2006) studied the offspring of dams 
fed a low-protein diet during various stages of pregnancy and reported female-specific 
decreases in locomotor activity during adulthood. However, this effect was present in only 
one of four experimental groups studied. Additionally, the Bellinger et al. results are limited 
in that activity measurements were conducted for only 30 or 60 minutes and, surprisingly, 
locomotor activity was not markedly different between the light and dark cycle.  Likewise, in 
female offspring of rat dams fed a lard-rich diet from before pregnancy through lactation 
displayed decreased physical activity at 180 days of age (Khan et al., 2003). Finally, 
significant contributions to understanding how maternal nutritional status influence physical 
activity levels have been made by Waterland and colleagues. Li et al. (Li et al., 2013) 
reported that postnatal overnutrition leads to decreased spontaneous physical activity in adult 
(180 days old) female offspring. Likewise, Baker et al. (Baker et al., 2015) unexpectedly 
observed that female, but not male, offspring of obese-agouti, viable-yellow dams displayed 
decreased spontaneous physical activity leading to adult-onset obesity. 
 Given the similarities of my data in Chapter 3 to previous human and rodent data 
demonstrating decreased physical activity in response to fetal undernutrition, I speculate that 
although the WD-fed dams in Chapter 3 were obese, F1-offspring to WD dams were 
undernourished due to their diet providing low protein. This notion is supported by my 
observation in Chapter 3 that juvenile WD F1 offspring had decreased body weight, as well 
as decreased bone mineral density (data not included), compared to SD offspring. Multiple 
publications have also reported similar reductions in body weight in juvenile offspring from 
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WD, or junk food, fed dams (Bayol et al., 2007; Ferezou-Viala et al., 2007; Ong and 
Muhlhausler, 2011; Rolls and Rowe, 1982). 
A key observation in Chapter 3 was that increased and decreased wheel-running 
observed in F1 WD female offspring associated with greater and lower levels of Drd1 in the 
NAc, respectively. This finding is matched by a publication in which maternal overnutrition, 
which like my results in Chapter 3 also resulted in reduced offspring body weight at juvenile 
ages, reported the up-regulation of DA-related mRNAs at 6 weeks of age, but down-
regulation of DA-related mRNAs at 3 months of age (Ong and Muhlhausler, 2011). Future 
studies addressing the contributions of dopaminergic signaling to physical activity following 
maternal over- or under-nutrition will provide valuable insight into potential mechanisms by 
which maternal overnutrition interacts with genetics to dictate the motivation for physical 
activity. 
Additionally, I noted novel observations among leptin, DA, and voluntary running 
distance. In Chapter 3, a significant negative association between Lepr mRNA expression in 
the VTA and Drd1 mRNA expression in the NAc in adult female offspring, and a significant 
negative association between serum leptin and wheel running distance in female offspring 
from WD dams. Likewise, Lepr mRNA in the VTA was significantly down- and up-
regulated in 6- and 18-week-old F1 female WD offspring, respectively. This observation is 
highly intriguing given that leptin receptor signaling is well characterized in DA neurons, 
primarily in the VTA, and previous reports highlighting leptin as a strong regulator or 
mesolimbic DA circuitry (Domingos et al., 2011; Fulton et al., 2006; Hommel et al., 2006). 
Fernandes et al. (Fernandes et al., 2015) demonstrated that intra-VTA leptin injection 
suppresses the rewarding effects of wheel running in mice via activation of STAT3 signaling 
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in mesolimbic DA neurons. Additionally, the same report found that the loss of STAT3 in 
DA neurons blunts DA overflow and function in the NAc, suggesting that leptin may 
influence the motivational and rewarding effects of wheel running. Equally fascinating are 
findings that maternal hyperleptinemia during pregnancy in mice increases spontaneous 
activity in adult female, but not male, offspring, (Pollock et al., 2015), and the offspring of 
diabetic and obese mothers display characteristic central leptin resistance (Chen et al., 2008; 
Steculorum and Bouret, 2011). Leptin levels inversely correlate with marathon run-time, 
after adjusting for BMI (Bobbert et al., 2012) and running performance (time and speed) in 
mice (Girard et al., 2007), also demonstrating that leptin could be a key regulator of the 
motivational and rewarding effects of running. My take on the above is future studies 
assessing the effect of intra-VTA leptin injection on wheel running in the offspring of SD 
and WD fed dams will further our understanding of how disruptions in mesolimbic leptin 
signaling influence physical activity levels.  
 In Chapter 3, I found minimal evidence for F0 maternal WD/obesity leading to 
transgenerational transmission influencing adiposity, voluntary wheel running, or brain 
mRNA expression. Contrary to my results, previous reports have identified transgenerational 
increases in body size (Dunn and Bale, 2011), insulin resistance (Dunn and Bale, 2009; 
Huypens et al., 2016), and leptin resistance and obesity (Sun et al., 2012) following maternal 
HFD/obesity during pregnancy in rodents. Interestingly, other findings show that changes in 
F1 and F2 offspring in response to maternal HFD may be dependent on maternal obesity. For 
example, White et al. (White et al., 2009) tested the hypothesis that maternal HFD 
consumption, independent from obesity, predisposes offspring to obesity and increased 
metabolic risk factors in adulthood in Long-Evans rats. In their experiment, White et al. fed 
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female dams either a HFD, a low-fat diet (LFD), or a HFD with paired caloric intake to the 
LFD group (PF). Intriguingly, by 18 weeks of age, offspring of obese HFD dams displayed 
increases in body weight, body fat percentage, food intake, serum leptin, and insulin 
resistance compared to offspring from both LFD and PF dams, with no differences reported 
between offspring of non-obese LFD and PF dams (White et al., 2009). Collectively, these 
findings highlight the importance of maternal adiposity for offspring metabolic health; 
however, to my knowledge, similar assessments of brain mRNA and protein levels have not 
been made using similar models to dissect the influence of maternal HFD consumption 
versus maternal obesity on altered brain mRNA expression patterns. 
Although I did not measure body fat percentage in F1 breeders to create SD and WD 
F2-offspring, no differences in body weight, body fat, or serum leptin were present between 
SD and WD F1 female offspring, suggesting that F1 SD and WD breeders did not differ in 
body fat percentage. Given the observations by White et al. (White et al., 2009), I speculate 
that the plausible lack of maternal obesity in F1 breeders led to the lack of differences in 
physical activity and adiposity in F2 SD and WD offspring. The observation that changes in 
physical activity and adiposity were not observed in the F2 generation may have important 
public health ramifications. For example, my data suggest that healthy lifestyle choices (e.g. 
eating a healthy or ‘standard’ diet) may protect an F2 offspring from predispositions to 
metabolic and behavioral ‘dysfunction’ that were inherited in F1 offspring following F0 
obesity. 
Unexpectedly, I did not observe differences in physical activity, dopamine or leptin 
receptor mRNA expression, or adiposity in F2 WD, compared to SD, offspring. However, 
Dat mRNA was decreased in F2 WD offspring, highlighting the ability for genetic 
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information to transmit across multiple generations. However, the lack of voluntary wheel 
running differences in F2 offspring suggests Dat mRNA could have, at most, a minimal role 
in the regulation of voluntary physical activity levels compared to other NAc mRNAs whose 
expression patterns matched changes in voluntary running in both F1 and F2 offspring, such 
as Drd1 mRNA. 
  
The preservation of dendritic density and dopaminergic activity in the nucleus accumbens 
could be paramount to preventing age-related declines in physical activity 
 Understanding the mechanisms causing physical activity to naturally decline 
throughout the life course will be valuable to the development of strategies or therapies to 
reduce human sedentary behavior. In Chapter 4, I performed transcriptomics (RNA-seq) 
analysis of the NAc of wheel running rats at 8 and 14 week of age, ages at which wheel 
running is at its max and have significantly declined by ~60%  from max, respectively. Based 
upon previous findings that the loss of DA in the striatum associates with reduced physical 
activity levels in humans (Sallis, 2000), I hypothesized that dopamine-related mRNAs would 
be down-regulated in the NAc at 14 versus 8 weeks of age, however these results were 
severely limited by the lack of age-matched sedentary control rats, such that the influences of 
age and physical activity level could not be distinguished. Additionally, these RNA-seq 
efforts allowed me to observe other non-DA pathway transcriptomic differences within the 
NAc that existed between the 8 and 14 week-old comparisons in order to generate new 
hypotheses for future experiments using this model. My analysis of transcriptomic 
differences between 8 and 14 week-old running rats led to follow-up mRNA, protein, and 
histological experiments in both wheel running and sedentary rats at 8 and 14 weeks of age. 
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In addition, the Cdk5 inhibitor roscovitine was injected into the NAc to assess its role in 
modulating wheel-running behavior. 
 The above experimental approaches resulted in the following novel observations: 1) 
reductions in mRNAs critical for synaptic plasticity, and decreases in dendritic density in the 
NAc may be central to age-related changes in voluntary running, and 2) inhibition of Cdk5, a 
key regulator of dendritic spine density and DA transmission in the NAc, reduced wheel 
running. 
 In Chapter 4, I found that pathways and networks associated with cAMP/DARPP-32 
signaling, PKA activity, and synaptic transmission were reduced from 14 vs. 8 weeks of age 
in wheel running rats. While the relative contributions of age and physical activity on the 
activity of these pathways could not be determined, follow-up analysis revealing age-
dependent reductions in Cadm4 and Cdk5r2 (p39) mRNA and protein suggest that reductions 
in these pathways change with age. I found similar results for changes in MSN dendritic 
density, in which dendritic spine density was inherently reduced from 8 to 14 weeks of age, 
suggesting my notion that inherent reductions in NAc dendritic density could influence 
reductions in wheel running behavior. Interestingly, my observations were independent of 
changes in dopamine receptor expression, which I speculate may contribute to the differences 
in physical activity levels observed in Chapter 3. Equally interesting was the lack of mRNA 
differences related to glutamate, opioid, or serotonin activity between 8 and 14 weeks of age 
in my dataset. Together with the fact that MSNs (which comprise ~95% of the neurons in the 
ventral striatum) have strong dopaminergic presynaptic connections (Nishi et al., 2011; 
Yager et al., 2015), I speculate that changes in dopaminergic activity may 1) accompany 
reductions in voluntary physical activity, and 2) influence age-related changes in voluntary 
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physical activity. In addition, I noted that injection of the Cdk5 inhibitor roscovitine into the 
NAc reduced wheel running via a mechanism that appears to promote a ‘substitution of 
reward’ by replacing ‘running reward’ with ‘drug reward’ via potential alterations in 
dopamine signaling. 
 Importantly, these results suggest that the preservation of dendritic density and 
processes related to synaptic transmission and dopamine signaling in the NAc may help stave 
off age-related reductions in physical activity. Although paradoxical to some, one potential 
mechanism to increase MSN dendritic density, and thus possibly physical activity, appears to 
be physical activity itself (Figure 4.7). While exercise did not prevent age-related reductions 
in dendritic density, physical activity itself drastically increased dendritic spine density. 
Therefore, it is possible that continuous high levels of physical activity may induce 
alterations in dendritic density that in turn influence physical activity levels. However, my 
thoughts on this are purely speculative, and future experiments must be performed to test this 
hypothesis in experimental settings better suited to address this specific question than my 
design in Chapter 4. Interestingly, this hypothesis is supported by the literature. Werme et al. 
(Werme et al., 2002) posit that physical activity-induced increases in ΔFosB, potentially via 
its influence on Cdk5, promote further increased physical activity levels. In addition, 
strategies to maintain dopaminergic tone in the NAc may also help ward off age-related 
declines in physical activity. Reductions in dopaminergic function (e.g. decreased tissue DA 
contention, dopamine receptor expression, Dat expression, etc.) with advancing age (albeit 
most often studied in adulthood and the elderly) are associated with various behavioral 
abnormalities, including reductions in physical activity (Hemby et al., 2003; Ingram, 2000; 
Severson and Finch, 1980; Volkow et al., 1996; Volkow et al., 1998). Given the profound 
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influence of physical inactivity on the development on numerous mental health disorders, it 
is plausible that the mechanisms causing physical activity to decrease may also increase 
behavioral abnormalities (e.g. depression, anxiety, etc). Therefore, I speculate that strategies 
preserving dopaminergic function in the NAc could prevent age-related declines in physical 
activity as well as reduce mental health disorders that develop with advancing age.   
 Decreases in physical activity with aging have been observed in C. elegans  (Herndon 
et al., 2002; Kirkwood and Finch, 2002), flies (Marden et al., 2003), dogs (Siwak et al., 
2003), and humans (Black et al., 1996), suggesting it is a fundamental to many species. 
Equally as important is the age at which voluntary running and its accompanying molecular 
changes initially decrease. It is not surprising that physical activity levels are lessened in old 
age (Hallal et al., 2012), but it is rather surprising that numerous reports suggest that 
voluntary physical activity decreases during adolescent ages in humans (Troiano et al., 2008; 
Trost et al., 2002; Wolff-Hughes et al., 2014), as well as other species such as C. elegans and 
mice (Marck et al., 2016). Further, these findings suggest gene expression alterations during 
the period of adolescence and sexual maturity contribute to reductions in physical activity 
[rats reach sexual maturity at ~7 weeks of age, while humans reach sexual maturity at ~11-12 
years of age (Sengupta, 2013)]. Sex hormones are key components in the regulation of 
various physiological parameters in both males and females, and thus have the potential to at 
least partially regulate physical activity. For example, estrogen (Garey et al., 2001; Park et 
al., 2016) and testosterone, likely through its aromatization to estrogen (McGinnis et al., 
2007), are known to increase voluntary wheel running in rodents. Therefore, it is possible 
that gene expression changes occurring at the onset of sexual maturity have direct, or 
indirect, effects on the control of physical activity, however future experiments must be 
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performed to assess the influence of sexual maturation on wheel running behavior. For 
instance, estrogen can regulate several aspects of dopaminergic functioning, including DA 
release and pre- and post-synaptic receptor expression (Di Paolo, 1994). Given the 
relationship between dopaminergic function and sex hormone function, I postulate that future 
experiments that can alter the age at which sexual maturity occurs may alter the age at which 
voluntary physical activity initially declines. One potential strategy is the use of caloric 
restriction. As early as 1947, it was known that caloric restriction influenced the ages at 
which sexual maturity and senescence were reached (Ball et al., 1947). Caloric restriction 
also enhances evoked DA overflow in the NAc (Diao et al., 1997). Therefore, to test my 
notion that sexual maturity influences wheel-running behavior, future studies should assess 
the ability of early-life caloric restriction to delay both sexual maturity as well the age at 
which voluntary wheel running initially declines.  
 Additional future directions from this work include assessing using transgenic 
animals to access whether the overexpression of genes up-regulated at 8 weeks versus 14 
weeks, and related to synaptic transmission and DA signaling, in the NAc either 1) increases 
wheel running, or 2) prevents age-related declines in wheel running. For example, I speculate 
that overexpression of either Cadm4 or p39, two molecules whose expression at the mRNA 
and protein levels inherently decreased from 8 to 14 weeks of age, whose expression 
correlate with wheel running distance, and whose functions influence DA action, in the NAc 
will both increase wheel running and prevent age-related declines in wheel running. 
Likewise, given the explicit usage of female rats in my study, it will be interesting to 
determine whether similar relationships are present in male rats. 
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Translational significance: linking dopamine signaling to physical activity regulation in 
humans 
 Strong cases have been made suggesting that wheel running in rodents is the best 
parallel to voluntary physical activity in humans (Eikelboom, 1999; Sherwin, 1998). Thus, I 
posit that the innate behavior mechanisms controlling voluntary wheel running in rodents 
provide the best approximate insight into mechanisms controlling physical activity in 
humans. Although the potential mechanisms of action differ between experiments (e.g. 
receptor expression in Chapters 2 and 3, synaptic function of MSN and Cdk5 activity in 
Chapter 4), the three aims of my dissertation suggest that alterations in NAc dopamine 
associate with, or contribute to, alterations in wheel running behavior. 
 It is well established that aerobic exercise increases DA release and metabolism in 
mesolimbic brain nuclei (Waters et al., 2005). In addition, while exercise itself increases DA 
action, these changes to the DA system can be accompanied by positive reinforcement in 
which DA, in turn, independently alters a behavior to seek additional rewarding responses 
(Wise, 2004). However, to my knowledge no studies have addressed the question “do 
differences in DA cause changes in physical activity in humans?” Such a question may be 
difficult to answer because of the next information. Locations of the brain networks 
controlling locomotion (e.g. striatum, nigrostriatal pathways) and reward (e.g. VTA, NAc) 
have multiple integrations via projections to multiple concurrent regions (e.g. ventral 
pallidum). Therefore, it is likely that the neuro-circuits controlling either the locomotor- or 
reward-associated aspects of physical activity do not act independently, and are/may be 
redundant and/or circular. This redundancy is partially highlighted by the common usage of 
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exercise as a treatment for depression, in which stimulating locomotor pathways appears to 
stimulate reward pathways (Dunn et al., 2005). 
 Non-pharmacological approaches may also influence physical activity. With new 
awareness of the health benefits of physical activity, wearable technologies quantifying 
physical activity level (e.g. Fitbit) have gained in popularity. One aspect of Fitbit and other 
accelerometers that I am perplexed by is “what is the biological mechanism by which a piece 
of plastic encourages someone to exercise?” Wearable technologies are becoming 
increasingly used in patients with neuropsychiatric illness to manage and/or reduce 
symptoms associated with numerous disease, and some “wearables” are thought to improve 
disease progression via dopaminergic modulation (Coffey and Coffey, 2016). Video games 
often produce variations in the dopaminergic system associated with reward dependence 
(Han et al., 2007). Thus, tools and devices that allow us to monitor our daily activities allow 
us to “gamify” our daily habits, and may provide ourselves with a “DA buzz” for reaching 
certain goals or milestones (e.g. step counts). To this end, I speculate one neuromolecular 
mechanism by which current strategies that improve physical activity adherence is via 
changes in dopaminergic signaling that associate physical activity with positive reward and 
physical inactivity with negative reward. 
The epidemic levels of physical inactivity present health burdens that challenge those 
of any recognized chronic disease/disorder. Understanding the neuromolecular control 
dictating physical activity levels should help create strategies of therapies to reduce sedentary 
behavior.  Regardless of the method of implementation, the findings from this dissertation 
suggest that inherent [e.g. selective breeding (Chapter 2) or age-related changes (Chapter 4)] 
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or environmentally produced [e.g. maternal WD (Chapter 3)] alterations in gene signatures 
which increase DA action in the NAc may be one vehicle to increase physical activity levels. 
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APPENDIX A: Abstracts from 1st author original research manuscripts 
 
 
Mu opioid receptor modulation in the nucleus accumbens lowers voluntary wheel 
running in rats bred for high running motivation 
 
Ruegsegger GN, Toedebusch RG, Will MJ, Booth FW 
 
Neuropharmacology. 2015; 97: 171-181. 
 
 
The exact role of opioid receptor signaling in mediating voluntary wheel running is 
unclear. To provide additional understanding, female rats selectively bred for motivation of 
low (LVR) versus high voluntary running (HVR) behaviors were used. Aims of this study 
were 1) to identify intrinsic differences in nucleus accumbens (NAc) mRNA expression of 
opioid-related transcripts and 2) to determine if nightly wheel running is differently 
influenced by bilateral NAc injections of either the mu-opioid receptor agonist D-Ala2, 
NMe-Phe4, Glyo5-enkephalin (DAMGO) (0.25, 2.5 μg/side), or its antagonist, naltrexone (5, 
10, 20 μg/side). In Experiment 1, intrinsic expression of Oprm1 and Pdyn mRNAs were 
higher in HVR compared to LVR. Thus, the data imply that line differences in opioidergic 
mRNA in the NAc could partially contribute to differences in wheel running behavior. In 
Experiment 2, a significant decrease in running distance was present in HVR rats treated with 
2.5 μg DAMGO, or with 10 μg and 20 μg naltrexone between hours 0-1 of the dark cycle. 
Neither DAMGO nor naltrexone had a significant effect on running distance in LVR rats. 
Taken together, the data suggest that the high nightly voluntary running distance expressed 
by HVR rats is mediated by increased endogenous mu-opioid receptor signaling in the NAc, 
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that is disturbed by either agonism or antagonism. In summary, our findings on NAc 
opioidergic mRNA expression and mu-opioid receptor modulations suggest HVR rats, 
compared to LVR rats, express higher running levels mediated by an increase in motivation 
driven, in part, by elevated NAc opioidergic signaling. 
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Reduced metabolic disease risk profile by voluntary wheel running accompanying 
juvenile Western diet in rats bred for high and low voluntary exercise 
 
Ruegsegger GN, Toedebusch RG, Braselton FJ, Roberts CK, Will MJ, Booth FW 
 
Physiology & Behavior. 2015; 152: 47-55. 
 
Metabolic disease risk is influenced by genetics and modifiable factors, such as 
physical activity and diet. Beginning at 6 weeks of age, rats selectively bred for high (HVR) 
versus low voluntary running distance (LVR) behaviors were housed in a complex design 
with or without voluntary running wheels being fed either a standard or Western (WD, 42% 
kcal from fat and added sucrose) diet for 8 weeks. Upon intervention completion, percent 
body fat, leptin, insulin, and mediobasal hypothalamic mRNAs related to appetite control 
were assessed. Wheel access led to differences in body weight, food intake, and serum leptin 
and insulin. Intriguingly, percent body fat, leptin, and insulin did not differ between HVR 
and LVR lines in response to the two levels of voluntary running, regardless of diet, after the 
8 wk. experiment despite HVR eating more calories than LVR regardless of diet and 
voluntarily running 5-7 times further in wheels than LVR. In response to WD, we observed 
increases in Cart and Lepr mediobasal hypothalamic mRNA in HVR, but no differences in 
LVR. Npy mRNA was intrinsically greater in LVR than HVR, while wheel access led to 
greater Pomc and Cart mRNA in LVR versus HVR. These data suggest that despite greater 
consumption of WD, HVR animals respond similarly to WD as LVR as a result, in part, of 
their increased wheel running behavior. Furthermore, high physical activity in HVR may 
offset the deleterious effects of a WD on adiposity despite greater energy intake in this group. 
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Rapid alterations in perirenal adipose tissue transcriptomic networks with cessation of 
voluntary running 
 
Ruegsegger GN*, Company JM*, Toedebusch RG, Roberts CK, Roberts MD, Booth FW 
 
PLoS One. 2015; 10: e0145229. 
 
*authors contributed equally to manuscript 
 
In maturing rats, the growth of abdominal fat is attenuated by voluntary wheel 
running. After the cessation of running by wheel locking, a rapid increase in adipose tissue 
growth to a size that is similar to rats that have never run (i.e. catch-up growth) has been 
previously reported by our lab. In contrast, diet-induced increases in adiposity have a slower 
onset with relatively delayed transcriptomic responses. The purpose of the present study was 
to identify molecular pathways associated with the rapid increase in adipose tissue after 
ending 6 wks of voluntary running at the time of puberty. Age-matched, male Wistar rats 
were given access to running wheels from 4 to 10 weeks of age. From the 10th to 11th week 
of age, one group of rats had continued wheel access, while the other group had one week of 
wheel locking. Perirenal adipose tissue was extracted, RNA sequencing was performed, and 
bioinformatics analyses were executed using Ingenuity Pathway Analysis (IPA). IPA was 
chosen to assist in the understanding of complex 'omics data by integrating data into 
networks and pathways. Wheel locked rats gained significantly more fat mass and 
significantly increased body fat percentage between weeks 10-11 despite having decreased 
food intake, as compared to rats with continued wheel access. IPA identified 646 known 
transcripts differentially expressed (p < 0.05) between continued wheel access and wheel 
locking. In wheel locked rats, IPA revealed enrichment of transcripts for the following 
functions: extracellular matrix, macrophage infiltration, immunity, and pro-inflammatory. 
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These findings suggest that increases in visceral adipose tissue that accompanies the 
cessation of pubertal physical activity are associated with the alteration of multiple pathways, 
some of which may potentiate the development of pubertal obesity and obesity-associated 
systemic low-grade inflammation that occurs later in life. 
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Hypothalamic Npy mRNA is correlated with increased wheel running and decreased 
body fat in calorie-restricted rats 
 
Ruegsegger GN, Speichinger KR, Manier JB, Younger KM, Childs TE, Booth FW 
 
Neuroscience Letters. 2016; 618: 83-88. 
 
The neuro-molecular mechanisms that regulate the relationship between physical 
activity level, energy homeostasis regulation, and body fat are unclear. Thus, we aimed to 
investigate the relationship between mRNAs in the hypothalamic arcuate nucleus(ARC) 
related to energy homeostasis, wheel running distance, and body fat in ad lib (AL) and 
calorie-restricted (CR) growing rats. We hypothesized that changes in select mRNAs (Pomc, 
Cart, Agrp, Npy, Lepr, Insr, Mc4r, Ampk, Sirt1, Sirt3) in CR would be associated with 
decreases in body fat percentage and increased wheel running behavior. Male Wistar rats 
were given access to voluntary running wheels at 4 weeks of age and randomized into AL 
(n = 8) and CR (70% of AL; n = 7) groups at 5 weeks of age until study termination at 12 
weeks of age. Body composition, serum leptin, insulin, and adiponectin, and ARC mRNA 
expression in AL and CR rats were assessed and correlated with week-12 running distance to 
examine potential relationships that may exist. By 12 weeks of age, wheel running was 
increased ∼3.3-fold (p = 0.03) while body fat percentage was ∼2-fold lower in CR compared 
to AL (p = 0.001). Compared to AL, ARC Npy mRNA expression was ∼2-fold greater in CR 
(p = 0.02), while Lepr, Insr, Ampk, and Sirt1 mRNA were additionally increased in CR (p 
< 0.05). Significant correlations existed between ARC Npy mRNA levels versus week-12 
wheel running distance (r = 0.81, p = 0.03), body fat (r = −0.93, p < 0.01), and between body 
fat and wheel running (r = −0.83, p = 0.02) in CR, but not in AL. These results reveal 
possible mechanisms by which fat-brain crosstalk may influence physical activity during 
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energy deficit. These data suggest that below a ‘threshold’ fat content, body fat may drive 
activity levels, potentially through hypothalamic Npy action.  
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Left ventricle transcriptomic analysis reveals connective tissue accumulation associates 
with initial age-dependent decline in V̇O2peak from its lifetime apex 
 
Ruegsegger GN, Toedebusch RG, Braselton JF, Childs TE, Booth FW 
 
Physiological Genomics. 2017; 49: 53-66. 
 
Peak oxygen consumption (V̇O2peak) strongly predicts morbidity and mortality better 
than other established risk factors, yet mechanisms associated with its age-associated decline 
are unknown. Our lab has shown that V̇O2peak first begins to decrease at the same age of 19-
20 weeks old in both sedentary and wheel-running, female Wistar rats (Toedebusch et al., 
Physiol Genomics. 48:101-15, 2016). Here, we employed a total systemic approach using 
unsupervised interrogation of mRNA with RNA-sequencing. The purpose of our study was 
to analyze transcriptomic profiles from both sedentary (SED) and wheel-running (RUN) 
conditions as a strategy to identify pathways in the left ventricle that may contribute to the 
initial reductions in V̇O2peak occurring between 19 and 27 weeks of age. Transcriptomic 
comparisons were made within both SED and RUN rats between 19 and 27 wks (n= 5-8). 
Analysis of mRNAs shared in SED and RUN between 19 and 27 wks found 17 up-regulated 
(e.g. Adra1d, Rpl17, Xpo7) and 8 down-regulated (e.g. Cdo1, Ctfg, Sfrp1) mRNAs, at 19 
wks, respectively. Furthermore, bioinformatics analysis of mRNAs common to SED and 
RUN produced networks suggestive of increased connective tissue development at 27 vs. 19 
wks. Additionally, Ctfg mRNA was negatively associated with V̇O2peak in both SED and 
RUN (p< 0.05). In summary, transcriptomic analysis revealed mRNAs and networks 
associated with increased connective tissue development, decreased α-adrenergic activity, 
and decreased protein translation in the left ventricle that could, in part, potentially influence 
the initiation of the lifelong reduction in V̇O2peak, independent of physical activity levels. 
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APPENDIX B: Abstracts from co-authored original research manuscripts 
 
Comparative adaptations in oxidative and glycolytic muscle fibers in a low voluntary 
wheel running rat model performing three levels of physical activity 
 
Hyatt HW, Toedebusch RG, Ruegsegger GN, Mobley CB, Fox CD, McGinnis GR, Quindry 
JC, Booth FW, Roberts MD, Kavazis AM 
 
Physiological Reports. 2015; 3: pii: e12619. 
 
A unique polygenic model of rat physical activity has been recently developed where 
rats were selected for the trait of low voluntary wheel running. We utilized this model to 
identify differences in soleus and plantaris muscles of sedentary low voluntary wheel running 
rats and physically active low voluntary wheel running rats exposed to moderate amounts of 
treadmill training. Three groups of 28-day-old male Wistar rats were used: (1) rats without a 
running wheel (SEDENTARY, n = 7), (2) rats housed with a running wheel (WHEEL, 
n = 7), and (3) rats housed with a running wheel and exercised on the treadmill (5 days/week 
for 20 min/day at 15.0 m/min) (WHEEL + TREADMILL, n = 7). Animals were euthanized 
5 weeks after the start of the experiment and the soleus and plantaris muscles were excised 
and used for analyses. Increases in skeletal muscle gene expression of peroxisome 
proliferator-activated receptor gamma coactivator 1 alpha and fibronectin type III domain-
containing protein 5 in WHEEL + TREADMILL group were observed. Also, 
WHEEL + TREADMILL had higher protein levels of superoxide dismutase 2 and decreased 
levels of oxidative damage. Our data demonstrate that the addition of treadmill training 
induces beneficial muscular adaptations compared to animals with wheel access alone. 
Furthermore, our data expand our understanding of differential muscular adaptations in 
response to exercise in mitochondrial, antioxidant, and metabolic markers.  
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AMPK agonist AICAR delays the initial decline in lifetime-apex V̇O2peak, while 
voluntary wheel running fails to delay its initial decline in female rats 
 
Toedebusch RG, Ruegsegger GN, Braselton JF, Heese AJ, Hofheins JC, Childs TE, Thyfault 
JP, Booth FW 
 
Physiological Genomics. 2016; 48: 101-115. 
 
There has never been an outcome measure for human health more important than 
peak oxygen consumption (V̇o2 peak), yet little is known regarding the molecular triggers for 
its lifetime decline with aging. We examined the ability of physical activity or 5 wk of 5-
aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) administration to delay the 
initial aging-induced decline in lifetime-apex V̇o2 peak and potential underlying molecular 
mechanisms. Experiment 1 consisted of female rats with (RUN) and without (NO RUN) 
running wheels, while experiment 2 consisted of female nonrunning rats getting the AMPK 
agonist AICAR (0.5 mg/g/day) subcutaneously for 5 wk beginning at 17 wk of age. All rats 
underwent frequent, weekly or biweekly V̇o2 peak tests beginning at 10 wk of age. In 
experiment 1, lifetime-apex V̇o2 peak occurred at 19 wk of age in both RUN and NO RUN 
and decreased thereafter. V̇o2 peak measured across experiment 1 was ∼25% higher in RUN 
than in NO RUN. In experiment 2, AICAR delayed the chronological age observed in 
experiment 1 by 1 wk, from 19 wk to 20 wk of age. RUN and NO RUN showed different 
skeletal muscle transcriptomic profiles both pre- and postapex. Additionally, growth and 
development pathways are differentially regulated between RUN and NO RUN. Angiomotin 
mRNA was downregulated postapex in RUN and NO RUN. Furthermore, strong significant 
correlations to V̇o2 peak and trends for decreased protein concentration supports 
angiomotin's potential importance in our model. Contrary to our primary hypothesis, wheel 
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running was not sufficient to delay the chronological age of lifetime-apex V̇o2 peak decline, 
whereas AICAR delayed it 1 wk.  
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Effects of intrinsic aerobic capacity and ovariectomy on voluntary wheel running and 
nucleus accumbens dopamine receptor gene expression 
 
Park YM, Kanaley JA, Padilla J, Zidon T, Welly RJ, Will MJ, Britton SL, Koch LG, 
Ruegsegger GN, Booth FW, Thyfault JP, Vieira-Potter VJ. 
 
Physiology & Behavior. 2016; 164: 383-389. 
 
Rats selectively bred for high (HCR) and low (LCR) aerobic capacity show a stark 
divergence in wheel running behavior, which may be associated with the dopamine (DA) 
system in the brain. HCR possess greater motivation for voluntary running along with greater 
brain DA activity compared to LCR. We recently demonstrated that HCR are not immune to 
ovariectomy (OVX)-associated reductions in spontaneous cage (i.e. locomotor) activity. 
Whether HCR and LCR rats differ in their OVX-mediated voluntary wheel running response 
is unknown. 
PURPOSE: To determine whether HCR are protected from OVX-associated reduction in 
voluntary wheel running. 
METHODS: Forty female HCR and LCR rats (age ~27weeks) had either SHM or OVX 
operations, and given access to a running wheel for 11weeks. Weekly wheel running distance 
was monitored throughout the intervention. Nucleus accumbens (NAc) was assessed for 
mRNA expression of DA receptors at sacrifice. 
RESULTS: Compared to LCR, HCR ran greater distance and had greater ratio of 
excitatory/inhibitory DA mRNA expression (both line main effects, P<0.05). Wheel running 
distance was significantly, positively correlated with the ratio of excitatory/inhibitory DA 
mRNA expression across animals. In both lines, OVX reduced wheel running (P<0.05). 
Unexpectedly, although HCR started with significantly greater voluntary wheel running, they 
had greater OVX-induced reduction in wheel running than LCR such that no differences 
168 
 
were found 11 weeks after OVX between HCROVX and LCROVX (interaction, P<0.05). 
This significant reduction in wheel running in HCR was associated with an OVX-mediated 
reduction in the ratio of excitatory/inhibitory DA mRNA expression. 
CONCLUSION: The DA system in the NAc region may play a significant role in motivation 
to run in female rats. Compared to LCR, HCR rats run significantly more, which associates 
with greater ratio of excitatory/inhibitory DA mRNA expression. However, despite greater 
inherent motivation to run and an associated brain DA mRNA expression profile, HCR rats 
are not protected against OVX-induced reduction in wheel running or OVX-mediated 
reduction in the ratio of excitatory/inhibitory DA receptor mRNA expression. OVX-mediated 
reduction in motivated physical activity may be partially explained by a reduced ratio of 
excitatory/inhibitory DA receptor mRNA expression for which intrinsic fitness does not 
confer protection. 
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